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Abstract

Over the past 30 years, encouraged by Ireland’s low rate of corporation tax (currently
12.5 %), and active promotion of FDI by the IDA, foreign owned pharmaceutical plants
have set up and multiplied in the Cork area. To Ireland’s advantages of a low tax rate, an
English speaking population, a pro-business environment and membership of EU, Cork
offered the added attractions of a deepwater port and large natural harbour, good freight
connections, an international airport, an educated workforce and excellent sporting and
leisure facilities for sailing, golf, etc. (Pfizer, Eli Lilly, Novartis, GlaxoSmithKline, Johnson
& Johnson and Sobering Plough have bases in the Cork area)
One strand of the Industrial Development Authority’s strategy for attracting FDI into
Ireland is “To develop clusters of excellence in which a range of companies and R&D
centres cooperate to create a climate of innovation and entrepreneurship.” Following a
Technology Foresight study in 1999, Ireland chose ICT and Biotechnology as platforms
for investment to build a knowledge economy for the 21st century. In furtherance of
this vision. University linked research centres in biosciences and biotechnology are being
funded through PRTLI and other programmes.
Cork has many of the ingredients of a biotechnology cluster: A concentration of phar
maceutical plants, a corps of high quality researchers in UCC, CIT and Teagasc, and a
strong tradition of medical research through UCC’s Faculty of Medicine and the teaching
hospitals. These assets, together with the State’s commitment to develop the biotech
nology sector through sustained research funding, and the attraction of further biotech
players to Ireland, enhance Cork’s status as an emerging biotech hub.
In the literature, firms in a cluster are geographically proximate or concentrated, and
they interact with each other in ways which spur growth through new products, more
effective marketing, and the attracting of further firms to beneht from the positive en-
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vironment provided by the cluster. Cluster firms also interact with the academic and
research community who share the location; and the exchange of knowledge, research
skills, new product concepts and trained staff, provide impetus to cluster activity and
growth.
The thesis compares the concentration of biotechnology firms in Cork, Dublin and Galway,
using industrial production data from CSO. It then presents survey data on interactions
and linkages between the biotech enterprises in each geographic area, and interactions
and spillovers between these enterprises and the local research community. Conclusions
are drawn about the extent of a biotechnology cluster in the Cork area, and the policy
options available, which might serve to accelerate cluster development.
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Chapter 1
Introduction

1.1

Aim of the Study

Interest in regional industrial development has been growing over the last number of years.
One of the concepts developed is the industry cluster concept. Developed by Michael
Porter, cluster theory has become a tool used by policy makers for promoting national,
regional and local competitiveness, innovation and growth. Tanaiste Mary Harney when
speaking about the creation of 180 new jobs in the development of a high-level R&D centre
and the expansion of production facilities at Abbott Vascular Devices Ireland Limited in
Galway stated; “The investment will further enhance the reputation of the west of Ireland
as a world-recognised location for the manufacture and, increasingly, the development of
medical devices, adding to the cluster of world-leading companies in this sector already
located in the Region.” (IDA, 2004a)
In literature it is argued that growth, innovation performance, profitability and pro
ductivity can be higher amongst geographically proximate cluster firms compared with
geographically dispersed firms. “If companies from the same sector co-located in the same
region grow faster than average, then that is suggestive.” (Beaudry and Swann, 2001, p 2)
Today, biotechnology is an international held of business with annual revenues topping
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$40 billion. “The science that was so promising back in the mid-1990s has been trans
formed into a flood of new products: 190 life-saving medicines; foods that are resistant to
disease or require less pesticide; and fuel, plastics, paper and other manufactured goods
made with a lighter environmental footprint” (BIO, 2005, p iii). Biotechnology is cross
disciplinary and embraces a number of different sectors of activity, including Agri-Food,
Bio-Environmental, Bio-Informatics, Healthcare Therapeutics, Healthcare Diagnostics,
Medical Devices, Pharmaceutical Production and Pharmaceutical Services.
Tanaiste Harney stated in her address to the National Agri-Food Biotechnology Confer
ence (2000) that; “There is universal consensus that biotechnology will be a key sector
in this century for world-wide innovation and growth. In Ireland, the Government has
identified biotechnology as a key strategic area for future investment in research^ Re
search in biotechnology is a major and integral element of the €1.95 billion investment
earmarked for Research, Technological Development and Innovation in the National De
velopment Plan over the period 2000-2006. Ireland is seen as being well established in
major components of the biotechnology and life sciences industry (pharmaceuticals, chem
icals, agriculture, fisheries, food and drink, and environment) and these sectors account
for significant employment, exports and revenue” (Harney, 2000).
Firms in biotechnology are beginning to redefine themselves as bio-pharmaceuticals. “This
development path is potentially important for Ireland, given the established critical mass
of multinational pharmaceutical companies. As a result, bio-pharmaceuticals represent a
significant opportunity for Ireland” (Forfas, 2003, p 8).
County Cork has many of the ingredients of a biotechnology centre; A concentration of
pharmaceutical plants, a corps of high quality researchers in UCC, CIT and Teagasc,
and a strong tradition of medical research through UCC’s Faculty of Medicine and the
teaching hospitals. These assets, together with the State’s commitment to develop the
biotechnology sector through sustained research funding, and the attraction of further
^Biotechnology is one of two industries targeted by the Irish government for support to encourage
research and excellence (the other being Information Communication Technology). Support has been
delivered through Science Foundation Ireland, the Biotechnology Directorate of Enterprise Ireland and
other support organisations.
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biotech players to Ireland, enhance Cork’s status as an emerging biotech hub.
Tanaiste Harney, former Minister for Enterprise, Trade & Employment, has mentioned
industrial growth through the cluster concept and the importance of biotechnology as a
key sector in Ireland. There is a close connection between the pharmaceutical sector and
the biotechnology industry. Therefore the thesis assesses the industry cluster concept and
applies it to the Irish biotechnology industry. More precisely this research assesses and
meaisures the potential biotechnology industry cluster in county Cork.
A Cluster^ is defined for the purposes of this project as:
“Clusters are drivers of innovation made up of mutually beneficial localised groupings
of specialised and interconnected organisations and institutions, which both compete and
co-operate. Cluster participants’ production processes overlap and members are therefore
closely linked through the complementary exchange of goods, services or knowledge. ”
This project investigates the biotechnology industry for the following reasons; The biotech
nology industry is a high growth industry currently, on a global scale. Ireland has a highly
skilled knowledgeable workforce. The Irish Government is investing millions of euro in the
development of the biotechnology industry within the regions of Ireland ICSTI (2003a,
P ii)For the purposes of this study Biotechnology^ is defined as follows:
“Biotechnology is the application of biological knowledge to living organisms or parts of or
ganisms, and techniques pertaining to molecular, cellular, and genetic processes to develop
products, processes or services of value to individuals, organisations and society. ”
This includes activity in the following industrial sectors
1. Agri-Food
2. Bio-Environmental
3. Bio-Informatics
detailed aeeount of how tins definition is chosen is j)rovided in Chapter 3 in particnlar section 3.10
■^A more detailed aceonnt of how this definition is chosen is provided in Chapther 2
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4. Healthcare Therapeutics
5. Healthcare Diagnostics
6. Medical Devices
7. Pharmaceutical Production
8. Pharmaceutical Services

It is apparent that in an innovative industry such as biotechnology, it may be beneficial
to have ‘groupings of specialised and interconnected organisations and institutions, who
both compete and co-operate’, as this may increase innovation and drive overall industry
growth ‘through the complementary exchange of goods, services or knowledge’.
Therefore this research seeks to answer the following questions:

1. Is there sufficient concentration of biotechnology actors and output in county Cork
to suggest that there may be a biotechnology cluster in the county?
2. What is the level of interaction and inter-linkage between members of the potential
biotechnology cluster in county Cork?
3. What conclusions or policy recommendations can be made to aid the development
of a biotechnology cluster within county Cork?

To provide answers to these questions this study proceeds as follows; Chapter 2 gives an
outline of the biotechnology industry and its development in Cork.
Chapter 3 provides a history of the industry cluster concept, and explores various cluster
definitions. This literature review leads to the statement of a definition for a cluster which
will be used in this project. (See section 3.10).
Chapter 4 describes the cluster identification techniques used in previous studies, through
an analysis of the requirements and strengths of each technique, the methodology for this
study is determined.
4
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Chapter 5, describes how primary and secondary research for this study was conducted,
in three phases: data collection from the Central Statistics Office, research trip to Boston,
Massachusetts, and data collected on inter-linkages through an online survey.
Chapter 6 contains the project findings, drawn from both ‘Census of Industrial Produc
tion’ data (provided by the Central Statistics Office) and data collected from an online
survey conducted in Cork, Dublin and Galway.
Chapter 7 contains the discussion, conclusion and recommendations arising from the
study.
It is important to note that this project uses its own dehnition of biotechnology, this defi
nition includes the following sectors agri-food, bio-environmental, bio-informatics, health
care therapeutics, healthcare diagnostics, medical devices, pharmaceutical production and
pharmaceutical services. Therefore when the term biotechnology is used it is to be inclu
sive of all the aforementioned areas of activity.

Chapter 2
Biotechnology Nature and
Development

2.1

Introduction

It is widely believed that biotechnology will be one of the most significant technologies of
the early decades of the 21st century. Bill Gates, founder of Microsoft, stated “I’m a big
believer in information technology, .... , but it’s hard to argue that the emerging medical
revolution, spearheaded by the biotechnology industry, is any less important...” (GEN,
1997, p 4).
What Is Biotechnology?
By dividing biotechnology into its constituent parts we get:
bio - the use of biological processes; and
technology - to solve problems or make useful products.
An agricultural engineer first used the term biotechnology in 1919. However, its appli
cations stretch much further back in history to the first brewing of beer. Humans began
growing crops and raising animals 10,000 years ago to provide a stable supply of food and
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clothing. Mankind has used the biological processes of microorganisms for 6,000 years to
make useful food products, such as bread and cheese, and to preserve dairy products.
Why is biotechnology suddenly receiving so much attention?
Forfas (2003) provides some interesting information on the development of biotechnology:
Although plant and animal breeding techniques were refined over time, they remained
confined to cross-breeding between individuals of the same species until the twentieth
century when biotech moved forward rapidly. During the 1950s, 60s and 70s understanding
of biology reached a point where researchers could begin to use the smallest parts of
organisms-their cells and biological molecules-in addition to using whole organisms. These
developments were made through a series of fundamental discoveries, including:
• The structure of DNA (Watson and Crick, 1953)
• The hrst synthetic antibiotic (1960)
• Cracking the genetic code, how DNA works (Nirenburg & Ochoa, 1966)
• Manipulation (cutting and pasting) of genes (Cohen & Boyer, 1973)
• Monoclonal antibodies (Kohler and Milstein, 1975)
These breakthroughs made it possible to “overcome the species barrier and greatly en
larged the scope for the deliberate engineering of desired genetic changes. New techniques
made it possible to introduce, delete, or enhance particular traits by inserting genes from
an organism into another to alter its genetic make-up” (Forfas, 2003, p 17). In 1985
genetically engineered plants were field tested; in 1988 the first patent for a genetically
modified animal, a transgenic mouse, was issued; Dolly, the first cloned sheep, appeared
in 1997 and the human genome was sequenced in 2001. At the same time, legal decisions
promoted commercial interest in these advances by opening the way for patent protection
in new life and near-life creations.
The new sciences - pharmacogenetics (the correlation of the DNA sequence of genes to
a drug response) and pharmacogenomics (the study of the pattern of expression of genes
7
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involved in drug response in a defined environment) will revolutionise the ways in which
drugs are researched, developed, marketed and prescribed. We are moving rapidly towards
an era of personalised medicine (within 10 years) whereby drugs will incorporate bio
recognition technology and will be capable of being tailored to specific patient populations
as well £LS being targeted at specific molecules and disease areas. The largest category of
biotechnology applications is in health and medicine: diagnosing, treating, and in some
cases preventing disease.
With each scientific development, knowledge has been translated into new techniques and
tools. For example, monoclonal antibodies revolutionised the diagnosis of diseases through
the provision of highly specihc antibodies. This new platform technology has given rise
to a large number of diagnostic reagents and technologies, and holds the promise of new
specific treatments for diseases such as cancer. Knowledge of how to manipulate genes
(known as genetic engineering) has allowed development of transgenic plants and animals,
i.e. species born with genes derived from another species or strain of their own species.
Now, the production of antibody-based diagnostics, drugs and of transgenic animals for
research are multi-million dollar industries.
With the knowledge of the components of biological systems at the molecular level now
greatly enhanced by advances in genomics and proteomics, a parallel step is the modelling
of these systems in silico i.e. electronically. Such models offering improved drug discovery
and development will become an essential tool for evaluating hypotheses. The e-R&D
environment will not stop here. It is predicted that the future will see a virtual community
for clinical trials including computer-aided trial design and simulation, electronic data
capture and on-line analysis, reporting and review. This has clear implications for the
process of drug discovery. Biotechnologies are also having an impact on the validation
process through advances in pre-symptomatic diagnostics where outcomes cannot be eaaily
determined through established methodologies.
A more appropriate dehnition of biotechnology that acknowledges these developments is;
“New biotechnology is the use of cellular and biomolecular processes to solve problems or
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make useful products. Biotechnology is a collection of technologies that capitalize on the
attributes of cells, such as their manufacturing capabilities, and put biological molecules,
such as DNA and proteins, to work for us” (BIO, 2005, p 1).

2.2

Biotechnology Industry Facts

The following industry facts are taken from BIO (2005, p 3);
• There are more than 370 biotech drug products and vaccines currently in clinical tri
als targeting more than 200 diseases, including various cancers, Alzheimer’s disease,
heart disease, diabetes, multiple sclerosis, AIDS and arthritis.
• Biotechnology is responsible for hundreds of medical diagnostic tests that keep the
blood supply safe from the AIDS virus and detect other conditions early enough to
be successfully treated.
• Consumers already are enjoying biotechnology foods such as papaya, soybeans and
corn. Hundreds of biopesticides and other agricultural products also are being used
to improve our food supply and to reduce our dependence on conventional chemical
pesticides.
• Environmental biotechnology products make it possible to clean up hazardous waste
more efficiently by harnessing pollution- eating microbes without the use of caustic
chemicals.
• Industrial biotechnology applications have led to cleaner processes that produce less
waste and use less energy and water in such industrial sectors as chemicals, pulp and
paper, textiles, food, energy, and metals and minerals. For example, most laundry
detergents produced in the United States contain biotechnology based enzymes.
• DNA hngerprinting, a biotech process, has dramatically improved criminal investi
gation and forensic medicine, as well as afforded signihcant advances in anthropology
and wildlife management.
9
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Biotechnology Defined

For the purposes of this thesis, the following dehnition of biotechnology will be adopted:
“Biotechnology is the application of biological knowledge to living organisms or parts
of organisms, and techniques pertaining to molecular, cellular, and genetic processes to
develop products, processes or services of value to individuals, organisations and society.”
These products, processes or services include areas such as new medicines and thera
pies, cloning, genetically modified foods, enhanced crops, and also environmental ‘clean’
technologies.
Forfas (2003, p 8) remarked that, “unlike many other industries, the biotechnology in
dustry is defined by the technology it employs and not by the products and services it
produces”.
The definition adopted embraces the full spectrum of biotechnology, to include the fol
lowing actors and fields of activity:

1. Agri-Food: Companies apply biotechnology in a wide range of agri-food appli
cations. These include extraction of specialist products from biological materials,
production of specialist microbial cultures for cheese production and for other medic
inal foods and the production of other specialist biochemical products for food or
feed uses.
2. Bio-Environmental: Companies in this sector provide biotechnology based prod
ucts and / or services related to detection, prevention or clean up of environmental
damage.
3. Bio-Informatics:

The science of Informatics as applied to biological research.

Informatics is the management and analysis of data using advanced computing
techniques. Bio-Informatics is particularly important as an adjunct to genomics
research, because of the large amount of complex data this research generates.

10
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4. Healthcare Therapeutics: Companies that make compounds that are used to
treat specific diseases or medical conditions.
5. Healthcare Diagnostics: Companies that make devices for the measurement of
parameters that are relevant to determining the state of human or animal health
either through diagnosis of a particular disease or its resulting consequences.
6. Medical Devices: An instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article, including a component
part, or accessory which is: “intended for use in the diagnosis of disease or other
conditions, or in the cure, mitigation, treatment, or prevention of disease, in man
or other animals, or intended to affect the structure or any function of the body
of man or other animals, and which does not achieve any of it’s primary intended
purposes through chemical action within or on the body of man or other animals
and which is not dependent upon being metabolized for the achievement of any of
its primary intended purposes.”
7. Pharmaceutical Production: Involvement in fine chemical plants producing bulk
active materials or finished product pharmaceuticals e.g. tablet production.
8. Pharmaceutical Services: This sector includes companies whose expertise is
essentially biotechnical. These companies provide a wide range of biotechnologybased services, usually to other companies in the healthcare area. These include the
contract manufacture of recombinant proteins, and genomic and analytical services.

2.4

Drug Development Process

The research process is complicated, time-consuming, and costly and the end result is
never guaranteed. Literally thousands of chemical compounds must be made and tested
in an effort to find one that can achieve a desirable result.
The Food and Drug Administration estimates that it takes approximately eight-and-a11
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half years to study and test a new drug before it can be approved for the general public.
This estimate includes early laboratory and animal testing, as well as later clinical trials
using human subjects. Figure 2.1 outlines the steps in the drug development process to
get a drug from discovery phase through all the trial stages, and finally onto the market.
The following information is adapted from the American, Centre for Drug Evaluation and
Research (ODER, 1998) and (Jacobs, 2000).
There is no standard route through which drugs are developed. A pharmaceutical com
pany may decide to develop a new drug aimed at a specific disease or medical condition.
Sometimes, scientists choose to pursue an interesting or promising line of research. In
other cases, new findings from university, government, or other laboratories may point
the way for drug companies to follow with their own research.
Discovery and Preclinical Testing

New drug research starts with an understanding of how the body functions, both normally
and abnormally, at its most basic levels. The questions raised by this research help
determine a concept of how a drug might be used to prevent, cure, or treat a disease
or medical condition. This provides the researcher with a target. Sometimes, scientists
hnd the right compound quickly, but usually hundreds or thousands must be screened.
In a series of test tube experiments called assays, compounds are added one at a time
to enzymes, cell cultures, or cellular substances grown in a laboratory. The goal is to
hnd which additions show some effect. This process may require testing hundreds of
compounds since some may not work, but will indicate ways of changing the compound’s
chemical structure to improve its performance. (ODER, 1998, p 5)
Phase 1

Phase 1 includes the initial introduction of an investigational new drug into humans.
These studies are closely monitored and may be conducted in patients, but are usually
conducted in healthy volunteer subjects. These studies are designed to determine the
12
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metabolic and pharmacologic actions of the drug in humans, the side effects associated
with increasing doses, and, if possible, to gain early evidence on effectiveness. During
Phase 1, sufficient information about the drug’s pharmacokinetics and pharmacological
effects should be obtained to permit the design of well-controlled, scientifically valid.
Phase 2 studies.
In Phase 1 studies. Centre for Drug Evaluation and Research (CDER) can impose a
clinical hold (i.e. prohibit the study from proceeding or stop a trial that has started) for
reasons of safety, or because of a sponsor’s failure to accurately disclose the risk of study
to investigators.

Phase 2

Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary
data on the effectiveness of the drug for a particular indication or indications in patients
with the disease or condition. This phase of testing also helps determine the common
short-term side effects and risks associated with the drug. Phase 2 studies are typically
well-controlled, closely monitored, and conducted in a relatively small number of patients,
usually involving several hundred people.
Phase 3

Phase 3 studies are expanded controlled and uncontrolled trials. They are performed after
preliminary evidence suggesting effectiveness of the drug has been obtained in Phase 2,
and are intended to gather the additional information about effectiveness and safety that
is needed to evaluate the overall benefit-risk relationship of the drug. Phase 3 studies
also provide an adequate basis for extrapolating the results to the general population and
transmitting that information in the physician labelling. Phase 3 studies usually include
several hundred to several thousand people. (CDER, 1998, p 8)
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Figure 2.1: Biotechnology Drug Discovery Process (Ernst and Young, 2000)
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Once a drug maker has all its data (completed phase 3), it makes a new drug application
to the FDA. By law, the FDA must approve or disapprove the application in 12 months.
The drug maker presents data to the FDA advisory panel in a detailed, high-stress presen
tation. The panel then makes a recommendation, which the FDA either adopts or rejects.
Disapproval usually means discussions with the FDA over trial design. A company can
decide whether it’s cost effective to run new trials and continue seeking approval. Any
thing can happen here: They can shelve the drug, sell it to another company, or enter
into an alliance with a partner, giving away some part of future revenue in exchange for
cash for further development.
If the drug is approved, it goes to market hoping for profit. The drug company has
likely obtained a patent, which lasts for 20 years from the date of the patent application.
Because the development process takes a long time, the company has fewer years of a
legal monopoly (left on the patent) in which to sell the product (Jacobs, 2000).
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Sales and Marketing

At the sales and marketing stage, drug makers maximize their revenue by manufacturing
and selling the drug themselves, licensing it to others, or a combination of both. Many
smaller biopharmaceutical companies choose alliances with the established, big pharma
ceutical houses, because ultimately those companies have the sales muscle: Huge, expe
rienced worldwide sales and marketing forces that can make a drug successful (Jacobs,
2000).
The established pharmaceutical companies are only too happy to pay the newer companies
for their biotechnological advances. They can spread drug development risks around with
out committing too many internal resources, and they take advantage of biotechnological
advances without building whole new capabilities in househ

Continued Scrutiny
Companies monitor post-approval results, sometimes with specific FDA requirements.
Once the drug is used widely the company learns much about its effectiveness and oper
ation. This may lead to approval of the drug for different indications. Or in the worst
case, problems that surface with wider use of the drug could require the company to pull
it from the market, e.g. In the case of Pfizer’s Viagra, there were reports of heart attacks,
but so far there has been no withdrawal from market, also after-market problems with
Rezulin, led to restrictions on its uses in the U.S. and a withdrawal of the drug in Great
Britain (Jacobs, 2000).
It is important to note, that the biotech is an industry that is highly regulated, and one in
which it takes significant time and investment to get a product from discovery to market.
In the words of Tabarrok (2002) “The average cost of bringing a drug to market is now
approximately 800 million dollars, and for every 5,000 compounds that are tested in the
laboratory it’s estimated that only one will end up as a marketed drug. Pharmaceutical
^This is a point that the researcher witnessed first hand at an SFI/IBIA networking event, where large
pharma and cliemical companies were actively looking to form alliances/joint ventures, or l)ny out start
up firms, who have just successfully completed phase 2 studies

15

CHAF’TEH 2. BIOTECHNOLOGY NyVITJHE AND DEVELOPMENT

firms spend hundreds of millions of dollars on research only because, if they get lucky,
they will invent a blockbuster drug that will earn them billions of dollars in profits. Take
away the prospect of a big payoff at the end of the 12 to 15 years of research that it takes
to bring a new drug to market, and the incentive to develop new drugs is substantially
diminished”.

2.5

Growth of The Biotechnology Industry

“Biotechnology is an enabling technology and advances in biotechnology impact on nu
merous industries such as: pharmaceutical and healthcare, medical devices, diagnostics,
agriculture, food and drink, environment and information technology. The industry con
sists of firms which develop newly discovered knowledge and exploit it commercially. Many
regions which are establishing themselves as biotech clusters, frequently include supplier
and service companies. This collection of industries is referred to as the biotech or life
sciences sector”. (Forfas, 2003, p 8)
Cortright and Mayer (2002, p 8) in an Eissessment of growth in biotech centres in the U.S.,
make reference to the role of various regional authorities in targeting particular sectors
to develop. “The interest in Biotechnology is especially strong among those involved in
promoting economic development. A survey of 77 local and 36 state economic develop
ment agencies reported that 83% listed biotechnology as one of their top two targets for
industrial development” .(Grudkova, 2001, p 8)
“The biotech industry is just 25 years old and already, more than one-quarter of a billion
people worldwide have been helped by this technology” says Carl B. Feldman of Biotech
nology Industry Organisation (BIO) (Facility City, 2004, pi). Biotechnology remains one
of the most research intensive industries in the world. “The industry spent $9.9 billion
in R&D in 1998. Put in other terms, the top five biotech companies spent an average of
$121,400 per employee on R&D (This compares to an average of $31,200 per employee
for the top Pharmaceutical companies)”. (Facility City, 2004, p 1)
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Biotechnology is seen as the next big boom industry and governments are supporting
the industry and developing educational facilities to provide for growth. Many authors
have identihed the cluster concept as being particularly relevant to the biotechnology
industry, and much work has been published and commissioned on biotechnology clusters
(DTI (1999); Sainsbury (1999); ICSTI (2001); Cortright and Mayer (2002); Van den
Berg, Braun, and van Winden (2001); Forfas (2003); Porter (2003a)) The Department
of Trade and Enterprise in England (DTI) have a section of their web-site dedicated to
clusters. (See www.dti.gov.uk) DTI commissioned numerous reports on biotechnology
clusters in the UK, such as Genome Valley (DTI, 1999), and Biotechnology Clusters
(Sainsbury, 1999). “The UK is seen to have the most developed biotech industry in Europe
and are said to have large biotech clusters around Cambridge, Oxford and Southeast
England”.(Facility City, 2004, p 1) These clusters are documented in both the ‘Genome
Valley’ report and ‘Biotechnology Clusters’ report.

2.6

Biotechnology a Key Strategic Area in Ireland

In March 1998, Noel Treacy, T.D., Minister for Science, Technology and Commerce re
quested the Irish Council for Science, Technology and Innovation to develop and undertake
a Technology Foresight exercise in Ireland. One of the recommendations of the Technology
Foresight panel was that Ireland become a centre of excellence in information communica
tions technology (ICT) and biotechnology niches. These areas are widely identified in the
Panel reports as representing the engines of growth in the national and global economy.
“In the context of the development of existing indigenous hrms, the attraction of a new
phase of multinational companies to Ireland and the creation of new technology-based
enterprises, the Irish economy must develop a credible base of knowledge and activities
in these key technologies. A world class research capability in selected niches of these
two enabling technologies is an essential foundation for future growth” (Irish Council for
Science, 1999).
Technology Foresight Ireland suggests that “Ireland will need to invest even further in
17
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its greatest asset, that is, its emerging population of young and well educated people, if
it is to maximise the benehts from knowledge-based industries in the coming decades.”
(ICSTI, 2003b, p 1) ICSTI sees the creation of high quality, rewarding jobs as essential
firstly for fulfilling the expectations of a growing population and secondly to sustain a
vibrant economy.
As mentioned previously, Tanaiste Mary Harney, whilst speaking at the National AgriFood Biotechnology Conference (2000) outlined that biotechnology will be a key sector
in this century for world-wide innovation and growth. “In Ireland, the Government has
identihed biotechnology as a key strategic area for future investment in research. Research
in biotechnology is a major and integral element of the €1.95 billion investment earmarked
for research, technological development and innovation in the National Development Plan
over the period 2000-2006”(Harney, 2000).
BioResearch Ireland (BRI) is Enterprise Ireland’s (El) Programme in Advanced Tech
nology for biotechnology. BRI, in partnership with university technology transfer offices,
manages the commercialisation of technologies arising from university research. BRPs
specihc objective is to create start-up companies based on new technologies. Predicting
the impact of biotechnology on the global economy, BRI cited in Forfas (2000) forecasts
that:

1. By 2010, 50% of all pharmaceutical sales will be biotech derived.
2. By 2010, DNA probes will take 50% of the disease test market.
3. Recombinant vaccines - which currently account for 3% of the market, will account
for 50% of the market in 10 years time.
4. Recombinant agri-bio product sales, currently worth €2.5 billion worldwide, will be
worth €8.1 billion by 2005.
5. Biotechnology related industries will employ up to 3.1 million people worldwide by
2006.
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Given these optimistic forecasts, it is not surprising that the government is seeking to de
velop the industry in Ireland. The formation of Science Foundation Ireland (SFI) (www.sfi.ie),
with “€646 million Irish government funding and dedicated research facilities are all de
signed to raise the research base in Ireland to new heights of internationally recognised
excellence. So far SFI has committed over €320 million to support over 750 world-class
researchers working in the fields underpinning biotechnology and information and com
munications technology”.(IDA, 2004a)
There has also been a national strategy “An integrated partnership approach” involving
the private sector, universities. Science Foundation Ireland, Enterprise Ireland and IDA
Ireland. Within this National Strategy framework. Enterprise Ireland’s Biotechnology
and Life science industry strategy aims to:
1. Maximise the creation of new commercially focused biotechnology companies in Ireland.
2. Nurture the development of early stage biotechnology companies.
3. Market Ireland as a business environment for early stage biotechnology entrepreneurs
with potential to establish themselves in Ireland.
4. Fast track the development of established biotech companies.
5. Promote and support the development of the private sector seed and venture capi
tal environment in Ireland, open to investing in commercially attractive biotechnology
companies.

2.7

Biotechnology in County Cork

Ireland is a key global location for the biopharmaceutical industry. “Thirteen of the top
fifteen pharmaceutical companies in the world have substantial operations in Ireland. 83
foreign companies operate 126 plants employing 17,000 people which export €33 billion
p.a. This represents 36% of total Irish exports and makes Ireland one of the largest
employers in pharmaceuticals in the world. The industry in Ireland is a highly sophisti-
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Gated one, incorporating advanced manufacturing technology, state-of-the-art equipment
and stringent quality control. Expertise in project design, engineering construction and
project management is available with the necessary physical infrastructure to support
new plants. An efficient planning permission process exists in Ireland to enable rapid and
trouble free start-up”.(IDA, 2004b)
Global pharmaceutical companies are attracted to Ireland for a variety of reasons. The
combination of high quality science graduates and generous tax incentives complement
the overall low operating costs. “From the first of January 2003, a corporation tax rate of
12.5% applies to all corporate trading profits. The tax position of companies carrying out
approved activities prior to 31st July 1998 will remain unchanged at 10%”.(IDA, 2004b)
Cork is the most populous county in Ireland outside Dublin, with a population of 447,829
people (Census, 2003, p 13). County Cork is well known for its strong pharmaceutical base.
If BioResearch Ireland’s prediction comes true, that by 2010, 50% of all pharmaceutical
sales will be biotech derived (See section 1), that suggests that Biotech in county Cork in
particular, will become an integral part of these pharmaceutical companies.
Cork City is Ireland’s second largest city and is the commercial capital of the South West
Region. “Cork has a ready supply of skilled people, excellent infrastructure and is accessi
ble through a principal port and expanding international airport. Cork is also recognised
for being a major centre of third level education with University College Cork, Cork In
stitute of Technology and the Tyndall Institute all located in the area. The Metropolitan
Broadband Ring around Cork city, will service all business parks and third level insti
tutions, will provide additional capacity, competitiveness and resilience to the existing
high quality telecom infrastructure. Considerable investment has also been made in the
road infrastructure over the last number of years, resulting in increased ease of movement
throughout the region”.(IDA, 2004c) In addition, from a social perspective, Cork is the
European Capital of Culture for 2005 - (See: www.cork2005.ie)
With essential support coming from the government sector, it is of interest to see if a
biotechnology cluster is present in county Cork, helping it to develop in conjunction with
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public sector support and development.
For this project the definition of biotechnology is chosen to be broad in its application
and include all actors involved in the biotechnology industry. In a CIRCA group report
(InterTradelreland, 2002), biotechnology was very narrowly defined. A total of just 59
companies recognised as biotechnology companies were operating in Ireland. Large phar
maceutical firms who were not considered part of the biotechnology firms in this report,
as their staff skills/expertise or manufacturing processes were not seen as being predomi
nantly based on modern biotechnology. The large pharmaceutical companies and medical
devices companies are included within the biotechnology definition for this study, as many
of these firms see the benefits of the technologies being created and are either beginning
researching or have established research facilities underpinning biotechnology. An ex
ample of this would be Centocor and GlaxoSmithKline opening biotechnology research
centres, joint funded by the IDA as new developments in their Cork plants. Service firms
like Clinical research organisations are also covered in the project definition of biotech as
many of the larger players within the industry, sub-contract the manufacture of different
parts of their production processes out to these firms.
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Chapter 3
Cluster Theory

3.1

Introduction

In order to define clusters a review of the literature and and compilation of the constant
features of these cluster dehnitions needed to be carried out. This is a prerequisite to
detecting whether a cluster exists and analysing how it functions.

The next section

outlines the development of the industry cluster concept. Section 3.3 deals with the
compilation of consistent cluster features. The chapter also examines the cluster concept’s
impact on such factors as location, competition and co-operation.
Chapter 4 deals with the various types of cluster identification techniques that have been
used by academics to try to gain an insight into the clustering concept.

3.2

Origins of the Industry Cluster Concept

Porter was not the first to notice the presence of geographic concentrations. Alfred Mar
shall, writing at the end of the nineteenth century, included a chapter in his ‘Principles
of Economics’ (Marshall, 1890) on ‘The concentration of specialised industries in partic
ular locations’. Marshall’s characterisation of these concentrations of specialised activity.
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Figure 3.1: Marshall’s Triad of External Ecoriornies of Industrial Localisation (Based on
Marshall, 1890)

is portrayed in his model the “Triad of External Economies of Industrial Localisation”
See Figure 3.1 Marshall identified three integral factors; the ready availability of skilled
labour, the growth of supporting ancillary trade and the specialisation of different firms
in different stages and branches of production.
Marshall had little to say about how the process of industrial localisation actually starts,
why it starts in certain places and not others, or exactly what is meant by ‘local’. It
was not until Porter in his text ‘The Competitive Advantage of Nations (1990)’ that
Marshall’s Triad was built upon, leading to Porter’s ‘Competitive Diamond’.
‘Why does a nation achieve international success in a particular industry?’ Porter (1990,
p 78) postulates that the answer lies in four broad attributes of a nation that shape the
environment in which firms compete, which promote or impede the creation of competitive
advantage. See Figure 3.2
The determinants, individually and collectively as part of a system, create the context
in which a nation’s firms are born and compete: the availability of resources and skills
necessary for competitive advantage in an industry; the information that shapes what
opportunities are perceived and the directions in which resources and skills are deployed;
the goals of the owners, managers, and employees that are involved in or carry out com23
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Figure 3.2: Porter’s Competitive Diamond of Local Industrial Clustering (Based on Porter
(1998a))

petition; and most importantly, the pressure on firms to invest and innovate.
Porter sees the ‘diamond’ as a mutually reinforcing system. The effect of one determi
nant is contingent on the state of the others. Advantages through out the ‘diamond’ are
necessary for achieving and sustaining competitive success in the knowledge-intensive in
dustries that form the backbone of advanced economies. Advantage in every determinant
is not a prerequisite for competitive advantage in an industry. The interplay of advantage
in many determinants creates self-reinforcing benefits, which become extremely difficult
for foreign rivals to replicate (Porter, 1998a).
Porter notes two additional variables that can influence the national diamond, that in his
view are necessary to complete the theory: chance and government.
1. Chance events are developments outside the control of firms and usually the nation’s
government, such as “pure inventions, breakthroughs in basic technologies, wars,
external political developments, and major shifts in foreign market demand. They
create discontinuities that can unfreeze or reshape industry structure and provide
the opportunity for one nation’s firms to supplant another’s. They have played an
important role in shifting competitive advantage in many industries” (Porter, 1990,
p73).
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2. The final element to complete the ‘diamond’ is government. Government at all levels
can improve or detract from the national advantage. Government’s role is seen most
clearly by examining how policies influence each of the determinants. Regulation
can alter home demand conditions, investments in education can change factor con
ditions, government purchases can stimulate related and supporting industries, and
policies implemented without consideration of how they influence the entire system
of determinants are ais likely to undermine national advantage as enhance it.
A result of the system of determinants is that a country’s competitive industries are not
spread evenly throughout the economy but are grouped together in what Porter term’s
‘clusters’, which consist of industries related by links of various kinds. Porter believes that
the operation and interaction of the determinants allow us to explore how competitive
industries and industry clusters are born and evolve through a process in which the role
of the individual determinants is constantly fluctuating.
The competitive industries in a nation will not be evenly distributed across the econ
omy, Porter has found this to emerge clearly from the analysis of individual nations.
The systematic nature of the ‘diamond’ promotes the clustering of a nation’s compet
itive industries. A nation’s successful industries are usually linked through ‘vertical’
(buyer/supplier) or ‘horizontal’ (common customers, technology, and channels) relation
ships.
It is Porter’s belief that the reasons for clustering grow directly out of the determinants of
national advantage and are a manifestation of their systematic character. (Porter, 2003b)
One competitive industry helps to create another in a mutually reinforcing process. The
crossover between industries and business helps the transfer of benefits across clusters
and the development of all connected industries. Porter explains that such competitive
industries are often the most sophisticated buyer of the products and services that they
depends on. A competitive industry’s presence in a nation becomes imperative to the
development of competitive advantage in supplier industries. Having a world class buyer
industry at home not only benefits suppliers domestically but also can help pull these
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suppliers abroad into foreign markets, e.g. The Japanese company Toyota, when estab
lished in the American market, helped Araco, a seat supplier from Japan to expand its
operations into the U.S. market (Liker and Choi, 2004). Competitive supplier industries
in a nation also help encourage world-class downstream industries. They provide technol
ogy, stimulate transferable factor creation, and become new entrants. One internationally
competitive industry also creates new related industries, through providing ready access
to transferable skills, through related entry by already established firms, or by stimulating
entry indirectly through spin-offs (Porter, 2000).
Once a cluster forms, the whole group of industries becomes mutually supporting. Ben
efits flow forward, backward, and horizontally. Aggressive rivalry in one industry tends
to spread to others in the cluster, through the exercise of bargaining power, spin-offs and
related diversification by established firms. Entry from other industries within the cluster
spurs upgrading by stimulating diversity in R&D approaches, and providing a means for
introducing new strategies and skills. Information flows freely and innovations diffuse
rapidly through the conduits of suppliers or customers who have contact with multiple
competitors. Interconnections within the cluster often unanticipated lead to the percep
tion of new ways of competing and entirely new opportunities. People and ideas combine
in new ways (Porter, 2000).
Porter views the cluster as becoming a vehicle for maintaining diversity and overcoming
the inward focus, inertia, inflexibility and accommodation among rivals, that slows or
blocks competitive upgrading and new entry. The presence of the cluster helps increase
information flow and the likelihood of new entry from spin-offs, downstream, upstream
and in related industries. The cluster plays the role of creating ‘outsiders from within
the nation that will compete in new ways. Therefore Porter feels that national industries
are thus more able to sustain advantage instead of losing it to other nations who innovate
(Porter, 1998a).
The presence of an entire cluster of industries magnifies and accelerates the process of
factor creation that is present where there is a group of domestic rivals. Firms form
an entire group of interconnected industries, where all invest in specialised but related
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technologies, information, infrastructure, and human resources, and numerous spill-overs
occur. The scale of the entire cluster encourages greater investment and specialisation.
Joint projects by trade associations involving firms from different industrial sectors are
common. Government and university attention is heightened. The pull of size and prestige
in attracting talent to the cluster becomes stronger, leading to an increase in the nation’s
international reputation in the field.
Porter stresses that the cluster of competitive industries becomes more than the sum
of its parts. “A cluster may thus be defined as a system of interconnected firms and
institutions whose value as a whole is greater than the sum of its parts” (Porter, 1998a,
p 213). It has a tendency to expand as one competitive industry meets another. The
directions of expansion depend on the cluster formation processes that are most recognised
culturally within the nation. In Japan clusters tend to widen horizontally as established
companies aggressively enter related industries. In Italy, clusters have a tendency to
deepen vertically, as new companies spin off to serve ever more specialised niches and
enter supplier industries (Porter, 1990).
As clusters develop, resources in the economy flow toward them and away from isolated
industries that cannot deploy the resources as productively. As more industries are ex
posed to international competition in the economy, the more pronounced the movement
towards clustering becomes. “The industry may not be the appropriate unit of analysis be
cause of the externalities across related industries within clusters” (Porter, 2003b, p 562).
National competitive advantage then resides as much at the level of the cluster as it does
in the individual industries.
Martin and Sunley (2003) make the point that, “Porter’s cluster notion is not the only
rediscovery and reinvention of Marshall’s ideas to have taken place in recent years. For
the past two decades or more, economic geographers have devoted considerable effort to
studying local industrial specialisation, spatial economic agglomeration and regional de
velopment, and to identifying the economic, social and institutional processes involved”
(Martin and Sunley, 2003, p 8). Economic geographers have also invented a series of
neologisms to capture and represent the spatial form and nature of local business concen27
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trations, including: ‘industrial districts’, ‘new industrial spaces’, ‘territorial production
complexes’, ‘neo-Marshallian nodes’, ‘regional innovation milieux’, ‘network regions’, and
‘learning regions’. (See, Amin and Thrift (1992); Harrison, Kelley, and Grant (1996);
Markusen (1998); Scott (1998) and Asheim (2000))
Why have economic geographers started using cluster terminology? One possible reason
is that, “from the beginning, Porter has rooted and promoted his cluster concept within
an overarching focus on the determinants of ‘competitiveness ’ (of firms, industries, na
tions, and now locations). This resonates closely with what has become a major issue in
economics and a key objective amongst policy-makers: namely, the importance of compet
itiveness for succeeding in today’s global economy” (Martin and Sunley, 2003, p 8).
Porter’s avowed aim is to inform companies, cities, regions and nations how to compete
on the world stage, and the undoubted lure of his cluster concept is that it sits well with
the current preoccupation with micro-economic supply-side intervention, and especially
with the policy imperatives of raising productivity and innovation.
A second, and related, reason why economic geographers started using cluster terminology,
could be the way in which Porter has conveyed his ideas on clusters. In the view of
Martin and Sunley, “His discussion is framed in terms of the economics of ‘business
strategy’ (a long-standing core theme in his work on competition), and not in terms
of the sorts of more general theoretical debates and concepts - such as ‘post-fordism’,
‘flexible specialisation’, ‘modes of regulation’, and so on - found in economic geography”
(Martin and Sunley, 2003, p 9). Martin and Sunley also support the opinion that the
latter do not translate readily into, practical business and policy strategy. In contrast.
Porter’s explicit goal “is to develop both rigorous and useful frameworks for understanding
competition that effectively bridge the gap between theory and practice” (Porter, 1998a,
p 2). Cluster theory, he argues, is “not only a tool for managers, but also a microeconomic
- based approach to economic development for governments that is closely tied to actual
competition” (Porter, 1998a, p 7).
Martin and Sunley go on to state, “At the same time, in line with this goal, his easy
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‘business- and policy-friendly’ writing style, at once both accessible and common-sense, is
undeniably seductive, and is quite different from the more ‘academic’ discursive approach
that characterises much economic geography writing” (Martin and Sunley, 2003, p 9).
Reinforcing this point Martin and Sunley hold the view that the popularity of Porter’s
cluster concept, compared to economic geographers’ work on similar notions, has more
support and holds interest invested in it. Porter’s reputation, combined with his selfconfident, authoritative and proselytising style, lends his cluster concept an apparent
authenticity and legitimacy that policy-makers have found difficult to resist (Martin and
Sunley, 2003).
A third, and equally important reason for cluster’s positive reception is the very nature
of the ‘cluster concept’ itself. “Porter’s cluster metaphor is highly generic in character,
being deliberately vague and sufficiently indeterminate as to admit a very wide spectrum
of industrial groupings and specialisations (from footwear clusters to wine clusters to
biotechnology clusters), demand-supply linkages, factor conditions, institutional set-ups,
and so on, while at the same time claiming to be based on what are argued to be funda
mental processes of business strategy, industrial organisation and economic interaction”
(Martin and Sunley, 2003, p 9). Rather than being a model or theory to be rigorously
tested and evaluated, the cluster idea has instead become accepted largely on faith as
a valid and meaningful ‘way of thinking’ about the national economy, as a template or
procedure with which to shape the economy into distinct industrial-geographic groupings
for the purposes of understanding and promoting competitiveness and innovation.

3.3

Cluster Definitions

Research in the area of industry clusters has been spearheaded by Michael E. Porter who
when studying regional economies noticed the geographic concentrations of industries.
From this he coined the term clusters. Porter suggests defining clusters in the following
way:
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‘‘Clusters are geographic concentrations of interconnected companies and institutions in
a particular field.

Clusters encompass an array of linked industries and other entities

important to competition. They include for example, suppliers of specialised inputs such as
components, machinery, and services, and providers of specialised infrastructure. Clusters
often extend downstream to channels and customers and laterally to manufacturers of
complementary products and to companies in industries related by skills, technologies, or
common inputs. Finally, many clusters include governmental and other institutions - such
as universities, standard-setting agencies, think tanks, vocational training providers, and
trade associations - that provide specialised training, education, information, research and
technical support” (Porter, 1998a, p 78).

However, this has not been wholly accepted as a standard cluster definition by academics,
researchers, policy makers and economic geographers. Table 3.1 provides an overview of
of differing cluster definitions (Martin and Sunley, 2001, p 15).
Study of these shows that two aspects of the cluster concept seem to be present in most
dehnitions. These are:
1. Firms in a cluster must be geographically proximate or concentrated.
2. These co-located firms must be interconnected or inter-linked in some way, which
results in a superior performance, when compared to spatially dispersed non-cluster
firms.
However, the literature affords no precise descriptions of these essential cluster features.
“The notion of geographic proximity is, for example, rather vaguely defined. Definitions
give no hint as to where the spatial boundaries of clusters are. Furthermore, we do
not know of what kind interactions between firms in clusters are and what performance
mecisures they may have an impact on” (Lublinski, 2002, p 25). To have an accurate
measure various critical characteristics need to be recognised.
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3.4

Geographic Proximity

Various authors (See Table 3.1) suggest that geographical proximity enhances the fre
quency of face-to-face contact and value-creating benefits may arise from these interac
tions between firms.
“T cluster is a form of network that occurs within a geographical location, in which the
proximity of firms and institutions ensures certain forms of commonality and increases
the frequency and impact of interactions” (Porter, 1998a, p 226).

Lublinski argues “Thus, Porter implicitly suggests that it is the ‘increased’ frequency of
contacts that defines the nature of proximity. However this does not sufficiently explain
the term” (Lublinski, 2002, p 26). The problem with Porter’s and other cluster definitions
is that they lack clear spatial boundaries. Porter does not provide any precise definition of
spatial boundaries for clusters. On the contrary he generalises the definition to argue that
clusters can be found at any geographical level: “The geographic scope of a cluster can
range from a single city or state to a country or even a group of neighbouring countries”

(Porter, 2000, p 254). This does not allow for ease of measurement or identification of
clusters, and critics have noted the elaisticity of this definition, none more so than Martin
and Sunley.
“The problem is that geographical terminology is used in a quite cavalier manner, depend
ing it seems, as Porter himself admits, on what the aim of the exercise is, or the client or
policy-maker for whom the analysis is intended. The key weakness is that there is nothing
inherent in the concept itself to indicate its spatial range or limits, or whether and in
what ways different clustering processes operate at different geographical scales. We are
not suggesting that the cluster concept should refer to a particular pre-specified geographi
cal size or scale; but to use the term to refer to any spatial scale is stretching the concept
to the limits of credulity, and assumes that ‘clustering processes’ are scale independent”

(Martin and Sunley, 2001, p 16).
Porter suggests identification of a cluster can be arrived at by following these steps.
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(Porter, 1998a, p 200):

1. Identifying the constituent parts of a cluster involves starting with a large firm or
concentration of firms and then looking upstream and downstream in the vertical
chain of firms and institutions.
2. The next step is to look horizontally to identify industries that pass through com
mon channels or that produce complementary products and services. Additional
horizontal chains of industries are identified based on the use of similar specialised
inputs or technologies or with other supply-side linkages.
3. The next step is the isolation of the institutions that provide it with specialised
skills, technology, information, capital, or infrastructure and any collective bodies
covering cluster participants.
4. The hnal step is to seek out government or other regulatory bodies that significantly
influence participants in the cluster.
Through the use of this process, examples such as “The Italian Footwear and Fashion
Cluster” and “The California Wine Cluster”, have been documented (Porter, 1998a, p 200201).
While Porter’s method provides a guideline for the identification of cluster participants,
the issue of defining a spatial scope or proximity is largely forgotten. In fact if one takes
Porter’s earlier statement “The geographic scope of a cluster can range from a single city
or state to a country or even a group of neighbouring countries” (Porter, 2000, p 254),
such clusters could spiral forever as certain companies within the cluster may be exporting
and sharing ideas and therefore have linkages and bonds with foreign firms who in turn
may be sharing ideas with other foreign firms, therefore, pulling more and more members
into the cluster.
When addressing the problem of spatial scope of clusters (Lublinski, 2002, p 11) took
a different approach. “In our study it is the firms themselves that decide which other
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firms and institutions are nearby and which ones are distant.” To achieve this Lublinski’s
team provided respondents with information about their concept of geographic proximity.
Three methods were used to allow respondents to reach their own definition of what was
close and what was far:
1. The notion of geographic proximity had been defined by a maximum radius of two
hours driving time.
2. The researchers explained that geographic proximity allows for regular face-to-face
contacts.
3. In the questionnaire two illustrations were provided which gave an example of geo
graphic proximity.
Enright (1996) attempts to describe the factors that indicate clusters’ geographical bound
aries. Enright maintains that these are identical to the spatial extent of the sources that
generate agglomeration advantages:
“The geographic area over which these features provide advantage to the region’s firms
defines the geographic scope of competitive advantage and the appropriate boundaries of
existing regional clusters. It is the geographic scope of these sources of advantage that will
determine the geographic scope of the regional cluster” (Enright, 1996, p 194).

Enright sees proximity being defined by these “sources of advantage” or that agglomera
tion advantages present within an area define the geographical boundaries of the cluster.
Therefore it would not be sufficient to define clusters through measurements of geographic
proximity alone without also taking into account agglomeration advantages which are
brought about by inter-firm linkages and regular face-to-face contact, which in turn lead
to heightened co-operation and mutual respect and trust.
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3.5

Agglomeration and Inter-Firm Linkages

It is argued that growth, innovation performance, profitability and productivity can be
higher amongst geographically proximate firms compared with geographically dispersed
firms.

“If companies from the same sector co-Iocated in the same region grow faster

than average, then that is suggestive” (Beaudry and Swann, 2001, p 2). “The driving
forces of such cluster growth are called agglomeration advantages. They may generate
and reinforce clusters because geographical proximity may allow frequent face-to-face
contacts at reasonable costs that may prove critical to business success and may not be
compensated by modern communication technologies” (Lublinski, 2002, p 27).
Porter suggests that “Drawing cluster boundaries is often a matter of degree, and in
volves a creative process informed by understanding the most important linkages and
complementarities across industries and institutions to competition. The strength of these
‘spillovers’ and their importance to productivity and innovation determine the ultimate
boundaries” (Porter, 1998a, p 202).
Agglomeration advantages, discussed in literature, can be grouped into three sections,

cls

follows:
1. Marshallian externalities
2. Porter’s market conditions
3. Transportation and Transaction costs

3.5.1

Marshallian externalities

Labour market pooling

Of the three Marshallian externalities labour market pooling is the most often mentioned.
Marshall (1890) and Porter (1998a) are of the opinion that firms in clusters may have
better access to workers and at lower recruiting and training costs. Lublinski (2002, p 29)
attributes this to the fact that firms can tap two sources of skills.
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“Firstly, firms can recruit graduates from local educational institutions that provide the
training that is locally requested. Secondly, a geographical concentration of teehnologieally related firms creates a heal pool of specialised and experieneed skills. If workers are
made redundant in one firm they may be absorbed by other local firms, because business
shocks are not necessarily correlated between firms.” Thus there are distinct advantages
for both firms and workers to participate in functioning clusters. Other benefits for the
firm may inelude decreased labour eosts which may therefore increase profitability. “Work
ing against a cluster’s advantages in assembling inputs and labour is the possibility that
such concentration will render these resources scaree and bid up their eost” (Porter, 2000,
p 261).
Labour market pooling also lowers search and transaction costs for recruiting and makes
possible more efficient matching of jobs to people (Porter, 1998a).
Privileged access to large local supplier markets
“The cluster represents a spatial form that can be an inherently more efficient or effective
means of assembling inputs - if competitive local suppliers are available” (Porter, 2000,
p 259). Firms in successful clusters benefit from privileged access to large local supplier
markets, in which firms offer a great depth of highly specialised intermediate goods and
services. “Expanding the range of inputs available from specialised suppliers at a single
location has long been observed to be one of the benehts of agglomeration” (Porter, 1998a,
p 215). Nowadays, the greater depth and specialisation of suppliers due to the presence of
clusters is brought about due to opportunities and niches being apparent in the market and
also from the lower risk of entry due to the large presence of customers in the locality. This
point is emphasised by Lublinski, “A greater depth and width of the local supplier base
may positively influence the firms profitability, as the local division of labour gets more
efficient. It may enable firms to ‘breathe’. They can then buy-in and out-source activities
locally thereby complying with complex and fast changing customer demands” (Lublinski,
2002, p 30). Firms in this situation should also be able to purchase intermediate goods at
a lower cost, if firms entering the cluster price more aggressively, which may drive down
market price. “As they do so, they may realise efficiencies due to economies of scale and
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b} sliding down the learning curve” (Lublinski, 2003, p 455). Access to inputs from within
a -duster may be more effective and efficient than alternatives such as vertical integration,
wliich can consume management time that may be spent better elsewhere. “Obtaining
iuDuts from nearby vendors with whom a firm has close and special relations offers cost
ar.d quality advantages. Proximity of vendors allows efficient quasi-vertical integration
while preserving strong incentives” (Porter, 1998a, p 215).
Knowledge spillovers

“Privileged access to tacit knowledge in geographic proximity through means of both
formal transmittal-processes as well as such informal channels as knowledge leakages are
made possible by casual inter-firm interactions, workers changing jobs, etc” (Lublinski,
2032, p 28). Further knowledge may be gained from public sources, such as patent infor
mation, industry publications or by reverse engineering and possibly even via espionage.
Saxenian (1994) sees informal meetings as a key to these knowledge spillovers and tacit
knowledge transfer, “By all accounts, these informal conversations were pervasive and
served as an important source of up-to-date information about competitors, customers,
markets and technologies. Entrepreneurs came to see social relationships and even gossip
as a crucial aspect of their business. In an industry informal communications was often
of more value than most conventional but less timely forums such as industry journals”
(Saxenian, 1994, p 33).
Irr.portant knowledge that is needed by firms for innovation and progress may be tacitlyheld as opposed to codified knowledge. Tacit knowledge has a higher degree or uncer
tainty and the precise meaning is more interpretative and is less easily conveyed through
a standard medium “When knowledge is more tacit in nature, face-to-face interaction
and communication are important and geographic proximity may promote commercial
activity” (Feldman, 2000, p 386). It is also argued that “in order to extract tacitly-held
knowledge from such routines people with overlapping knowledge need to get continuous
innovative processes underway, thus forcing tacitly-held knowledge to go through mo
ments in which such knowledge is articulated and recombined” (Lublinski, 2003, p 455).
For such processes to occur, regular face-to-face contacts within a geographic proximity
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for ease of arrangement are of great advantage. Therefore, access to tacit knowledge can
be a driver of agglomeration.
However, it is unclear how much of an impact tacit knowledge spillovers can have on
competitiveness as is argued by Porter (1990), (1998a) and (2000). Martin and Sunley
are of the opinion that critical success factors of many firms may be low costs of production
and low wages, rather than knowledge externalities (Martin and Sunley, 2003).

3.5.2

Porter’s Market Conditions

Rivalry

Rivalry within a locality can lead to benefits which can be highly motivating and therefore
which may have a positive effect on productivity and the innovative performance of firms.
“Rivalry with locally based competitors has particularly strong incentive effects because of
the ease of constant comparison and because local rivals have similar general circumstances
(for example, labour costs and local market access), so that competition must take place
on other things” (Porter, 1998a, p 219).
If companies can compare performance with each other, then this peer pressure to con
stantly outdo each other can have a very positive effect within the cluster, with cluster
members constantly competing for respect. “Pride and the desire to look good in the local
community motivate firms in their attempts to outdo each other” (Porter, 1998a, p 219).
“Geographical proximity allows for a greater transparency, which may lead to stronger
benchmarking activities in which the rivals’ performance is monitored” (Lublinski, 2002,
P 31).
Clusters also have a facility for the measurement and benchmarking of in-house activities
against local rivals, as they will perform similar functions. Managers can compare internal
costs with other companies within the cluster and can also “lower employee monitoring
costs by comparing employee performance with others within the cluster” (Porter, 1998a,
p 220).
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Clusters have the advantage of limiting opportunistic behaviour e.g. when one cluster
participant takes advantage of another or provides sub-standard products or services.
“Because of repeated interactions, the easy spread of information, the spread of reputa
tion, and the desire to maintain a standing in the local community, cluster participants
usually strive for constructive interactions that will positively affect their long-term in
terests” (Porter, 1998a, p 220).
Sophisticated and Demanding Buyers
“Sophisticated and demanding buyers pressure local firms to meet high standards in terms
of product quality, features, and service” (Porter, 1990, p 89). Firms gain competitive
advantage if domestic buyers are among the most sophisticated buyers of the product.
Such buyers give an assessment of advanced buyers needs and wants.
“Companies that expose themselves to these pressures and that are able to meet these
demands may attain competitive advantage over firms that do not. Thus it is the desire to
fulfil sophisticated local buyers’ requirements that helps suppliers to attract new distant
customers and increase market shares on distant markets” (Lublinski, 2002, p 31). An
example of this would be the dominance of Finland’s Nokia in the mobile phones worldwide
market. This dominance was brought about by the sophisticated demands of their local
customers in their home market. As Finland is sparsely populated, local customers saw
mobile phones as essential for good communication, however they needed these phones
to have great coverage and range, as some customers lived in very isolated areas. Nokia
developed the best of technology to satisfy their home customers’ needs. These customers
therefore gave Nokia their competitive advantage in the mobile phones handsets market,
on the global stage in addition to their home market advantages.
Von Hippel (1988) makes the point that geographic proximity may function as an addi
tional driver to this effect. It may enlarge the window to the market allowing for better
access to customer information.
Complementarities
Another agglomerative force that may be operating in clusters is the way cluster par39
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ticipants may complement each other in the activities they perform. Porter believes the
most obvious form of complementarities is amongst products. Porter gives an example
of the tourism industry. The quality of the visitor’s experience depends not only on the
appeal of the primary attraction (e.g. beaches or historical sites) but also on the comfort
and service ability of area hotels, restaurants, souvenir outlets, airport, and other trans
portation facilities (Porter, 2000). As this example illustrates, the parts of the cluster are
often mutually dependent: bad performance by one part of the cluster can undermine the
success other parts.
“Coordination and internal pressures for improvement along parts of a cluster, made pos
sible by co-location, can substantially improve its overall quality or efficiency. Co-location
makes it easier to access inputs, achieve technological linkages and accomplish ongoing
coordination. As with access to inputs, achieving these and other complementarities inter
nally within a cluster offers advantages over having to resort to formal alliances” (Porter,
1998a, p 217). Marketing is another form of complementarity at work within clusters.
The presence of a group of similar firms and industries within a particular location, can
provide advantages growing out of their relationships, trade fairs, firm referrals etc. The
particular location’s reputation can be enhanced by the profile of the companies also, and
people may begin to associate the area with quality in whatever industry operates there.
The Swiss for example have a reputation for production of fine watches and chocolate.
“The presence of a cluster can also enhance buying efficiency. Visiting buyers can see
numerous firms in a single trip. The presence in a location of multiple sources for a
product or service can also reduce perceived buying risk by offering buyers the potential
to multi-source or switch vendors if the need arises” (Porter, 1998a, p 218).
Porter also suggests clusters enable better alignment of activities amongst cluster par
ticipants: Clusters include participants from all levels of the economy, from government
departments to retailers. Alignment of policy and industry standards are more easily
achievable if the cluster works together as the companies are located in the same area.
Additionally all levels of the industry present recognise what needs to be achieved at
each level, to improve policy or classifications in the industry or cluster. Porter gives the
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example of the wood products cluster in Portugal (Porter, 1998a, p 218).

3.5.3

Transport costs

In the work of Krugman (1991) there is a focus on the role density plays in reducing
transport costs between suppliers and customers. Although Krugman’s interpretation of
density was related to cities, these advantages have also been said to arise in geographic
proximity (Losch (1954); Von Thunen (1966); Weber (1920)).
Lublinski supports this point when he states “Suppliers / buyers may under transportation
cost considerations, beneht from short distances to their buyers / suppliers with respect
to prohtability. This is especially the case for suppliers with just-in-time agreements, in
which the risk of delivery delay is laid upon the supplier” (Lublinski, 2002, p 32). Timely
delivery in these cases can save storage costs and reduce transaction costs.
“Extensive market, technical and other specialised information accumulates within a clus
ter in firms and local institutions. This can be assessed better or at lower cost from within
the cluster thus allowing firms to enhance productivity and get closer to the productivity
frontier” (Porter, 1998a, p 216).
Trust

“For a deep division of labour and co-operation between hrms to be efficient at reasonable
cost, trust is essential” (Schmitz, 1999, p 142). It is fair to say if the clustering concept is to
bear fruit that trust is an essential element. When we look at the linkages between firms,
trust brings with it comfort and is the bedrock of any strong relationship. Lublinski states
“To develop trust, agents need to be able to learn about each others motives, character,
performance and socio-cultural background, in order to be able to evaluate each other’s
reputation capital and overall trust worthiness” (Lublinski, 2002, p 33). Therefore with
frequent interaction on a face-to-face level, which is more easily arranged at a geographic
level, this trust which is so integral to cluster development can be built.
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3.6

Location and Firm Productivity

The role of clusters grows out of a broader set of influences of location on competition and
competitive advantage. Until recently when the question of where to locate was asked,
the decisions made were based on a relatively simplistic view of how companies competed.
Competition in industry was seen as largely static and as resting on cost minimisation in
relatively closed economies, comparative advantages in factors of production e.g. labour
and capital, were decisive, as were the benefits derived from the presence of economies of
scale, e.g. bulk buying, mass production etc.
For Porter this view however fell short of an accurate reflection of real competition, “Com
petition is dynamic and rests on innovation and the search for strategic differences. Three
conditions contribute to rendering factor inputs per se less valuable: the expanded input
supply, as more countries open to the global economy; the greater efficiency of national and
international factor markets; and the diminishing factor intensity of competition. Instead
close linkages with buyers, suppliers, and other institutions contribute importantly not
only to efficiency but to the rate of improvement and innovation” (Porter, 2000, p 256).
Porter goes on to make the point, that while extensive vertical integration e.g. in-house
production of parts, services or training may once have been the norm, a more dynamic
environment can render vertical integration inefficient and inflexible.
Therefore in this broader and more dynamic view of competition. Porter sees “location
affecting competitive advantage through its influence on firm productivity, especially on
productivity growth. While sound political/legal structures and stable macroeconomic
policies create the potential for investment and productivity growth” (Porter, 2000, p 256).
Porter’s view is that productivity will increase only if a nation or location improves its
capabilities at the microeconomic level. The micro-economic foundations of development
can be understood only by examining the way in which productivity increases at the firm,
industry and cluster levels (Porter, 1998a, p 78).
Porter (2000) maintains that the micro-economic foundations of productivity rest on two
interrelated areas; the sophistication of company operations and strategy and the quality
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of the micro-economic business environment. The sophistication e.g. technology and skill,
with which companies compete ultimately decides national productivity. Unless compa
nies become more productive, an economy cannot become more productive. Companies
sophistication and approach to competing determines the prices that their products and
services can command, and the efficiency with which they produce.
Company sophistication in competing in Porters view can be divided into two parts
(Porter, 2000):

1. The most basic is what Porter terms ‘operational effectiveness’, or the extent to
which companies in a location approach international best practice in their modes
of operating, in areas such as production processes, technologies employed, and
management techniques.
2. Company sophistication relates to the ’types of strategies’ companies employ in
competing. Primitive forms of strategy rely on factor (input) costs, while more
advanced forms involve competing based on differentiated products and services
and, ultimately, on unique competitive positioning against rivals.

Yet the sophistication and productivity with which companies compete in any location is
conditioned by the quality of the macro-economic business environment. Porter stresses
the point that firms can not employ advanced logistical techniques, unless a high qual
ity transport infrastructure is available. Firms cannot operate efficiently under onerous
amounts of red tape that requires endless dialogue with government, or under a court
system that fails to resolve disputes fairly and quickly. These factors, amongst others
consume company time, energy and resources, without contributing to value added for
customers.
The effects of some aspects of the business environment, such as the road system, cor
porate tax rates, and the legal system, cut across all industries. These economy wide
areas often represent the constraints to competitiveness in developing economies. In more
advanced economies however, the more decisive aspects of the business environment are
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often cluster specific e.g. the presence of particular types of suppliers, specialised labour
pools, or university departments. Firms located within a cluster are more likely to attain
competitive advantage, both in terms of operational effectiveness and types of strategies.
Location can powerfully shape the trade offs between markets and hierarchies. Clusters
offer obvious advantages in transaction costs. Repeated interactions and informal con
tacts within a cluster result from living and working in a circumscribed geographic area.
These interactions foster trust, communication, and also lower the costs of serving and
maintaining market relationships.
Porter is of the opinion that “The social glue that binds clusters together also facilitates
access to important resources and information. Tapping into the competitively valuable
assets within a cluster requires personal relationships, face-to-face contact, a sense of
common interest, and ‘insider’ status. The mere co-location of companies, suppliers, and
institutions creates the potential for economic value; it does not necessarily ensure its
realization” (Porter, 1998a, p 88).

3.7

Competition and Co-operation

One of the most striking features of industry clusters is the fact that within clusters both
competition and co-operation are said to co-exist, in a healthy arrangement unlike what
is found in cartels. (Porter (1998a); Feser (1998); Simmie and Sennett (2001)) Porter
states “Clusters promote competition and co-operation. Rivals compete intensely to win
and retain customers. Without vigorous competition, a cluster will fail. Yet there is
also co-operation, much of it vertical, involving companies in related industries and local
institutions” (Porter, 1998a, p 79). Porter views the reason behind this co-existence as
due mainly to the fact that competition and co-operation occur on different dimensions
within a cluster and among different players (Porter, 1998b).
Porter (2000, p 255) in a later work supports this co-operation and competition point
“Most cluster participants do not compete directly, but serve different industry segments.
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Yet they do share many common needs and opportunities and encounter many common
constraints and obstacles to productivity. Seeing a group of companies and institutions as
a cluster, highlights opportunities for co-ordination and mutual improvement in areas of
common concern, without threatening or distorting competition or limiting the intensity
of rivalry.”
The cluster can therefore offer a constructive and efficient forum for dialogue among all
cluster members e.g. related companies and their suppliers, government etc.

3.8

Competitiveness and Company Strategy

To explain the link between clusters, competition and company strategy, (Porter, 2000)
deems that clusters influence competition and competitive advantage in three broad ways:
1. Increasing the (static) productivity of constituent firms or industries.
2. Increasing their capacity for innovation and thus productivity growth.
3. Stimulating new business formation that supports innovation and expands the clus
ter.
Static Productivity

Access to specialised inputs and employees, located within a cluster can provide companies
with superior or lower cost access to specialised inputs such as components, machinery,
business services, and personnel, as compared to the alternatives - vertical integration,
formal alliances with outside entities, or ‘importing’ inputs from distant locations. Porter
states “The cluster represents a spatial organisational form that can be an inherently
more efficient or effective means of assembling inputs - if competitive local suppliers are
available” (Porter, 2000, p 259). Working against a cluster’s advantages in assembling
inputs and labour is the possibility that such concentration will render these resources
scarce and increase their cost. Porter counters this point however when he states “Yet
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a firm’s ability to outsource inputs limits any cost penalty relative to other locations.
More importantly, the presence of a cluster not only increeises the demand for specialised
inputs but also increases their supply. Where a cluster exists, the availability of specialised
personnel, services and components and the number of entities creating them usually far
exceeds the levels at other locations: a distinct benefit, despite the greater competition”
(Porter, 2000, p 260).
Clusters provide access to information and knowledge. Extensive market, technical, and
other specialised knowledge both explicit and implicit, accumulates within a cluster in
firms and local institutions. This can be accessed better or at lower cost from within
the cluster, thus allowing firms to enhance productivity. In his cluster concept. Porter
emphasises personal relationships and the fostering of trust, when he makes the point, that
proximity, supply, technological linkages, the existence of repeated personal relationships
and community ties fostering trust, facilitate the information and knowledge flow within
clusters. Clusters contain information about current buyer needs, sophisticated buyers
are often parts of clusters, and other cluster participants often gain and share knowledge
about their needs (Porter, 1998a).
Static Productivity is also relevant to complementarities, such as arise in marketing and
better alignment of activities amongst cluster participants, etc.
Clusters provide access to institutions and public goods. They make many inputs that
would otherwise be costly into public or quasi public goods. The ability to recruit em
ployees trained in local programs, for example, eliminates or lowers the cost of internal
training. Firms can often access benefits, such as specialised infrastructure or advice
from experts in local institutions at very low cost. Porter supports this view when stating
“public or quasi public goods at cluster locations often result from private investments in
training programs, infrastructure, quality centres, and so on” (Porter, 1998a, p 219). Such
investments frequently take place via trade associations or other collective mechanisms.
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Clusters help to solve or mitigate some problems that arise in more isolated locations
and in vertically integrated hrmsh Clusters improve the incentives within companies for
several reasons. Foremost is competitive pressure. Rivalry with locally based competitors
has particularly strong incentive effects because of the ease of constant comparison and
because local rivals have similar general circumstances (e.g. labour costs and local market
access) so that competition must take place on other things.
Clusters also facilitate measurement of internal performance and benchmarking of activ
ities because, often other local firms perform similar functions. Managers gain wider op
portunities to compare internal costs with arm’s length transactions, and lower employee
monitoring costs by comparing employee performance with others locally. The accumula
tion of cluster knowledge in financial institutions, for example, should make loan decisions
and also other financial choices easier as these institutions are better informed (Porter,
1998a).
Clusters and Innovation
Firms within a cluster are often able to perceive more clearly and rapidly new buyers
needs, and benefit from the concentration of firms with buyer knowledge and relation
ships. Cluster participation also offers advantages in perceiving new technological, oper
ating, or delivering possibilities. Participants learn early and consistently about evolving
technology, component and machinery availability, service and marketing concepts, and
so on, facilitated by on-going relationships with other cluster entities, the ease of site
visits, and frequent face to face contacts.
Porter believes the potential advantages of clusters in perceiving both the need and the
opportunity for innovation are significant. However he believes flexibility can be equally
important as can the capacity clusters have to act rapidly to turn these opportunities
into advantages in operations or strategy. “A firm within a cluster often can more rapidly
source new components, services and machinery, and other elements needed to implement
innovations, whether a new product line, a new process, or a new model. Local suppliers
Hsolated firms may have difficulties in areas like employee incentives and performance measurement,
due to being located away from competitors
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and partners can and do get closely involved in the innovation process, thus ensuring that
the inputs they supply better meet the hrms requirements” (Porter, 2000, p 262).
Reinforcing these advantages for innovation is the sheer pressure and intensity of competi
tion, peer pressure and constant comparison due mainly to the presence of multiple rivals.
These factors force hrms to distinguish their hrm creatively. The pressure to innovate is
therefore elevated. Individual hrms in the cluster have difhculty staying ahead for long,
but many hrms progress faster than do those based at other locations (Porter, 1998a).
Porter also sees the potential drawbacks of cluster participation on innovation, in the
comment, “Under certain circumstances, however, cluster participation can retard inno
vation. When a cluster shares a uniform approach to competing, a sort of groupthink
often reinforces old behaviours, suppresses new ideas, and creates rigidities that prevent
the adoption of improvements” (Porter, 2000, p 262).
Clusters and New Business Formation

Porter, when addressing the issue of new business formation, states “Many new businesses
(i.e. headquarters, not branch offices or ancillary facilities) form within existing clusters
rather than at isolated locations. This occurs for a variety of reasons. First, clusters pro
vide inducement to entry through better information about opportunities. The existence
of a cluster in itself signals an opportunity. Individuals, working in or near clusters more
easily perceive gaps in products, services, or suppliers to hll. Having had this insight,
these individuals more readily leave established firms in order to start new ones aimed at
hlling the perceived gaps” (Porter, 2000, p 263).
Opportunities perceived at cluster locations are pursued there because barriers to entry
are lower than elsewhere. Needed assets, skills, inputs, and staff, often readily available
at the cluster location, can be assembled more easily for a new enterprise. Local hnancial
institutions and investors may also have knowledge of the cluster, and therefore may
require lower risk premiums on capital.
Porter makes reference to the pulling power of clusters, and their ability to attract key
entrepreneurs towards themselves, “While local entrepreneurs are likely entrants to a
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cluster, entrepreneurs based outside a eluster frequently relocate sooner or later, to a
cluster location. The same lower barriers attract them, as does the potential to create
more economic value from their ideas and skills at the cluster location or the ability to
operate more productively. The intense competition within a healthy cluster, together
with lower entry and exit barriers, sometimes leads to high rates of both entry and exit
at these locations. The net result is that many of the surviving firms in the cluster can
gain position vis-a-vis rivals at other locations” (Porter, 2000, p 263).

3.9

Development of Competitive Advantage

It is Porter’s belief that “The existence of clusters suggests that much of a company’s
potential to achieve competitive advantage lies outside the company and even outside the
industry. The presence of a well-developed cluster provides strong benefits to productivity
and to the capacity for innovation that are difhcult for firms based elsewTere to match”
(Porter, 1998a, p 198). Porter holds this opinion due to the fact there is a strong tendency
for competitive firms to be co-located. Often, for any given industry, only a few locations
ill the world provide such an environment. An obvious example is Silicon Valley, seen as
perhaps the largest cluster in the world, analysed by Leadbeater (2000).
Porter points out that clusters affect both the ability of firms to attain operational effec
tiveness and their ability to choose distinctive, rather than imitative, strategic positions.
Both operational effectiveness and strategy can be best understood by breaking down
what firms do into individual activities, or the diserete economic processes firms perform
in competing in any business. Operating within a cluster can multiply opportunities for
distinctive competitive positions. A concentration of visible rivals encourages the search
for ways of competing that are not head on. Niche opportunities overlooked by others can
reveal themselves. Ready access to suppliers and partners provides flexibility to create a
value chain in a variety of ways. A more positive form of competition can result when
customer choice is widened and different customers are served more efficiently (Porter,
2000).
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Martin and Sunley (2003) are quite critical of Porter when they raise two questions to be
considered:
1. To what extent it is possible to construct a universal theory of cluster formation,
dynamics and evolution capable of covering the wide range of cluster types and pro
cesses thought or argued to exist, without degenerating into superficial generalities
of the sort that have surrounded industrial districts?
2. Just how far can the full complexity of economic, social and institutional factors
and processes alleged to underpin cluster formation, development, and success, be
reduced to or subsumed within an overarching concept of ‘competitiveness’ ?
In Porter’s work the notion of “competitiveness’ is used to link a variety of conceptual
scales: the individual firm, the industry, the regional or local business cluster, and the
nation. For Porter (as mentioned previously), firms compete, clusters compete and na
tions compete. Porter speaks of the ‘competitiveness of locations’ (Porter, 1998a). At
the heart of Porter’s ‘theory of competitiveness’ is one of his ideals ‘competitive strategy’.
With regard to his work on competitive strategy Porter suggests that a company must
choose one of the following three generic strategies in order to establish a lead in its mar
ket: differentiation (of product or service), cost leadership, and focus strategy (focusing
activities on the needs of specific segments of the market). “The role of clusters in this
theory is that through concentrating the interaction between the elements of the ‘com
petitive diamond’ they enhance all three aspects of strategy. But while clustering may
well enhance the competitiveness of firms, this is not the same thing as talking about the
competitiveness of clusters or locations’. Locations obviously can not develop competitive
strategies in this sense though many policy-makers seem to believe they should” (Martin
and Sunley, 2003, p 14-15).

3.10

Cluster Definition

From this review of literature, clusters have the following features:
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1. Firms in a cluster must be geographically proximate or concentrated.
2. These co-located hrms must be interconnected or inter-linked in some way, which
results in superior performance, when compared to spatially dispersed non-cluster
hrms. Membership of the cluster creates benehts for every member, which are
synergistic by their nature. The sum of the industry parts is greater value than a
simple addition of each individual company or organisation.
3. Specialised, interconnected organisations and institutions are linked together in this
mutually benehcial grouping through overlaps in the production process.
4. Clusters promote competition, and co-operation. Rivals compete intensely to retain
and win customers; it is this vigorous competition which makes clusters competi
tive. However there is also co-operation, where ideas are shared, mostly vertically,
involving companies in related industries and local institutions.
5. Clusters create innovation. Firms within a cluster are often able to perceive a
clearer picture of buyers needs, and cluster participation encourages innovation to
keep competitive advantage or to gain competitive advantage over rivals.
6. Clusters encourage new business formation. Many new businesses form from within
clusters. Individuals working within or near clusters more easily perceive niches for
products, services or suppliers to hll, and they may leave established hrms to hll
these niches and start their own business.
Taking account of these key factors, clusters have been dehned as follows:
“(Clusters are drivers of innovation made up of mutually benehcial localised groupings of
specialised and interconnected organisations and institutions, which both compete and
co-operate. Cluster participants’ production processes overlap and members are therefore
closely linked through the complementary exchange of goods, services or knowledge.
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3.11

Summary

In this chapter the functioning of clusters has been explored and a cluster definition has
been devised and justified. The next chapter outlines how clusters can be identified and
measured.
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Chapter 4
Cluster Identification Techniques
In the previous chapter it is shown that there is no single agreed upon cluster dehnition.
Through a dissection of various cluster definitions proposed by scholars, two aspects of the
cluster concept are seen to be constant. These are, geographic proximity and inter-firm
linkages within this geographic proximity. Therefore firms in clusters must be geographi
cally concentrated and they must be interconnected in some way, such that agglomeration
forces may result in a superior performance compared to spatially dispersed non-cluster
firms.
The objective of chapter 4 is to describe tools that have been used to assess both ge
ographic proximity and inter-firm linkages. The chapter is in two sections, section 4.1
investigates spatial concentration quotients used to analyse the degree to which firms in
the same sector are spatially proximate. Section 4.2 reviews techniques to assess inter-firm
linkages and face-to-face contact and their role in the cluster concept.

4.1

Defining Geographic Proximity

In regard to the geographical boundaries of clusters, empirical studies have regarded the
spatial scope of clusters as identical to the boundaries of political regions e.g. Saxenian
(1994); Baptista and Swann (1999); Feldman and Audretch (1999); Sivitandiou (1999)
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and Beaudry and Swann (2001). These studies have used industry-level data taken from
official sources to measure cluster size and intensity.
By contrast Lublinski’s approach defines the geographical boundaries of clusters endoge
nously: “the geographic scope of agglomeration advantages, which determines the geo
graphical boundaries of a cluster, does not necessarily match the spatial boundaries of
political regions. It is the surveyed firms themselves, that - having a maximum radius
of two hours driving time in mind - systematically decide which other businesses and
institutions are nearby, and thus within the potential cluster, and which ones are distant.
This allows us to investigate the relevance of proximate in contrast to distant inter-firm
linkages” (Lublinski, 2002, p 69).
Lublinski (2002) states that cluster actors need to be within a reasonable distance of
each other to allow regular and spontaneous face-to-face contacts (See figure 4.2). Porter
(2003a) on the other hand takes a more ad hoc approach to geographic boundaries, while
also concerning himself with the ‘frequency and impact of interactions’. “A cluster is a
form of network that occurs within a geographical location, in which the proximity of
hrms and institutions ensures certain forms of commonality and increases the frequency
and impact of interactions” (Porter, 1998a, p 226). Porter’s ‘Multiple Geographic Levels’
at which clusters can be identified can be seen in figure 4.1.
Lublinski’s approach differs from previous studies, in that it focuses on a specific cluster.
It forms a control group of spatially dispersed firms, in order to compare with the potential
cluster firms. Thus, Lublinski identified enterprises that with all probability belong to a
specific cluster, as well as a group of spatially dispersed firms that are similar with respect
to key characteristics. By doing so, Lublinski attempted to achieve a quasi-experimental
status (Lublinski, 2002).
Given the importance of face-to-face contacts for cluster activity, Lublinski’s questionnaire
gave respondents a diagram to help them identify potential cluster actors within a two hour
driving distance. Competitors, customers, educational institutions, suppliers and research
institutions which were within a two hour driving distance are designated geographically
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Figure 4.1: Multiple Geographic Levels, See Porter (2003a, p 6)
Multiple Geographic Cluster Levels
World Economy
Groups of Neighbouring Nations
e.g. NAFTA

Nations
States, Provinces
e.g. Massachusetts

Metropolitan Areas
e.g. Greater Boston

Smaller Cities and Counties
e.g. Berkshire Region

proximate. Those outside a two hour driving distance are designated as distant. These
distinctions are of critical importance in comparing the extent of cluster flows, as between
proximate actors and distant actors. Lublinski’s respondent hrms were shown a diagram
outlining different categories of hrms and institutions (See hgure 4.2), and were invited to
designate those which he within a two hour driving distance, and those which are more
distant.
Beginning in the next section, three methods: a location quotient, the Hirschman-Iierhndahl
index and an agglomeration index, are outlined in order to assess their value as tools for
measurement of industry concentration within a region.

4.1.1

A Location Quotient

The location quotient technique is the most commonly used economic base analysis
method. The technique compares the regional economy to a reference economy, in the
process attempting to identify specialisations in the regional economy.
The location quotient technique is based upon a ratio between the level of activity in
a local economy and the economy of some reference unit. The ratio, called an industry
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Figure 4.2: Categories of proximate firms and institutions (Lublinski, 2002)
Firms have access to both spatially proximate as well as distant firms and
institutions - geographic proximits’ (max. 2 hours diising rime) may enhance
regular and spontaneous face-to-face contacts

geographic
distance /^O
coraperitors

c. 2 houi'v diivins tune

‘location quotient’ gives this technique its name. The location quotient approach estimates
the relative local importance of employment in each industry by relating an industry’s
regional employment share to its national employment share. (Klosterman, 1990)
Location quotients are calculated for all industries to determine whether or not the re
gional economy has a greater share of each industry than expected when compared to a
reference economy. So location quotients measure to what extent an industry is concen
trated in a region.
Location Quotient Calculation

To calculate any location quotient the following formula is applied. In the formula we
are comparing the regional economy to the national economy. Simply stated, the lo
cation quotient method compares the composition of regional employment to national
employment.
ljOC3>tion C^iioti6nt —tre yi
{

)^

tne{yi)
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where; REI = regional employment in a named industry; TRE = total regional em
ployment; NEI = national employment in the named industry; TNE = total national
employment and (Yl) — year 1. A similar formula adapted for output can be used to
measure the concentration of output in a region or county.
Interpreting Calculated Location Quotients
Interpreting the Location Quotient is very simple. Only three general outcomes are pos
sible when calculating location quotients, namely:

1. LQ < 1.0: A LQ that is less than 1 suggests that local employment is less than
what the national pattern would imply for a given industry.
2. LQ = 1.0: A LQ that is equal to one suggests that the local employment is exactly
the same as national pattern for employment in a given industry.
3. LQ > 1.0: When an LQ > 1.0, the analyst concludes that local employment is
greater than expected, and it is therefore assumed that these firms must export
their goods and services to non-local areas.
In order to find out which are the leading regions of a spatially concentrated industry.
Hoover (1936) and Kim (1995) calculate for each locational unit in a given sample, in
dustries’ employment shares with respect to each industry’s total employment m the
aggregated locational unit. Denoting employment of industry k m the locational unit i as
the region’s employment share in the industry is represented by the following term:
[k =

Next, this term needs to be developed in order to control for the size of

regions, as the various locational units in our sample may differ with respect to their size.
Hence, the denominator is normalised with the region’s total manufacturing employment,
(Lublinski, 2002). This results in the following locational quotient proposed by (Kim,
1995)who restated (Hoover, 1936, p 78):

y'l! Ei y k

VilYlkv'i

I

0/
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A major advantage of the location quotient is that all data to deploy this measure are
available from the Central Statistics Office. Also this measure takes account of the relative
importance of the selected industry on a national scale.

4.1.2

Hirschman-Herfindahl Index (HHI)

The Hirschman-Herhndahl index is generally estimated as:
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(4.2)

=

i=\

] =

•

1

industry

= region

n = number of regions
Si

= share of industry j’s employment in region i

Xi =

share of total employment in region i

The spatial Hirschman-Herhndahl index has a value of zero if the regional distribution of
industry j’s employment is identical to the distribution of total employment. Index values
greater than zero are interpreted to indicate a spatial concentration of industry activity.
The spatial Hirschman-Herhndahl index has two inherent limitations for detecting and
measuring the spatial concentration of manufacturing establishments. First, the index
does not distinguish between random and non-random distributions of establishments.
Second, the index is sensitive to the number of establishments in an industry, if establish
ment numbers are less than the number of regions. That is an industry with a relatively
small number of establishments may have a relatively high index value since

= 0 for

many regions simply because the number of regions exceeds the number of establish
ments. Thus a small number of establishments will inhate an industry’s index value,
making comparisons across industries problematic (Barkley, Kim, and Henry, 2001, p 6).
58

CHAPTER 4.

CLUSTER IDENTIFICATION TECHNIQUES

For example, assume the nation is divided into 10 equal size regions {xt = 10), and
assume an industry with only three establishments. The spatial Hirschman-Herhndahl
index has a minimum value of 0.233, a maximum value of 0.900, and a mean value of
0.354. Alternatively for 10 equal sized regions and an industry with four establishments,
the index has a minimum value of 0.150, a maximum value of 0.900 and a mean value of
0.286. Thus the index provides a higher mean value for the three establishment industry
than for the four establishment industry.
Due to the sensitivity of the spatial HH index and the data requirements of the index,
the researcher believes that the location quotient is more suitable as a measure of con
centration for this project.

4.1.3

An Agglomeration Index

An alternative index is proposed by Ellison and Glaeser (1997).

They first dehne a

measure of raw geographic concentration

= Vi/Y^iVi represents location i's share of employment in industry k,
and

Xi

=

Vi/^i Yli Vi is location i’s share in overall manufacturing employment.

Thus G%q is based on a comparison between the fraction of the industry’s employment
in the region and the fraction of overall manufacturing employment.
To control for industrial concentration Ellison and Glaeser (1997) calculate a standard
Herhndahl index for industry k,

where

is the share of plant j in total

industry k output.
From these two components, G%q and

they build the following index of the degree

to which an industry is geographically concentrated:

Yeg = G^eg -

^V(l -
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The scale of the index is essentially defined by a no-agglomeration benchmark. Ellison
and Glaeser show that the expected value of this concentration index is zero if plants are
located randomly. In contrast, an industry is considered localised if the respective index
value is different from zero.
It would be impossible to build an agglomeration index from the data set available to the
project, therefore the location quotient is the most appropriate measure of concentration
available to this study.

4.1.4

Cluster Group and a Control Group

Lublinski believes studying cluster firms may provide information about how effectively
inter-linked these co-located firms are. However, “unless these results are compared to
those of a control group nothing can be said

els

to whether or not the effects measured

are cluster-specific” Lublinski (2002, p 72).
Lublinski’s goal was to identify cluster firms as well as a control group of firms. Us
ing Hoover (1936) and Kim (1995), Lublinski proposed to calculate the location quo
tient, which he termed the relative concentration {RCiand) of aeronautic employment
(aeroempl) for each federal Bundesland (Land). Thus, he identified search areas for po
tential aeronautic clusters. Additionally, “we can identify regions that with all probability
have no aeronautic cluster” (Lublinski, 2002, p 72). Firms in these regions constituted
his “control group”. Lublinski employed published industry data to calculate the relative
concentration:

CLGTOCTTLpl 1,11^1(1 .CLCTOCmplQ^fTrnQjriy

GlTipl [^dnd

CLGT OCTfipl

,

GTT^plLand

7--------- 1-------------- = ------------- 1-----------/------- \----------- =

emplaermany

aeroemplc ermany emplc.ermany

over-representation if RCiand > 1
under-representation if RCiand < 1
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In order to distinguish cluster search areas as well as non-cluster regions, Lublinski pro
ceeded as follows. Bundeslander (Regions) that had an index-value greater than unity
are considered over-represented concerning the region’s aeronautic employment share in
relation to the aeronautic employment share of Germany as a whole.(Lublinski, 2002)
This led Lublinski to the assumption that aeronautic clusters may be found in these
regions. Federal bundeslander (Regions) with an index value of below one were therefore
regarded as under-represented. Aeronautic clusters were not believed to be found in these
regions. Therefore, firms in these regions were taken as the control group.(Lublinski,
2002)
Once a cluster search area and control group regions had been determined, Lublinski
merged various lists of hrms that have an aeronautic affinity. Lublinski defined these as
“hrms that are either officially assigned to the aeronautical sector or linked to aeronautic
hrms by hows that, in principle, can generate agglomeration advantages, such as inputoutput hows, knowledge hows etc” (Lublinski, 2002, p 74).
Lublinski made a list of 376 potential aeronautic cluster hrms in Northern Germany
(cluster group) and 138 hrms in the Eastern and Western German Lander (control group,
that with all probability do not operate within an aeronautic cluster).

4.1.5

Measurement of Geographic Proximity

From the above analysis, the method chosen to measure geographic proximity in this study
is the location quotient. The method is selected as it highlights regions that contain
an excess of biotechnology employment concentration when compared to the national
industry. Also data required to assemble this quotient is available from CSO.
For the purposes of this study it was decided to dehne the boundaries of potential cluster
regions as identical to the boundaries of political regions following the approach used in
empirical studies such as Saxenian (1994); Baptista and Swann (1999); Feldman and Audretch (1999); Sivitandiou (1999) and Beaudry and Swann (2001). As data for industrial

61

CHAP'rER. 4. CLUSTER IDENTIFICATION TECHNIQUES

output and employment is published for individual counties by CSO, county boundaries
were deemed appropriate to define areas in which to look for evidence of a biotech cluster.
Instead of using a cluster and a control group of hrms, in this study it was decided that two
other centres, counties Galway and Dublin, would be analysed along with data for county
Cork for comparative purposes. The reasons that Galway and Dublin were included in
the study are:

1. In a previous Irish study on the biotechnology industry (InterTradelreland, 2002),
“Mapping the Bio-Island”, four cities^ show concentrations of companies involved
in biotech (See hgure 4.3). Therefore it was decided to assess counties Galway and
Dublin, where potential clusters may exist and compare hndings with results for
county Cork.
2. Much reference is made regarding the Medical devices cluster in the West of Ireland
(County Galway), in the IDA Ireland website www.ida.ie (See press releases 12 Nov
2002 & 29 June 2004).
3. The Irish Bioindustry Association (IBIA) is now the leading representative body
for the Irish biotechnology sector, representing nearly 40 members. Over 60% of
IBIA’s members are based in Dublin, therefore it is proper to include county Dublin
for comparative purposes.
4. The phenomenon that biotechnology companies tend to develop around sources of
high technology such as universities, institutions, hospitals etc is well established
(InterTradelreland, 2002), Cork, Dublin and Galway are all university cities which
host institutes of technology and quality hospitals.

CSO produces ‘The Census of Industrial Production’ (CIP) annually. Data from CIP are
used to calculate the location quotients to assess concentration and geographic proximity.
Mhe four cities indicating concentration in the “Mapping the Bio-Island” study, were Belfast, Cork,
Dublin and Galway. Belfast is excluded as it is part of Northern Ireland and C'SO only produce data for
the Republic of Ireland in the ‘Census of Industrial Production’.
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Each manufacturing company employing more than three staff members fills out the
Census of Industrial Production, which requests, inter alia, details regarding employment,
turnover, inputs and outputs. Companies are assigned NACE^ codes. NACE codes are
two to four digit industrial code which relate to a specific industrial sector. Companies
are assigned these NACE codes with regard to their principal product. The methodology
for building up location quotients based on NACE codes is described in section 5.2.
The following location quotient is used in this study:

RCRegion

BiocTTipljiqqIqji . Biocinpl[j-qIqjki
Bzo&TnplfiQgiQji , EuiplfiggiQji
Empln,egion
EinplBiocTTipljygid-fid Euipl[j-Qidjid

(4.5)

RCRegion = Relative Concentration in the Region
Bioemplfiegion = Biotochnology Employment in the Region
• Einpl Region

Total Manufacturing Employment in the Region

BioemplIreland = Biotochnology Employment in Ireland
EmplIreland — Total Manufacturing Employment in Ireland

over-representation if {RCregion) > 1
under-representation if (RCregion) < 1
The location quotient will be assessed for both employment data and net output data, for
the regions selected in the study^. Once concentration within the regions to be studied
is measured, there is a need to identify inter-linkages within the regions that contain a
concentration of biotechnology employment or net output. The next section deals with
the issue of searching for inter-linkages within regions.
One limitation of measurement of concentration through figures derived from the ‘Cen
sus of Industrial Production’ (CIP), is that this publication only takes into account the
^See section 5.2.1 for a detailed explanation of NACE codes
■^Net Output is entered into the RC location quotient fornnila above in the place of einploynient, when
calculating location quotients for Net Onty)ut
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concentration of biotech actors involved in manufacturing production. The CIP does not
include data pertaining to service firms such as analytical labs, clinical research organ
isations etc or data for university research centres. Whilst concentration data for these
non manufacturing actors is not collected in this section of the study, it is envisaged that
an account of this group’s contribution to the potential cluster will be made within the
assessment of inter-linkages between cluster actors.

4.2

Identification of Inter-Linkages

Previous research efforts to collect cluster-specific firm-level data are descriptive case
studies such as Hall and Markusen (1985); Sivitandiou (1999)'^ and Oakey, Kipling, and
Wildgust (2001). Lublinski in contrast to these descriptive studies employs an econometric
approach to cluster measurement, concentrating on which of the “various types of inter
firm linkages that may generate agglomerative advantages, have in fact an impact on the
innovation performance of firms”.(Lublinski, 2002, p 67)
Lublinski (2002) used a survey to collect data on firms’ innovation counts in addition to
the perceived importance of the various types of spatially proximate inter-firm linkage
flows. Lublinski felt that the firms themselves are best equipped to evaluate the relevance
of such linkage flows.
Section 4.1 documented a number of techniques for detecting to what extent firms from
either the same or differing industries are located in spatial proximity. However, none of
these techniques considered the inter-linkages of clusters, because results do not assess to
what degree co-located firms are indeed inter-linked, such that agglomeration forces are
being provoked and exploited.
'See Appendix A.2 Sivitandiou Southern California Computer Software Case Study
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4.2.1

Input/Output data

Input Output data (I/O) have been used to identify groups of industries that are inter
linked by flows of goods and services. Clusters have been identified by grouping sectors
that are linked by maximal I/O flows, by ‘shaking out’ all weak values from the I/O table,
by applying graph theoretic concepts and by measuring the degree of similarity of sales
and/or procurement profiles between sectors, (Lublinski, 2002). A brief description of
these Input Output cluster identification techniques follows.
Roelandt et al. (1997) joined sectors into clusters on the basis of either relatively strong
forward or backward linkages. Hauknes (1999) attempted to identify clusters of vertically
linked industries such that inter-cluster flows are relatively small compared to intra-cluster
flows. All sectors with linkages found to be robust towards a certain algorithm are con
sidered clusters.
Czamanski (1974), Roepke (1974) as well as Feser and Bergman (2000) presented a tool
for the recognition of industrial groupings that show a high degree of similarity of I/O
transaction profiles, thus focussing on indirect linkages between sectors. Two sectors may
not have any direct transactions. However, they may have transactions with a commonto-both third sector. In that case the two sectors are said to be indirectly linked via the
third sector.
However, these methods of cluster identification have several defects in the opinion of
Lublinski. “First, I/O methods proposed by Roelandt et al. (1997), Hauknes (1999) and
Campbell (1975) are rather arbitrary. They employ cut-off schemes that solely depend
on an individual judgment of the analyst. Thus, two researchers would not necessarily
identify the same cluster when employing such a method. Hence, these studies should not
be used for comparative cluster studies. Second, none of the methods sketched above are
complete and theoretically consistent, in the sense that all essential features of clusters are
captured according to theoretical considerations. Third, none of these studies is operable
in the sense that the results of the cluster identification exercises provide starting points for
public policy. They do not explain which agglomeration externalities are in fact generated
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and exploited within each cluster. Hence, practitioners do not know whether or not there
are market failures, which may indicate a justification for public intervention” (Lublinski,
2002, p 63-64).
Input/Output data may not be the best method to assess inter-firm linkages in the biotech
nology industry, as Input/Output only takes account of the flows of goods and services.
In this project it is planned to take account of a wider variety of inter-linkages includ
ing face-to-face meetings, and personal contact between potential cluster actors. Added
to this is the fact that Input/Output data would be extremely difficult to get for the
biotechnology industry, as biotechnology intersects a number of different industries.

4.2.2

Empirical Literature on Cluster Identification

In the previous section, I/O techniques used in cluster identification are outlined. It has
been seen that these identification methods capture only one of many types of linkages
that may generate agglomeration forces. Moreover, I/O results provide no indication as
to whether or not these linkages in fact give rise to agglomeration forces. Now, it is
appropriate to investigate what other strands of analysis contribute to an understanding
of what the driving forces in clusters are.
While Jaffe (1986), Jaffe (1989), Acs et al.

(1992), and Feldman (1994) have shown

that investments in R&D by private enterprises as well as universities may ‘spill-over’ to
third-party firms; Jaffe, Trajtenberg, and Henderson (1993) provide some evidence that
the extent to which knowledge spills over may be dependent on the spatial distance from
the knowledge sources. The method they apply is that of tracing the ‘paper trails’ of
knowledge diffusion by linking the location of inventors, as indicated by patent data, and
the locations of patent citations. The authors explain that patents contain geographic
information about both the inventor and the technological ancestry of the invention.
Audretsch and Feldman (1996) argue that if geography matters for the extent to which
knowledge diffuses, spatial concentration of innovative activity can be observed. Their
aim was to explain the propensity for U.S. innovative as well as economic activity to
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cluster geographically, by linking geographic concentration to the existence of knowledge
spillovers. The latter were captured by measures of; size of industry R&D expenditures
in relation to sales; university R&D that is relevant to the industry in question as well
as the industry’s employment share of skilled labour. Their findings show that certain
industries’ economic activities tend to cluster in geographic space due to the importance
of skilled labour as well as industry’s R&D. And, even after controlling for the extent to
which industries’ production is spatially concentrated, the knowledge-generating determi
nants were still found to have a significant impact on the propensity for these industries’
innovative activities to cluster in geographic space.
Accounting for the results of Audretsch and Feldman (1996) that have suggested that
knowledge spillovers may have an impact on clustering, draws attention to the work
taking place on different types of externalities. The literature on new growth economics
has distinguished between two types of knowledge externalities.
The hrst type is called MAR externalities the name derived from Marshall (1890); Arrow
(1962) and Romer (1986). Romer (1990) refers to learning of firms from other local firms
in the same industry. Firms may aecumulate knowledge that spills over from other both
geographically as well as technologically proximate firms. Therefore, firms may benefit
from the degree to which a region is specialized in a specific industry and may thus grow
faster.
The second type refers to effects of knowledge spillovers that occur between firms of dif
ferent but complementary industries. These effects are called Jacobs (1969) externalities.
These benefits stem from the variety or diversity of local industries.
The issue of agglomeration forces analysed by empirical researchers in the field of new
growth theory, has provided some insights on the extent to which either aggregate effects
of these forces or, more specifically, knowledge spillovers and local competition deter
mine cluster growth. However less attention has been given to the issue of the relative
importance of each of the specific forces.
All of the studies mentioned in previous sections have used ‘top-down’ approaches, with

68

CHAPTER 4.

CLUSTER IDENTIFICATION TECHNIQUES

their research area spanning many sub-national regions. They aimed at either identifying
various clusters in the national economy or analysing agglomeration forces from a ‘bird’s
eye view’. So far no method has yet been developed to identify a specific cluster.
However, two points identihed in a quantitative case study (Sivitandiou, 1999)^, are as
follov'/s:
1. Primary survey data is essentially required in order to arrive at meaningful answers.
2. The relevance of the sources of agglomeration forces can be quantified with the help
of Likert-scale indicators®.

4.2.3

Survey Approach

The survey approach in this study follows Lublinski (2002). Lublinski decided to select
a sample of potential cluster and control group firms for survey purposes. The firms
were selected from the list of 376 potential aeronautic cluster hrms in Northern Germany
(clister group) and 138 hrms in the Eastern and Western German Lander (control group).
The hrms had to be comparable with respect to key characteristics: in regard to R&Dpeisonnel employed, sales level, percentage share of sales with aeronautic customers, age
of company etc.
All 376 potential cluster hrms and 138 control group hrms were contacted by telephone
and e-mail in order to arrange a telephone interview with each of their general managers.
Ill co-located Northern German aeronautic (supplying) hrms and 68 non aeronautic clus
ter hrms (the control group) were willing to give an interview, which corresponded to a
resoonse rate of 34.8% of potential respondents. These 111 Northern German aeronautic
(supplying) hrms are considered potential cluster hrms due to the fact that the region
in vhich they operate recorded a relative concentration greater than 1 for the aeronautic
industry, and also these hrms signalled their interest in the cluster by participating in
'See Appendix A.2 Sivitandiou Southern California Computer Software Case Stud}'
'Additional information on the use of Likert-scale indicators, is provided in Section 4.2.4
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the survey. Next Lublinski needed to find out, whether these firms were in fact clus
ter firms, i.e.

“if agglomeration advantages are being generated and exploited in the

cluster”(Lublinski, 2002, p 76).
Lublinski interviewed general managers only, as it is his belief that general managers
have a better overview of the various topics addressed than any other firm representative.
Interviews were conducted using a detailed questionnaire by a group of ten under-graduate
economics students following pilot studies. This approach is applied in this study. A
detailed description is given in section 5.7.2.

4.2.4

Measurement of Agglomeration Forces

Lublinski’s attempt to analyse the relative importance of the various types of inter-firm
networks posed the problem of choosing adequate indicators. “We can for instance directly
measure the amount of cars on a street. However, the amount of love, freedom, selfdetermination or, in our case, the amount of knowledge spillovers, labor market pooling
or motivational effects due to rivalry etc. cannot be directly measured” (Lublinski, 2002,
p 76). For this purpose indicators are required to satisfy two criteria.

1. They need to sufficiently reflect the subject of measurement, i.e. the ‘true’ flow
size of each inter-firm linkage type, such as the amount of knowledge spillovers
from the various sources of knowledge e.g. universities, customers, suppliers, and
competitors.
2. The indicators need to enable comparisons between the flow size of the various
linkage-types. Lublinski asked firms “how important on a 6-point scale universities,
customers, suppliers, competitors etc. are as sources of knowledge, ranging from 1
(lowest) to 6 (highest)”(Lublinski, 2002, p 79).

In order to differentiate between proximate and distant linkage flows, Lublinski’s questions
were systematically asked for both inter-firm linkages in proximity (that may, in principle.
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generate agglomeration economies) as well as for linkages to distant firms and institutions
(that, by definition, cannot generate agglomeration advantages). Lublinski’s systematic
approach applied only to those linkages for which latent indicators of the 6-point scale
type were found to be appropriate. For all other linkage types different indicators were
used.(Lublinski, 2002)
In comrELst to Porter’s innovative measure^, Lublinski employed the number of innova
tions as an indicator of innovative performance and output, therefore accounting for both
product and process innovations. This is applicable in this study as it allows comparable
measuiements in the three regions, selected to participate.

4.2.5

Testing of Lublinski’s hypothesis

Lublinski tested the hypothesis that the average perceived importance of inter-firm link
ages in geographic proximity is different from that of linkages to distant firms. The null
hypothesis is that the average perceived importance of linkages in geographical proximity
(Fprox) is identical to that of geographic distance

H.C\ . 'Yrtrn'r
prox

Y’dist

{Ydist)'-

III • Ypj-Qx

d

Ydist 7^ 0

(4.6)

Lublinski assumes that firms in the aeronautic cluster will regard their geographically
proximate linkages as more important than linkages to distant agents. Hence, the average
valuation of geographic proximity® is assumed to be larger and significantly different from
the valuation of geographic distance among the aeronautic cluster firms. “Results will
provide some evidence that agglomeration forces may be operating if the null hypothesis
can be rejected and the difference between the valuation of proximity and distance is
positive. If results suggest that proximity matters for at least some types of interfirm
linkages that may generate agglomeration advantages, we will have an indication that
' Porter uses number of patents as a measure of innovation
^Respondents average valuation of the benefits of having competitors, customers, educational institu
tions, sui^pliers and research institutions within a two hour driving distance
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agglomeration forces may be operating” (Lublinski, 2002, p 81).
Lublinski’s results suggest that geographical proximity is relevant and statistically signihcant for only a few types of linkages “that may lead to the following effects: labour market
pooling, knowledge spillovers. Porter like motivational effects that stem from customers
pressure as well as trust based effects. These results suggest that these firms constitute a
potential cluster, as proximity matters for at least these types of cluster specihc linkages”
(Lublinski, 2002, p 111).
In order to hnd out whether or not a cluster was present in the aeronautic sector in the
search area, econometric analysis was carried out by Lublinski. “This investigation has
shown that cluster hrms beneht from nearby rivals as well as ‘other hrms’ with respect
to inter-hrm knowledge flows, whereas rivalry and demanding customers have no positive
impacts. However, cluster Arms do not benefit exclusively from geographically proximate
sources of knowledge, but also from distant ones” (Lublinski, 2002, p 111).
Surprisingly Lublinski’s results do not indicate that localised advantages are restricted to
the cluster group of strongly connected aeronautic firms because certain effects can be
found in the control group of spatially dispersed aeronautic firms, too. So results seem
to suggest that agglomeration forces are at best operating weakly, indicating that the
aeronautic firms in Northern Germany constitute at best a weak cluster. These findings
suggest that these companies constitute “a strong co-location of firms with an aeronautical
affinity that are, however, hardly inter-linked such that agglomeration forces are generated
and exploited” (Lublinski, 2002, p 112).

4.2.6

Measurement of Inter-Linkages

In this study a survey was taken of key actors in the Cork area, (manufacturers, researchers
and academics) to ask about the extent of agglomeration forces, making use of Likert scale
questions. The findings record the perceived extent of agglomeration forces, and allows
comparisons to be made with other areas.
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Section 5.4 provides a description of the survey collection method. An online survey is
the primary method used for collection of data relating to inter-linkages and interconnec
tion between potential cluster members. This method was deemed to be appropriate for
contacting respondents, while also being cost effective, i.e. reducing the time and expense
of travel and communication that mail questionnaires or face-to-face interviewing would
entail. The online survey technology allows for groups up to 1000 respondents to be con
tacted instantaneously (see Section 5.8. Instead of using a cluster and a control group of
hrms, in this study it was decided that two other counties Galway and Dublin would be
analysed for comparative purposes^.

4.3

Summary

As noted in this chapter, no standard method of cluster identification exists. The cluster
concept remains vague in its everyday use, due in part to a lack of understanding of the
spatial scope and boundaries of clusters. After reviewing cluster definitions throughout the
literature, two features are common to most definitions, namely geographical proximity
and an inter-linkages dimension.
The two main strands of cluster identification literature have been reviewed, each focusing
on one of the two cluster dimensions (See section 3.3). One line of inquiry focused on
employment and output data, thereby investigating to what extent firms are spatially
proximate. The other strand investigated to what extent the actors in industries are
inter-linked.

1. To measure concentration or spatial proximity a location quotient the following
location quotient is used^°:
reasons for cfioosing these regions are given in section 4.1.5
'^The keys for this location quotient are provided in section 4.1.5
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(4.7)

2. To assess inter-linkages a survey was taken of the strength of linkages between
actors in counties Cork, Galway and Dublin, e.g. linkages between manufacturers,
researchers and academics. The survey makes use of Likert scale questions. The
findings record the perceived extent of inter-linkages, and allows comparisons to be
made with the other regions.

In the next chapter, survey methods and data collection are described. This allows ap
plication of the two cluster criteria in Chapter 6.
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Chapter 5
Data Collection

5.1

Introduction

In a previous Irish study on the biotechnology industry (InterTradelreland, 2002), the
CIRCA group reported on the, mapping of the private biotechnology sector, on the island
of Ireland. In the report, biotechnology was very narrowly defined, hnding a total of
just 59 companies recognised as biotechnology companies in the island of Ireland. “In
identifying the stock of biotechnology companies in the North and South of Ireland, only
those whose staff skills/expertise or manufacturing processes were predominantly based
on modern biotechnology were selected and surveyed” (InterTradelreland, 2002, p 10).
The aim of the present study is to include “pure” biotechnology manufacturing, research
or service providing companies, but also companies engaged in manufacturing, R and D,
in the helds of pharmaceuticals, medical devices and medical diagnostics. In the Porterian
tradition, companies and professional hrms which provide services to biotechnology firms
are also considered part of a potential biotechnology cluster, such as specialist engineering
firms that design manufacturing plant or processes, quality compliance specialists, and
patent and IP advisers. A factor that sparked the present project was the concentration
of mostly foreign owned large pharmaceutical manufacturing facilities located near Cork
City, together with the engineering and service providing firms that have prospered in
/D
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the Cork metropolitan area. This approach to identifying companies as possible cluster
participants follows Porter (1998a, p 200) steps, as outlined in Section 3.4 of this thesis.
The goal of this chapter is to describe data collection methodology for measurement of the
potential biotechnology cluster in county Cork. A number of steps have been followed:
a review of cluster literature has been made (see chapter 3), first hand observation of a
renowned biotechnology cluster in Boston was made during a fact finding trip (details are
provided in section 5.3), contact was made with CSO to access industry data and surveys
were taken of biotechnology actors.
Data collection for this project concentrated on two key features of industry clusters
(previously mentioned in section 3.3):

1. Firms in a cluster must be geographically proximate or concentrated. Census of
Industrial Production data are used to calculate location quotients.
2. These co-located firms must be interconnected or inter-linked in some way, which
results in superior performance, when compared to spatially dispersed non-cluster
firms. Primary data is collected through a survey of key actors in the Cork area:
manufacturers, researchers and academics to ask about the extent of agglomeration
forces. Likert scale type questions are used in this study, to enable comparison of
the relative strength of forces of agglomeration. Instead of using a control group
of firms, in this study it was decided that two other centres, Galway and Dublin,
would be analysed for comparative purposes.

“Clusters cannot be adequately identified unless both dimensions are captured” (Lublinski, 2002, p 70). Lublinski’s view is echoed in this research project, where data pertaining
to geographical concentration and also inter-linkages between potential cluster members
are gathered and assessed.
County boundaries are used to define the statistical scope of potential clusters due to the
availability of specihc industrial sector data available at county level from the Central
Statistics Office. Data derived from the annual ‘Census of Industrial Production’ are
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used to create location quotients to assess concentration and geographic proximity. Each
manufacturing company employing more than three staff members fills out the census,
which requests details regarding employment, turnover, inputs and outputs. Companies
are assigned NACE codes (A four digit code which relates to a specific industrial sec
tor. Companies are assigned NACE codes with regard to their principal product). The
biotechnology industry embraces many different industries (See section 2.3), therefore
it is pertinent to ask CSC for information for the NACE codes specifically involved in
biotechnology manufacturing. The methodology for the collection of data to build up
these location quotients is described in section 5.2.
Section 5.4 provides a description of the survey method. An online survey is the pri
mary method used for collection of data relating to inter-linkages and interconnection
between potential cluster members. This method was deemed appropriate for contacting
potential respondents, while also being cost effective, i.e. reducing the time and expense
of travel and communication that mail questionnaires or face-to-face interviewing would
entail. The online survey software - ‘Survey Monkey’ allows for groups of 1000 potential
respondents to be contacted instantaneously.

5.2

Measuring Concentration in Geographic Regions

An aim of the research is to measure the concentration of biotechnology activity within
the regions selected; Cork, Dublin and Galwayh Data used to create these concentration
measures is sourced from ‘the Census of Industrial Production . Data for biotechnology
specific NACE codes, manufacturing in the selected regions is requested from CSC.
This section proceeds as follows;
1. A description of NACE codes (section 5.2.1).
2. An Introduction to the Census of Industrial Production (section 5.2.2).
' For coiiiparisoii purposes National level figures are also calculated
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3. The Methodology and stages that were navigated through, which led to the Selection
of NACE codes to represent the biotechnology industry (section 5.2.3).

5.2.1

NACE Codes; Origins and Explanation

NACE is a statistical classification of economic activities within the European Community.
It is designed to ensure comparability between national and community statistics.
NACE History
Between 1961 and 1963 the classihcation of industries in the European Communities was
developed and became known by its acronym NICE. In 1965 the classification of trade and
commerce in the European Communities was compiled to cover all commercial activities
known as NCE. In 1967 a classification for services was compiled followed by one for
agriculture. In 1970 the General Industrial Classification of Economic Activities within
the European Communities was compiled and known as NACE, later as NACE 70 or
NACE 1970.
NACE Rev. 1 (“Nomenclature statistique des Activites economiques dans la Communaute
Europeenne” - Statistical classification of economic activities in the European Commu
nity) replaced NACE 1970.

• NACE Rev. 1 has the following structure:
• 17 Sections - letters A to Q e.g. Section D is Manufacturing
• 31 Subsections - 2 character alphabetical codes
• 60 Divisions - 2 digit codes e.g. 24 is the code for manufacture of chemicals.
• 222 Groups - 3 digit codes e.g. 241 is manufacture of basic chemicals.
• 503 Classes - 4 digit codes e.g. 2411 is manufacture of industrial gases.
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Table 5.1: Format of NACE Rev. 1
NACE Code
24
244
2441
2442

Corresponding Industrial Sector
Manufacture of Chemical and Chemical Products
Manufacture of Pharmaceuticals and Medical/Botanical Chemicals
Manufacture of Basic Pharmaceutical Products
Manufact ure of Pharmaceutical Preparations

NACE Explanation

Using of NACE Rev. 1 codes, CSO produce the Census of Industrial Production annually.
This report contains data pertaining to manufacturing production, inputs, output and em
ployment etc. Each four digit class in NACE Rev. 1 relates to a specific type of economic
activity, e.g. production and distribution of electricity (NACE 4010) or manufacture of
cement (NACE 2651)

The NACE Rev. 1 codes take the following format (See table 5.1):
NACE code 24 is the overall division for the manufacture of chemicals and chemical
products. Within this division are a series of 3 digit groups e.g. NACE 244 is the groups
of Manufacture of pharmaceuticals, medicinal chemicals and botanical products. These 3
digit groups are again broken into 4 digit classes e.g. NACE 2441 Manufacture of Basic
Pharmaceutical Products and 2442 Manufacture of Pharmaceutical Preparations.

“The statistical units in the Census (local unit and enterprise) are coded to the NACE
class relating to their principal industrial activity during the census year. In the case
of local units, this is determined on the basis of detailed information provided on the
production of individual products. The activity classihcation of the enterprise is based on
the NACE codes of the constituent local units. An enterprise that operates several local
units coded to different NACE classes is classified to the activity which accounts for the
highest proportion of the total value added of the enterprise”. (CSO, 2004a, p7)
Therefore by targeting only biotechnology specific NACE codes it is possible to gather
data on the industry. Codes for the sectors in biotechnology can be selected from the
79

CHAl^TER 5. DATA COLLECTION

Table 5.2: Selected Variables from Table 1 in Census of Industrial Production
Description of Variable
Number of Local Units
Total Persons Engaged
Total Persons Engaged of which Male
Total Persons Engaged of which Female
Gross Output
Net Output
Total Wages and Salaries

Unit
No.
No.
No.
No.
EUR 000
EUR 000
EUR 000

entire list of NACE Rev. 1, and those not involved in biotechnology may be excluded
from the study.
When the list of industrial sub-sectors to represent biotech had been drawn up (see sec
tion 5.2.3), it is necessary to select variables to measure geographical concentration of
the industry. Seven variables^ were selected from Table 1 in the Census of Industrial
Production to make an assessment of concentration in the selected regions. Table 5.2 lists
the variables.

5.2.2

The Census of Industrial Production

Since 1973 industrial statistics in Ireland have been compiled by CSC using the General
Industrial Classification of Economic Activities in the European Community (NACE).
Prior to 1991, industrial activities were classified using the 1970 edition of the NACE
classification (NACE 70). In accordance with EU legislation, the NACE Rev. 1 classifi
cation has been used to classify from 1991 onwards. (CSC, 2004a, p 7)
The Census is conducted by post. A permanent up-to-date register is kept of all local
units and enterprises with three or more persons engaged. The register is maintained from
the Central Business Register, administrative and public utility records, announcements
in the press, business journals, field personnel contacts, etc.
^Definitions for the selected variables are shown in Appendix B
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All returns are scrutinised clerically for internal accuracy. They are compared with returns
for previous years and in some instances with returns to other industrial inquiries. “Local
unit and enterprise returns relating to the same enterprise are examined together for
consistency. A further set of consistency checks is carried out in the computer processing
of the data” (CSO, 2004b, p 8). Queries arising from these scrutiny operations are referred
to respondents via telephone, writing or a field officer.

5.2.3

Selection of NACE Codes to Represent Biotech

To select specific NACE codes to represent biotechnology sectors of industry for the
purpose of calculating concentration ratios a number of pretesting stages were passed
through.
Step 1

The advice of a research scientist in Cork Institute of Technology was sought, in regard to
which codes should be included to represent the biotechnology sector in Ireland. The codes
were selected from the entire list of NACE Rev. 1 Codes and Corresponding Industrial
Sectors from Appendix 1 of the Census of Industrial Production 2001. The list of NACE
codes indicated to be engaged in the biotechnology industry (provided by the research
scientist) was extremely broad.
Data was requested at 4 digit NACE level for the selected codes from the industry depart
ment of CSO. This request included data for the variables in table 5.2 at regional level for
Cork, Dublin and Galway. The data was requested for 1991, 1996 and the latest figures
available, 2001. These figures were requested to show trends in the industry during the
1991 - 2001 period. Eigures provided would enable the creation of location quotients and
other concentration measures. These concentration measures allow comparison among
various regions in the study, at five year intervals.
A problem encountered during the compilation of the data to build the various con
centration measures, was the confidentiality issue. The data set selected contained many
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individual sub-sectors. To keep confidentiality of company information within the request,
CSO was not free to report the data results to 4 digit level.
To overcome this problem, the CSO reported at 2 digit level (e.g. sector level). The
selected 4 digit codes were aggregated together by CSO and reported in a project specific
2 digit level. This allowed the CSO to keep confidentiality in regard to results released.
However the following difficulties arose due to the figures being reported in this fashion;
1. There is a difficulty in identifying which of the different NACE 4 digit
sub-sectors has industrial firms in each region, e.g. If Cork had 32 companies
across the sub-sectors selected for this research, it is possible 31 of them may be in
one NACE sub-section selected. This would indicate that Cork has strength in this
sub-section, however, with the data being reported at 2 digit level, it is impossible
to be certain in which sub-sectors each region has a concentration. This problem
was addressed in the online survey research, where respondent firms would be asked
to categorise their companies into specific industrial sectors.
2. The size and age of firms is not detailed in the reporting of these results,
e.g. If Galway’s results indicate that there are 47 companies in the region as opposed
to Cork’s 32, this can give a confusing picture, as the size or age levels of the
companies are unknown.

It is possible that many of the companies in Galway

are start ups employing 5 employees or less, whereas Cork may have larger more
experienced firms. This problem was addressed in the online survey research, where
respondent firms are asked for numbers in employment and also the year their
company was established.
3. Difficulties were encountered in obtaining yearly national data. Data was
not requested at National level as the researcher was informed that this data was
available in the Census of Industrial Production for the years in question i.e. 1991,
1996 or 2001. Therefore, difficulties were then encountered in obtaining this yearly
national data. In the Census of Industrial Production some 4 digit sub-sectors are
joined together at national level to keep the confidentiality of firms reporting. This
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meant that even though the county level figures requested from CSO were aggregated
to 2 digit level and were project specific, the national level figures provided through
the Census were overstated^. This minor problem was overcome by requesting the
national level data from CSO.

When the results of this stage of the research were compiled into the various concentration
indices, the results were distributed amongst a group of scientific academics. The reaction
from this group was that a large proportion of the NACE codes listed in the study may
not be involved in the biotechnology sector.
Step 2
To refine the definition of NACE codes to be included in the study, a group of 20 academics
from various life sciences departments in University College Cork and Cork Institute of
Technology were surveyed to assess their opinions as to which sectors should be included
in the study.
Academics were asked to review the entire NACE REV. 1 list from Appendix 1 of Census
of Industrial Production 2001. Respondents were asked to check a box next to each NACE
code that they felt should be included in the study‘s Further to this survey it was decided
to use both a broad definition and a narrow definition of biotechnology used.
These definitions were as follows; from the results of the academics survey if a code had
been indicated as being within biotechnology by 70% or more of the academics then it
would be considered within the narrow definition of biotechnology, if a code was indicated
as being within biotechnology by 30% or more of the academics it was to be considered
to be within the broad definition and would be used in the study.
When the survey was completed, results were compiled. Four codes were selected in the
narrow definition, whilst there were 32 codes in the broad definition of the biotechnology
■^Sonie of the codes tiiat were considered bioteclinology sirecific by tlie research scientist were aggre
gated witii other codes (not indicated by the researcii scientist) in the Census of Industrial Production
(National Level) to keep confidentiality in the results, d’his is the case in instances where there were less
than 3 companies manufacturing in that sector
■^A copy of this questionnaire is included in Appendix C.
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industry. However the author had concerns that some of the codes not selected in this
process were actually involved in the biotechnology industry.
Step 3
In an effort to test if all the main industrial units within the biotechnology industry were
included in both the narrow and broad dehnitions of the industry, it was decided to contact
some of the larger Pharmaceutical, Medical Device and Food production companies in
Cork, to ask them what was their principal product. As mentioned previously, principal
product is the main criterion on which companies are assigned to different NACE codes.
Contact was made with a group of companies actively involved in the biotechnology/pharmaceutical
industry with regard to the principal product they produce. Representatives from the fi
nancial departments of these companies were then asked to choose from a list of NACE
codes, the code they felt best described their company’s principal activity. Taking note
of the specific 4 digit NACE codes chosen it became apparent that the same NACE codes
were constantly reappearing.
It was decided that a new request would be sent to CSO, requesting the aforementioned
variables (See Table 5.2) for the group of 4 digit NACE codes indicated by representatives
of the companies contacted.
The researcher is of the opinion that of the methods used to select a NACE code dehnition
of the biotechnology industry, manufactures are the ultimate experts and most qualified to
say what industrial sectors they are manufacturing in. The 4 digit NACE codes selected
to participate in the study are shown in Table 5.3. Data supplied for these codes enabled
concentration indices to again be built up and analysed, details of which are provided in
Chapter 6.
The next task is to assess the extent of interlinkages in the potential Cork biotechnology
cluster. In preparation for this the researcher visited Boston to take a first hand look at
the workings of the Boston biotech cluster.
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Table 5.3: Codes selected to represent biotechnology production
NACE Code
1551
1596
2414
2451
2463
2466
3310

5.3

Corresponding Industrial Sector
Operation of Dairies and Cheese Making
Manufacture of Beer
Manufacture of Other Organic Basic Chemicals
Manufacture of Soap and Detergents, Cleaning Preparations
Manufacture of Essential Oils
Manufacture of Other Chemical Products ri.e.c.
Manufacture of Medical and Surgical/Ort hopedic Equipment

Boston Biotechnology Cluster

During November 2004 a visit was made to firms and academic institutions in the Biotech
nology cluster, centered in Boston and Cambridge (A list of individuals who were inter
viewed and the companies or universities that employ them is in table 5.4). The main
function of this visit to Massachusetts was to learn how this world renowned Biotechnology
cluster formed, and how it functions today.
The academic community in Boston and Cambridge is not only housed within the top
universities such as Harvard University, Massachusetts Institute of Technology (MIT) and
Boston University; academic research extends into the hospitals in Boston and Cambridge.
These hospitals are teaching hospitals whose roots stem from the original Universities.
Massachusetts General Hospital (MGH) conducts the largest hospital-based research pro
gramme in the United States, with an annual research budget of more than $400 million.
It is the oldest and largest teaching hospital of Harvard Medical School, and nearly all of
the hospital’s staff physicians are members of the Harvard Medical School faculty. Also
linked to Harvard are the Brigham and Women’s Hospital in Boston, the Dana-Farber
Harvard Gancer Gentre and the Children’s Hospital Boston. MIT also has significant
linkage with MGH and the Brigham and Women’s Hospital, as does Boston University.
Boston University also has linkages with the Boston Medical Centre.
Questions used to guide the interviews were:
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Table 5.4: Meetings in Boston and Cambridge

N aine

Company

Position

Located

Phil Newton
Sean Johnston
Ashley Stevens
Janice Reichert
Neil Exter
Brian Fenton
Clare Fisher
Keith O’Neill
Kerry A. Flynn
Marc Thevenin
Kieran Connolly
Cohn Lawler
Catherine Ives

Paratek Pharma
Paratek Pharma
Boston University
Tufts University
Millennium Pharma
Codexis Inc
Mass Biotech Council
Broad Institute - MIT
Transkaryotic Therapies
WUrldcare
Worldcare
Mass General Hospital
Boston University

Director, Human Resources
VP Manufacturing Op
Dir. Office of Tech Transfer
Senior Research Fellow
VP Business Development
Dir. Business Development
Dir. Business Development^
Special Projects Manager
VP IP and Licensing
Bio Informatics Dept
Bio Informatics Dept
Sr Licensing Associate
Licensing Associate

Boston
Boston
Boston
Boston
Cambridge
Boston
Boston
Cambridge
Cambridge
Cambridge
Cambridge
Boston
Boston

1. What factors have brought about the biotechnology cluster in Boston?
2. Was there a lot of Government support through funding and policy etc?
3. Who/What are the key contributors to the cluster? i.e. what companies or institu
tions does the biotechnology cluster need to function in Boston?
4. How much face to face contact among Industry and Academics do you have within
the Biotech Cluster in Boston?
5. Is knowledge shared between members of the Biotech Cluster?
G. Does Intellectual Property protection allow for the dissemination of knowledge be
tween cluster members?
7. What is the likelihood of employees leaving your company after being headhunted
from other companies within the biotech cluster?
8. Is the location of all cluster members close together in Boston one of the main
reasons for the success of the Biotech cluster?
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9. What are the payoffs or benefits of being located within the biotechnology cluster
in Boston?
It was hoped that information collected from responses to these questions might be used
to make recommendations as to how the biotech Industry can be supported, developed
and improved in Ireland, and also to develop questions for the survey on interlinkages to
be conducted on companies and academics in Ireland.
Listed below are some of the key factors which aided the development of the biotechnology
cluster in Massachusetts. The author accepts that these factors were drawn from the
perceptions and experiences of representatives of academia and industry. The majority
of business personnel interviewed were working as part of the business development or
intellectual property functions of these firms.
The main points that emerged from of the fact finding trip are;
1. Industry creates linkages with academia and also links with the hospitals. This is
of great benefit to firms as they have access to primary research going on in both
universities and hospitals. Besides when research is put into product trials, the
hospitals supply patients for final clinical trials before products can go to market.
This triangular type linkage is therefore of great importance to the strength of the
Biotechnology cluster. (Neil Exter, Millennium Pharmaceuticals)
2. Collaboration is of great significance in Boston, as collaborating is a natural growth
mechanism for many smaller companies. Start-up firms are seed funded by govern
ment programmes. Over time these firms develop their intellectual property (IP).
This IP is the smaller start-up firms most valuable asset. Companies attempt to
identify an industry partner (using the IP as their selling point) who wishes to col
laborate on the development of a potential product arising from their IP. Funding
derived in this way allows smaller firms to continue operating and also increase staff
numbers and development within the company. (Sean Johnston, Paratek Pharma
ceuticals^.)
’Paratek have 2 collaborations with Serorio and Bayer and this funding is lielping them take these
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3. Business development is an increasingly important function for companies in the
Biotechnology cluster.

Business development personnel spend large amounts of

time in face to face communications actively searching for funding or collaboration
opportunities to develop company products. Meetings involve giving presentations
on the potential of their company’s IP, and how this IP could also impact on the
future development of potential collaborators technologies®. Personnel involved in
the business development function, originate usually from either of two academic
streams; marketing and management, or a mixture of science and business which
allows for better understanding of the technology. Another demanding function of
business development personnel is to plan how the company is to grow and expand.
(Claire Fisher, Massachusetts Biotechnology Council (MBC).)
4. Management experience with respect to the growth and development of a company
is essential. Boston contains a large pool of this specific type of management ex
perience. Imagine company development passes through 3 stages. These stages are
the points when a company has 3 employees, 100 employees and 1600 employees. It
is unlikely that the same people will be involved in growth of the company from one
stage to the other. In Boston, management with specific experience of growth and
expansion of companies are brought in to firms to take them through these devel
opment stages. The founders of the company (frequently scientists) take back seats
in the company as scientific advisors, and let professionals take over the tasks of
company development and expansion. (Sean Johnston, Paratek Pharmaceuticals)
5. One of the advantages of being in the cluster from a company point of view, is
that qualified personnel in all functions are available from within the cluster, either
through head hunting or other methods of recruitment. An advantage for employees
within the cluster is that there are job vacancies in other companies if your company
is downsizing etc. A large amount of staff turnover takes place within the industry,
and grudges are not held, as qualified replacement staff are available from within
ideas through clinical trials and onto market.
*^'Presenters need up to date knowledge of the products and technologies currently in the development
stage, both in house and within industry
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the cluster. (Phil Newton, Paratek Pharmaceuticals)
6. Another factor which was highly evident during the trip is the attitude to failure
within the US. In the US, the attitude to failure is that you can always try again, or
“So it didn’t work out that time. Ill try something new.” This attitude seems to be
in stark contrast to the attitude to failure in Ireland. (Kerry Flynn, Transkaryotic
Therapies)
7. Adding to the success of the biotechnology cluster in Boston/Cambridge may be
the fact that Venture Capital (VC) firms which invest in Biotechnology companies
are primarily located there. VC is extremely important to the industry, and the VC
firms actively want the companies they support to be located within Boston/Cambridge
regardless of their origin. This is to gain the benefits of proximity to the quality
knowledge in the cluster i.e. academics and researchers in industry. VC firms can
then question these academics on the quality of the firms or the companies looking
for support as an aid to protecting their investment. (Marc Thevenin and Kieran
Connolly, Worldcare)
8. The Massachusetts Biotechnology Council on the request of companies involved in
the cluster, prescribe topics and content for the curriculum of academic courses.
These inputs are to assure that the relevant skills are supplied to the future work
force, giving the students a higher chance of gaining employment in the industry.
(Mark Trusheim, Interim President, MBC)

5.3.1

BioLink USA-Ireland

During the visit to America, the Boston Chapter of BioLink USA-Ireland were scheduled
to meet in the Broad Institute, a section of the Massachusetts Institute of Technology.
BioLink USA-Ireland is an organization formed in 2003, by scientists and others from
Ireland working in biotechnology in the US. The aims of BioLink are to foster community
among the expatriates and to develop links to and resources for the Irish biotech commu
nity, and others who support these aims. BioLink also seeks to foster links to and contacts
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Figure 5.1:
18/11/2004

Colm Lawlor and Catherine Ives speaking at the Broad institute on

for the nascent Irish Biotech industry. They also encourage academic, governmental and
other links, to facilitate collaboration, personnel exchange and information sharing.
The author was invited to attend their meeting by Chapter Director Keith O’Neill. The
theme was, 'Turning your ideas into money - Technology transfer and intellectual prop
erty management’. Speakers for the evening. Dr. Cohn Lawler and Dr. Catherine Ives
(See Picture in hgure 5.1) are licensing associates with MGH and Boston University, re
spectively. Their presentation touched on the concepts behind technology transfer and
patenting of research, as well as the commercialisation of that research and the vari
ous licensing options available. This presentation was extremely informative especially
with respect to what can or cannot be patented. The presentation also highlighted the
importance of IP to start up companies, and how they need to invest to protect their IP.
Insights gained by the researcher in Boston helped to shape questions for the surveys of
biotech actors in Cork. Section 5.4 discusses online survey methodology. Sections 5.5 and
5.6 outline the rationale for questions asked in the surveys.
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Conducting a Survey Online

This section begins by assessing the benefits of using online research, and why this form
of surveying is deemed appropriate for this study. Narrative on the design of the ques
tionnaire follows.
Burns and Bush (2005b, p 13) dehne online research as:
“The use of computer networks, including the Internet, to assist in any phase of the
marketing research process including development of the problem, research design, data
gathering, analysis and report writing and distribution. ”
Online research takes many facets, but the Internet based questionnaire, in which the
respondent answers questions online is becoming the standard for online research. The
reasons are as follows:
“Internet based online surveys are fast, easy and inexpensive. These questionnaires ac
commodate all of the standard question formats, and they are very flexible, as they have
the ability to present pictures, diagrams or displays to respondents.” (Burns and Bush,
2005a, p 208) Also in the majority of packages available for questionnaire preparation
online, the researcher can check the web-site for current tabulations at any point in the
process, therefore the researcher has real-time access to the data. Additionally respon
dents can access the online survey at any time of day or night, which may be convenient
to the respondent when completing the questionnaire.
However there are drawbacks to online research: these are “sample representativeness,
respondent validation and difficulty in asking probing types of questions.

(Burns and

Bush, 2005a, p 209)

5.4.1

Designing an Online Data Collection Form

The speed of online electronic delivery, although adding significant benehts, does nothing
to lessen the importance of a well-designed, properly worded, logically organised ques-
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tionnaire. The burden is still on the questionnaire to encourage respondents to cooperate
and engage them in meaningful communication.
“Consider art. Consider good hne art. You are drawn to it. It engages. Initially you are
not aware of how it was painted or presented; you are simply drawn into it. Similarly
a good survey engages the recipients and draws them in with a compelling invitation,
followed by a natural and logical sequence of questions. For online surveys, this means
the invitation and initial presentation must captivate the audience; the survey itself must
be highly interactive, dynamic, and engaging. As with any survey, the first question or
two must capture the attention of survey respondents so they become more committed
and, thus, are more likely to complete the survey” (Mancinelli, 2005)

5.4.2

The Functions of a Questionnaire

According to Burns and Bush (2005b, p 302) a questionnaire serves six key functions:
1. It translates the research objectives into specific questions that are asked of the
respondents.
2. It standardises those questions and the response categories so every participant
responds to identical stimuli.
3. By its wording, question flow, and appearance, it fosters cooperation and keeps
respondents motivated throughout the interview.
4. Questionnaires serve as permanent records of the research.
5. Depending on the type of questionnaire used, a questionnaire can speed up the
process of data analysis. Online questionnaires, for example can be transmitted to
thousands of potential respondents in seconds. In the case of a package like Web
Surveyor, questionnaires can be delivered and returned online.
G. Finally, questionnaires contain the information on which reliability assessments may
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be made, and they are used in follow up validation of respondents’ participation in
the study.

5.4.3

The Questionnaire Development Process

A questionnaire ordinarily goes through a number of drafts and pretests before it even
tually find its final form. Even before the first question is constructed there is need to
review alternative question formats to decide which ones are best suited to the survey’s
respondents and circumstances.
Burns and Bush (2005b, p 303) list the steps in questionnaire development:
1. Determine Survey Objectives
2. Decide Data Collection Method
3. Question Development
4. Question Evaluation
5. Pretest
6. Revise as Needed
7. Einalise and Duplicate
8. Gather Data
9. Tabulation and Final Report
“In developing any question, the ultimate goal is to devise a way to tap the person’s
true responses without influencing him or her either overtly or subtly. Compounding this
problem is the fact that the researcher will have only one chance to accomplish the goal,
so the wording of each question is critical. Unfortunately, there is a far greater potential
to generate unreliable or inaccurate responses than we care to admit” (Burns and Bush,
2005b, p 303).
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Creating the Academic Questionnaire

A copy of the full questionnaire that was sent to academics engaged in biotechnology in
county Cork is included in Appendix D.
In this section the purpose of each question put to academics is explained. For the readers
convenience, pages from the academic questionnaire alternate with pages of commentary.
In question 1 (figure 5.2) respondent details are requested to ensure only one response
from each individual.
The aim of question 2 (figure 5.2) is to assess the size of research departments across the
selected regions and institutions studied.
Question 3 (figure 5.2) is a matrix style question that allows multiple answers. It’s pur
pose is to categorise respondents’ specific research sectors within the entire biotechnology
industry.
Question 4 (hgure 5.2) aims to assess if there is contact between academia and companies
with regard to the skills companies require graduates to posses^.
Question 5 (hgure 5.2) asks about the nature of linkages that respondent’s departments
have with biotech companies.
Question 6 (hgure 5.2) is included at the request of the Irish Bioindustry Association. It
seeks to assess the potential avenues of research funding researchers are likely to use.
Question 7 and 8 (hgure 5.3) aim to discover academics perceptions and experiences about
the accessibility of research funding. Their perceptions are relevant in the context of high
prohle funding to biotech by PRTLI and SFI.
The aim of question 9 (hgure 5.3) is to assess the amount of personal contact between
academia and employees of the biotech industry.
Question 10 (hgure 5.3) seeks information on how often representatives of academia and
'I'his linkage is active in Boston. The Massacliusetts Biotechnology Council on the request of corn]3anies involved in biotech, prescribes topics and content for the curriculum of academic courses
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Figure 5.2: Academic Biotechnology Cluster, Questions 1 to 6
Cork Academic Biotechnology Cluster
1. Survey of Academics with potential link to Biotech Industry

1. Contact Details

Name of Respondent
Institution
Department/Centre
Telephone
2. Employment

Total number of Researchers in your Department/Centre
3. Nature / Sector of Biotechnology Research

AgriFood Industry

Research
^

Healthcare - Therapeutics
Healthcare - Diagnostics
Pharmaceutical

V

Pharmaceutical services
Medical Devices
Bio-Environmental
Bio-Informatics
None of the Above
4. Is there contact between your academic department/centre and companies in Cork, in regard
to the skills they require their graduate recruits to have?

Yes

No

Don't know

5. Does your department/centre have links with Cork based Biotech companies in any of the
following areas? (Please tick as appropriate)

Consultancy/Funded
Research

Personal
Research

Analytical
Services

Training

N/A

6. If your research discovers a new technology, product or process, on a scale of 1 to 6 how likely
are you to take the following options? 1 = not likely and 6 = extremely likely

Patent and sell the patent
Patent and Licence out
Patent and commercialise the
discovery yourself
Commercialise with an
Industry partner
Collaborate with your
University/Institute

j
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Figure 5.3; Academic Biotechnology Cluster, Questions 7 to 11
7. Have you found funding for research to be more accessible in the last 2 years?
More

Less

8. Which of the following sources has been to the forefront for funding of research in your
department/centre?
^ Industry Partners
j Science Foundation Ireland
j Enterprise Ireland
^ Program for Research in Third Level Institutions
^ EU framework programme
j Other (please specify)

9. Have you personal contact with employees in Biotech/Pharma companies within Cork. Please
choose from the following list
^ 1-3 companies
^ 4-6 companies
^ More than 6 companies

^ No personal contacts

10. Have you met employees of Biotech/Pharma companies within Cork recently? (Tick as
appropriate)
Social Context

Business Context

In the past week
In the past Month
In the past 3 Months
More than 3 months ago
No contact

11. Are graduates from your department working in any Biotechnology companies within Cork?
Yes
^

No
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Figure 5.4: Academic Biotechnology Cluster, Questions 12 and 13
12. Have you met graduates from your department \A/ho work within Biotech companies in
Cork? (Tick as appropriate)
Social Context
In the past Month
In the past 3 Months
More than 3 months ago
No contact

Business Context

r

r

r
r

13. If there is one thing that could be done to enhance co-operation between Cork companies
and academia, what would it be?

3

zl
industry were actually meeting face-to-face, over intervals from a week to three months
plus.
The purpose of question 11 (hgure 5.3) is to assess if departments/centres are providing
graduate employees for the biotech industry in their region. Question 11 develops the
labour pool theme of question 4.
Question 12 (figure 5.4) was included to see if academics keep lines of communication
open with their graduates who have gone into the biotech industry. It also asks about the
frequency of meetings and the context in which they take place.
Question 13 (figure 5.4) is open end and seeks feedback from respondents on how they
feel co-operation could be enhanced, between academia and industry.
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Creating the Company Questionnaire

The full questionnaire sent to companies in biotechnology in county Cork is included in
Appendix E.
In this section the purpose of each question put to company respondents is explained. For
the readers convenience, pages from the company questionnaire alternate with pages of
commentary.
Section 1 of the company questionnaire is concerned with general company information
and the individual views of respondents. The section contains 13 questions and can be
seen in figures 5.5 to 5.7.

Question 1 (figure 5.5) is asked in order to ensure that only one response comes from each
company.
Question 2 (figure 5.5) asks respondents to specify whether the company is a multinational
or an indigenous company.
Question 3 (figure 5.5) seeks to categorise respondent companies into specihc sectors
within biotechnology. It seeks evidence of any regional specialisation, and asks at what
points in the biotech value chain respondent companies engage.
Question 4 (figure 5.5) asks about sales revenue and what percentage of turnover is being
put back into research and development annually.
Question 5 (figure 5.5) and 6 (figure 5.6) seek evidence of vertical supply chain linkages
in the country. Question 6 asks where respondents source their raw materials. Are the
majority of materials being sourced inside the cluster area?
Question 7 (figure 5.6)aims to assess what are the contributing factors that lead biotech
companies to locate in the county where they operate.
Question 8 (figure 5.6) is concerned with the cluster notion of critical mass. The question
seeks to find out how many customers, suppliers and competitors that respondents have
within the specific region. For Cork, the numbers for suppliers are of great interest, with
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Figure 5.5: Company Biotechnology Cluster, Questions 1 to 5
Cork Biotechnology Cluster

Section 1. Company & Respondent Details

1. Contact Details
Company name:
Principal product or service:
Year established in Ireland: P"
Name of respondent:
Position in company:
Telephone:

2. Type of company
Multinational

Indigenous

3. Nature / sector of biotechnology business.
Please tick the sector which describes your main business, please also indicate if you have
products and processes in R&D phase or on the market
Main Business
AgriFood
Industry
Healthcare Therapeutics
Healthcare Diagnostics
Pharmaceutical

R&D Phase

Products on sale in Market place

^

Pharmaceutical
services
Medical
Devices
BioEnvironmental
BioInformatics

4.Turnover - C(Euros)
Total
R&D spend as % of Turnover

5. What percentage of your sales are accounted for in the following markets?
Cork
Rest of Ireland
Rest of Europe
Rest of the World
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regard to input linkages, as much of the product is assumed to be exported.
Question 9 (hgure 5.6) asks about employment numbers for respondent hrms in the po
tential cluster®. Also this question seeks the percentage of total employees which are in
research positions.
Question 10 and 11 (figure 5.6) continues the labour pool theme. They ask about the
extent of sourcing employees within the cluster area, and the extent of leakage of employees
to within the cluster area. It is noteworthy that headhunting f employees is considered a
normal everyday occurance in the biotechnology cluster in Massachusetts®.
In America “business development” is seen by many as a key process when moving a
company through development and expansion. Question 12 (figure 5.7) assesses if this is
also the case in the locations selected in Ireland, or if perhaps a different process need to
be supplemented to achieve expansion in Ireland.
Question 13 (hgure 5.7) is linked to question 12.

With regard to skills mentioned in

question 12, respondents were asked to indicate the likelihood that these skills could be
sourced within the specihc region of operation. Answers to this question should indicate
any strengths regions have in producing staff for the different functions; in effect the
presence or absence of a labour market pool.
Section 2 of the survey is concerned with Academic Linkage, Collaboration, Innovation
and Policy. The section contains 9 questions, and can be seen in figures 5.7 to 5.9.
Question 14 (figure 5.7) lists research centres located in the respective region and asks
respondents if their employers have linkages with any of these centres, and asks the nature
of such linkages.
Question 15 (hgure 5.8) asks about company to company collaboration in the specihc
region, and in what helds of activity are these collaborations.
labour pool figure is also assessed through CSO data, but only for manufacturing employees.
(See Chapter G
®Phil Newton, Director of Human Resources in Paratek Pharmaceuticals in Boston, made this point
during a personal interview in November 2004
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Figure 5.6: Company Biotechnology Cluster, Questions 6 to 11
6. What % of raw materials and inputs does your company purchase from suppliers in?
Cork
Rest of Ireland
Rest of Europe
Rest of the World

7. In your opinion, please rank for importance the factors that lead Biotechnology companies
to choose a Cork location. Please rank the 5 most important factors 1 = Most important, 2 =
second etc.
Similar companies in the area
State support
Close to major airport
Close to major harbour
Close to 3rd level academic institutions
Highly skilled workforce
Access to European market
Wage Rates
Supportive state agencies/local government

8. Please indicate numbers for the following
Number of your Business Customers in County Cork
Number of your Suppliers in County Cork
Number of your Competitors in County Cork

9. Employment in your Cork unit
Total Employees in Cork
Number of R&D employees

10. What percentage of your employees in Cork were recruited from:
Cork based companies in similar industries
Straight from 3rd level educational institutes in Cork

11. Can you indicate the frequency with which your employees may be recruited by other
companies? (On a scale of 1 = very infrequent to 6 = quite frequent)
1
by Cork
companies
by Irish
companies
by companies
abroad

2

3

V

4
V

10L>

5

6

>
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Figure 5.7: Company Biotechnology Cluster, Questions 12 to 14
12. If your Cork operation were to expand, please indicate which skills would need to be
supplemented through recruitment
^

Business Development

^

Clinical

^

Engineering

^

Legal / IP

^ Marketing
^

Manufacturing

^

Research / Scientific
Other (please specify)

13. Regarding skills you would need to recruit (Q12), please indicate the likelihood that you
would manage to source these skills within Co. Cork, on a scale of 1 = most unlikely to 6 =
very likely

1
Business
Development
Clinical

2

3

4

5

>

>

V

-o'

>

-o'

6

-✓

Engineering
Legal / IP
Manufacturing
Research /
Scientific
Other

>

J

>

V

-o'

V

>

_✓

-✓

>

>

-✓

Marketing

-o'

>

>

>

>

Section 2. Academic linkage. Collaboration, Innovation & Policy

14. Which of the following Cork based Institutions do you have links with, and in which areas are
these linkages? (Please Tick as many as are relevant)

Further Training
University College Cork
Cork Institute of Technology
National Microelectronic Research
Centre
National Food and Biotechnology
Centre (UCC)
Other Cork based

j
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Question 16 (figure 5.8) is linked to question 15 and asks if there is opportunity for
collaboration within the region, and in what field of activity.
Question 17 (figure 5.8) again is linked to questions 15 and 16. This question tries to
discover significant barriers to joint collaboration.
Question 18 (figure 5.8) asks respondents to identify a key action which would enhance
co-operation between companies in the respective region.
Question 19 (figure 5.9) asks about the significance that various actors within the region
had as a source of knowledge for respondents’ product development. Likert scale indicators
give an estimate of the flow size between firms. The assumption is if company represen
tatives’ perceived importance of linkages to sources of knowledge is minimal, there are
indeed only small flows of knowledge. If the perceived importance is large, the respective
knowledge flows are large in reality. The logic is that used in Lublinski’s surevy.
Question 20 (figure 5.9) deals with the issue of trust and face-to-face contact. The lit
erature section revealed that trust and face-to-face contact are essentials for building of
relationships and therefore cluster success.
Question 21 (figure 5.9) seeks to assess to what extent different organisations listed provide
support to respondent company operations.
Question 22 (figure 5.9) is an open end question which asks respondents how policy can
be enhanced to help the operations of their individual companies.
The next step is to discuss the sampling techniques used to create a pool of qualihed
respondents to answer the questionnaires outlined in the previous sections. Two pools of
respondents need to be constructed. An academic pool and an industry pool of respon
dents.
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Figure 5.8: Company Biotechnology Cluster, Questions 15 to 18
15. Do you collaborate with other companies in Cork in the following areas?
Yes

No

Shared Technology
Licensing arrangements
R&D

V

j

>

>

Training

>

>

Marketing / Sales / Distribution

>

>

Sub contracting of manufacturing
Other Joint Venture

V

J

>

16. Please specify any areas where you see an opportunity for collaboration within Cork?
(Please Tick as appropriate)
Yes
Shared Technology

>

Licensing arrangements

^

R&D

^

Training

^

Marketing / Sales / Distribution

^

Sub contracting of manufacturing

^

Other Joint Venture

^

17. Which of the following would you see as significant barriers to joint collaboration? (Please
Tick as appropriate)
r

Availability of suitable partners
Availability of capital

r

Government support

P

Commercial confidentiality
Availability of qualified personnel
Other (please specify)

18. If there is one thing that could be done to enhance co-operation between companies in
Cork, what would it be?
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Figure 5.9: Company Biotechnology Cluster, Questions 19 to 22
19. What significance do the following (customers, suppliers etc.) have as a source of
knowledge for your product development, on a scale of 1 = low significance to 6 = high
significance
2

1
Business
customers in
Cork
Suppliers in
Cork
Competitors in
Cork
Academic
institutions in
Cork

4

3

V

V

V

>

5

N/A

6

V
V

y

y

20. How important are the following factors as a foundation of an effective business
relationship. Please rate on a scale of 1 (Not Important) to 6 (Very Important)
4

3

2

1
Trust
Face-to-Face
contact

6

>

21. Please rate the level of support you receive from the following organisations from 1 = Little
support to 6 = Large support.
1
Irish Biolndustry
Association
Other Trade
Associations
Chamber of
Commerce
IDA
Enterprise
Ireland
SFI
Other
Government
Agencies
National
Government
Local
Government

2

3

4

V

22. How can policy be enhanced to help your operations?

5

6

N/A

■y

y

y

y

y
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Sampling Techniques
Creation of Academic Database

It is necessary to survey those academics currently researching within the biotechnology
arena. The search for researchers names began with Science Foundation Ireland (SFI).
In July 2003, SFI was given a statutory basis under the Industrial Development (Science
Foundation Ireland) Act, 2003. SFI had been established in 2000, as a sub-board of
Forfas, to administer Ireland’s Technology Foresight Fund. SFI is investing €646 million
between 2000-2006 in academic researchers and research teams who are most likely to
generate new knowledge, leading edge technologies, and competitive enterprises in two
helds: Biotechnology and Information and Communications Technology (ICT).
SFI makes grants based upon a review of proposals from distinguished scientists. SFI also
advances co-operative efforts among education, government, and industry that support
its fields of emphasis namely biotechnology and ICT.
The Biotechnology division supports research in the biological and other sciences un
derpinning biotechnology including bioengineering. No sub-specialties are highlighted to
avoid restricting the creative potential of investigator initiated proposals. Excellence of
the proposal coupled with the greatest perceived potential for seizing opportunities as
they arise during the course of the work, are the criteria for successful selection.
The SFI web-site (www.sfi.ie) includes a current research section which details research
grants awarded between 2001 and January 2004. This information is in PDF format and
can be accessed through the url, http://www.sfi.ie/uploads/documents/upload/
Those SFI funded researchers involved in biotechnology research, based in the three coun
ties to be studied i.e. Cork, Dublin and Galway were placed on a list of target respondents.
Researchers based in these target locations, had their details noted e.g. title name and
academic institution. This information was transferred into three Microsoft excel files, one
for each target region, hereafter referred to as academic databases. Information collected
needed to be supplemented by e-addresses for each researcher as these are essential for
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Table 5.5: Details of Database and Respondent Numbers

Database
Cork
Dublin
Galway

Academic
Database Respondents
41
16
13
38
14
48

Industry
Database Respondents
16
66
114
28
11
23

the use of online survey. To collect this information the researcher visited the individual
university and college web-sites and searched for specific e-addresses of the academics
drawn from the SFI research grants PDF.
The databases created were supplemented through the addition of biotechnology re
searchers in universities and colleges in the regions to be studied, e.g. in Cork researchers
in departments such as biological sciences in Cork Institute of Technology and the De
partment of Microbiology in University College Cork were added into the Cork database
of academic researchers, in an effort to make the population representative.
Table 5.5 summarises that 127 researchers were included in the academic database com
piled for the online survey, the institutions where these researcher are currently working
are as follows:
The academic institutions included in Cork were: Cork Institute of Technology and Uni
versity College Cork.
The academic institutions included in Dublin were: Dublin City University, Dublin Insti
tute of Technology, National University of Ireland Maynooth, Royal College of Surgeons,
Trinity College Dublin and University College Dublin.
The academic institutions included in Galway were: Galway Mayo Institute of Technology
and National University of Ireland Galway.
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Creation of Company Database

The biotech industry is by its nature broad, with the borders of the industry constantly
being pushed outwards. This is apparent with large Pharmaceutical companies open
ing Bio-Pharmaceutical research centres e.g. Centocor and GlaxoSmithKline are both
currently opening Bio Research centres in Cork, whilst The National Institute for BioProcessing Training is to be built in University College Dublin on the recommendation of
the Irish Development Authority.
The researcher feels that the concentration measures used in the study only take account
of manufacturing hrms in biotechnology in the counties studied. To assess the viewpoints
of the entire biotechnology industry, an effort is made to include all industry actors, whilst
conducting the surveys. It was decided that companies manufacturing, servicing and/or
researching in any of the sectors listed below within the regions to be studied would be
included in the company databases^^:
1. AgriFood Industry
2. Bio-Environmental
3. Bio-Informatics
4. Healthcare Therapeutics
5. Healthcare Diagnostics
6. Medical Devices
7. Pharmaceutical
8. Pharmaceutical Services
^^’Com])anies involved in clinical research centres (CRO’s), IP firms or organisations servicing specif
ically the biotechnology and life sciences industry (e.g. DPS Engineering and Construction Ltd., is a
process engineering and project management comi)any specialising in the pliarmaceutical industry, who
are based in Cork) are inclnded in the company databases

108

CHAPTER T).

DATA COLLECTION

To identify companies it was decided to search the directories of the Irish Bioindustry
Association, IDA Ireland and Enterprise Ireland. To supplement this search the golden
pages directories of the Cork, Dublin and Galway phone books were also consulted, with
reference to the variables listed above. The phone books served as a safety net to ensure
all companies involved in biotechnology had a chance to take part in the survey.
Irish Bioindustry Association (IBIA):
The Irish Bioindustry Association provided the starting point for creation of the com
pany databases. Established in 1998 the IBIA is the leading representative body for the
biotechnology sector, representing nearly 40 members. IBIA’s vision is to establish Ire
land as a smart place to do Biotechnology. The mission statement of the IBIA is: “To
enhance the environment in Ireland for the development of a successful multinational and
indigenous biotechnology sector”
In the IBIA web-site (www.ibec.ie/ibia) an ‘About Us’ section contains a ‘Members’
section. (http://www.ibec.ie/Sectors/ibia/). Member company web-sites are detailed in
this section. Whilst navigating around each company’s web-site the researcher assessed
whether or not the company operateds within the target regions for the study, i.e. Which
companies operate plants or factories in counties Cork, Dublin or Galway.
IDA Ireland
IDA is an Irish Government agency with responsibility for securing new investment from
oversecis in manufacturing and internationally traded services sectors. IDA also encourages
existing investors to expand and develop their businesses in Ireland. Over 1,050 overseas
companies have chosen Ireland as their European base and are involved in a wide range
of activities in sectors as diverse as e-Business, engineering, information communications
technologies, pharmaceuticals, medical technologies, financial and international services.
The IDA Ireland web-site (www.ida.ie) contains a ‘Business Sectors’ section; within this
section is a ‘Company Search’ tool. This search engine allows users to search for companies
in Ireland, under the following variables:
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1. Company Name
2. Sector
3. Country of Origin
4. Location in Ireland

Through the selection of either ‘Pharmaceuticals’, ‘Medical Technologies’ or ‘Chemicals’
under the sector variable, and by selecting ‘Cork’, ‘Dublin’ or ‘Galway’ in the location
variable, the search engine produces a list of all companies including web-site address in
each of these sectors, operating within the selected regions.
Enterprise Ireland (El):
Enterprise Ireland is the government agency responsible for the development of Irish
industry, working in partnership with client companies to help them build competitive
advantage in the global marketplace. El’s aim is to bridge the gap between innovation and
internationalisation by working with the research community and with clients to exploit
the benefits of technology innovation.

Through a network of 13 Irish offices and 34

international offices, El works with its clients to win more export business by introducing
them to key buyers and decision makers.
The Enterprise Ireland website (www.enterprise-ireland.com) contains a ‘Source from Ire
land’ section. Within this section web-site users can search for companies by clicking
the ‘Source’ link. This opens a search engine which searches the El list of client com
panies by key word. The researcher entered the sectors of Biotechnology listed in sec
tion 5.7.2 to search for companies involved in biotech in Ireland e.g. agrifood industry,
bio-environmental, etc. After entering these key words individually a list for all compa
nies involved in each sector is shown. By navigating through this list and selecting each
company, details of location and web-site address are found.
Individual Contacts within the Firms:
Through the use of the search engines in the Irish Bioindustry Association, IDA and En110
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terprise Ireland web-sites the researcher was able to search individual company web-sites
for telephone and fax contact details. This information was checked and supplemented
through use of the golden pages sections of the telephone directories for the relevant
search areas. A database for Cork, Dublin and Galway was created with the following
information included:

• Company name
Telephone number
• Fax number
• Web-site address

The researcher needed a contact person in each of the firms in the database who would
have an expansive knowledge of the company, to answer the varied questions in the online
survey. It was decided each company would be contacted by telephone by the researcher.
The researcher phoned each company asking for an e-address for the managing director
or the manager of the business development. In many instances these details were given
over the telephone, in other instances voice mail messages were left asking the individuals
occupying those positions to contact the researcher with their e-mail details. In cases
where this did not bear fruit, details for a contact in management (e.g. in finance or HR)
were sought.
Each database was built to include the details listed above and the contact persons posi
tion in the company^^ where possible. The databases contains 203 companies located as
shown in Table 5.5.
^'Suniriiaric.s of the i)ro(luct or service type and the position field by tfie respondent are given for each
comity in tallies 6.9, Fb4 and G.4
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Distribution of Surveys

Survey Monkey is the name of the software selected for the development, distribution and
analysis of the online survey. Available online at www.surveymonkey.com, the software
package is extremely user friendly, and the feedback and information provided to users
(i.e. researchers) is exceptional. The Survey Monkey technology allows for groups up to
1000 respondents to be contacted instantaneously. After surveys have been distributed.
Survey Monkey provides details such as; how long each respondent actually spent filling
out his responses to the survey. The package also provides the researcher with realtime
data. As soon as respondents send back their responses, the researcher is able to see their
individual responses to specific questions online.
The surveys were sent out via e-mail, each e-mail contained a web-link. The web-links
were specihc to the survey e.g. Cork Academic, Cork Company, Dublin Academic, Dublin
Company, Galway Academic and Galway Company each had its own corresponding weblink. When respondents opened the e-mail, information on the study was provided, and
respondents were asked to give their responses to the online survey by clicking their cursor
on the web-link.
Potential respondents were sent three e-mail messages in total, the first e-mail message^^
gave a full description of the research project and a link to the online survey form. The
second e-mail gave a short summary of the research project and served as a reminder.
The third e-mail was a hnal reminder to submit results for the survey.

5.9

Summary

This chapter outlined the data collection methodology for measurement of the potential
biotechnology cluster in county Cork. Section 5.2.3 produced a dehnition of NACE codes
to represent biotechnology for this project, the data provided through these codes will be
used to create location quotients and therefore measure concentration of biotech in the
b\ copy of the first c-rnail message is reproduced in Appendix H
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counties included in the study. In section 5.3 a description of the research trip to Boston
to assess the biotech cluster is included. A survey to measure interlinkages is created
in this chapter and sections 5.5 and 5.6 outline the rationale for questions asked in the
surveys, the sampling techniques used in this study are included in section 5.7 and hnally
how the survey was distributed is included in section 5.8.
In chapter 6 results for the concentration ratios (location quotients) and surveys are
reported.
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Chapter 6
Results

6.1

Introduction

This chapter is in two broad sections; measurement of geographic proximity and measure
ment of interlinkages between biotech actors within this proximity. Section 6.2 contains
measures of biotech concentration calculated in this study.
Results from the surveys on cluster linkage conducted in Cork are included in section 6.3.
Academic and company survey findings for Dublin and Galway are reported in full in
Appendixes F and G. The chapter progresses with a comparison of the academic (sec
tion 6.3.3) and company (section 6.3.4) responses in Gork, Dublin and Galway.
Discussion of results, conclusion and recommendations arising from the study are outlined
in Chapter 7.

6.2

Geographic Concentration of Biotechnology

The Census of Industrial Production provides data for manufacturing activity in Ireland.
These figures are separated into different industrial sectors using the international indus-
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trial classification NACE Rev. 1 codes^ . In addition, a meeting was arranged with CSO
industry analysts to request specific data for the biotechnology industry.
Data for selected NACE codes were requested as biotechnology crosses many industrial
classifications. The set of NACE codes requested to represent the biotechnology industry
is shown in Table 5.3. Details of how this set of codes were selected are found in sec
tion 5.2. The following regions were assessed; Cork, Dublin, Galway, Other^ and State^.
To capture the geographical concentration of biotech in these regions a location quo
tient was calculated. The results for the employment and net output location quotients
calculated are included in sections 6.2.3 and 6.2.4.

6.2.1

Number of Biotech Units per Region

There were a total of 215 production units in the biotech industry in the Republic of
Ireland in 2001 (See column 2 (Units) of table 6.1).

These units have more than 2

employees. 22% of these production units were located in county Cork, Dublin was the
location for 13% and Galway accounts for 8% of the 215 units. The percentages justify
the selection of these regions, as the three counties account for approximately 45% of
units in this industry in the Republic of Ireland.

6.2.2

Biotech Manufacturing Employment

The total number of biotechnology/pharmaceutical manufacturing employees in the Re
public of Ireland was 30,946 in 2001 (See column 3 (BME), Table 6.1). 24% of this total
employee figure are in County Cork. 11% of industry employees are in Dublin and 16%
are employed in Galway. The three counties analysed in this study account for over 50%
of the biotech/pharma industry workforce in 2001.
Tv)r a list of all NACE codes see Appendix 1 in the Census of Industrial Production 2001 published
bv the CSO (2004a, p 150)
'^This region accounts for all counties within the Republic of Ireland, excluding figures for Cork, Dublin
and Galway
■^State is defined as total figures for the Republic of Ireland
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6.2.3

Relative Concentration: Employment (RC EMP)

Using the location quotient as described in section 4.1.1, column 4 of table 6.1 indicates
that there is a strong concentration of biotech employment in both the Galway and Cork
regions. The RC hgures for 2001, 3.00 (Galway) and 1.97 (Cork), are indicative of an
over representation of biotech employment in these counties, when compared to Ireland’s
biotech employment as a whole^. Dublin reports a figure of 0.44, which is indicative of
an under representation of biotech employment. For a graphical presentation of relative
concentration of biotech employment see hgure 6.1
The large figure (3.00) for Galway may be due to the medical devices cluster^. In CSC
(2001) data provided for this study, Galway had 13 firms involved in Nace 33 (the NACE
code that best describes medical device companies) compared to Cork’s 8 and Dublin’s
7. 4,776 people were employed in NACE 33 (2001) in Galway, a very large number when
compared to Cork’s 1,443 and Dublin’s 535.
Dublin reports total biotech employment of 3,294, and therefore, has the smallest pool of
biotech employees of the three regions studied (See column 3 of table 6.1).
A similar pattern of relative concentration (of employment) is seen across the three coun
ties in 1996. However in 1991 the three selected regions report under representations.
The fluctuation between figures in 1996 and 1991, may in the opinion of Owen Blackburn
(CSO) be explained by changes in product mix or the relocation of production facilities
within Ireland or internationally.

6.2.4

Relative Concentration: Net Output (RC NET)

The location quotient (see section 4.1.1) was used to calculate the concentration of biotech
nology net output in each of the selected counties. Figure 6.2 plots the the location
quotients at three dates, 1991, 1996 and 2001. Results indicate that there is a strong
^Thc State figure reported for RC is always 1
'’Much reference is made to the Medical Devices cluster in Galway, in the IDA Ireland website
www.ida.ie. See i)ress releases 12tli Nov 2002 & 29th .June 2004
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Figure 6.1: Relative Concentration Employment (1991-2001)

concentration of biotech net output in Cork. The RC hgure of 2.14 for Cork in 2001 is
indicative of an over representation of biotech net output in the region, when compared to
Ireland’s total biotech net output. Galway is slightly above the national average reporting
a figure of 1.05, while Dublin indicates under representation at 0.25 for 2001.

6.2.5

Biotechnology Gross Output

Column 7 in table 6.1 reports hgures for biotech gross output at national and study
county levels. These are the total gross output hgures for the 7 codes® selected to represent
biotechnology in this study. The national biotech gross output in 2001 is €25,664,668,000,
and the three counties studied make up over 65% of the national hgure. County Cork
accounts for approximately 56% of the national hgure, while Dublin (6%) and Galway
(3%) make up the difference. In 2001 the gross output hgure for Cork is €14,253,397,000.
Of the 7 codes selected to represent biotechnology, four of these codes are from NACE
24, and 90% of Cork’s gross output is derived from these four industrial sectors. This
®See table 5.3

117

CHAPTER 6. RESULTS

Figure 6.2: Relative Concentration Net Output (1991-2001)

0.40
Galway
• State

0 58
0 82

0.00
1.00

0.25
1.05

1.00
Time in Years

suggests that Cork has a major concentration of biotech within the NACE 24 sector.

6.2.6

Biotechnology Gross Output as a Percentage of Total Man
ufacturing Gross Output

In section 6.2.5, it is shown that in 2001 approximately 56% of biotech gross output at a
national level occurred in county Cork, whilst Dublin accounted for 6% and Galway 3%.
These figures confirm the large manufacturing biotechnology base within county Cork.
In column 7 of table 6.1, a percentage figure for the ratio of biotech gross output to total
manufacturing gross output is presented^. These figures indicate how much of total man
ufacturing gross output is made up of biotech gross output in each region analysed. Each
percentage hgure shows how important the biotech (including pharmaceutical) industry
is as a creator of manufacturing output within the regions analysed. The national average
is 26.0% for 2001; this indicates that approximately | of national manufacturing gross
^Total manufacturing gross output is equal to total gross output for all NACE codes in the Census of
Industrial Production
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output is made up by the biotech/pharma industry. In 2001 the Cork and Galway re
gions total gross output are heavily reliant on biotech/pharma. In particular Cork stands
out recording a hgure of 61.6%, whilst Galway is above the national average with 29.6%.
These figures are in contrast to county Dublin 6.5% and the ‘Other’ region 18.7%. In
these regions biotech/pharma gross output as a percentage of their total gross output is
below the national average. Evolution of these gross output percentages can be seen over
time, through reference to table 6.1.
1996 data shows how biotech/pharma has become increasingly important as a source of
gross output in Cork. In Table 6.1, the BGO%^ hgure for 1996 was 36.5%. Importance
of the biotech/pharma industry to gross output, also increased in Galway and ‘Other’
region.

6.2.7

Biotechnology Gross Output per Capita

The hgures recorded in 2001 for biotech gross output per capita in the study regions
(See column 8 in table 6.1) show that, whilst this is not a measure of concentration or
geographic proximity, there is more output per capita in the biotech industry in county
Gork (€31,828), than in other regions. The 2001 hgures for biotech gross output per
capita population for Dublin, Galway and ‘Other’ regions are below the national average
of €6,552. The 1996 data aligns with the hndings for 2001, with Cork (€7,787) being the
only region above the national average of €2,503. 1991 results show the ‘Other’ region
(€2,542) as the only region above the national average of €1,518.

Cork and Dublin

regions fall well below the national average, with hgures of €303 and €364 respectively.
Population hgures for each of the years used in the study can be seen in table 6.2.
Tiotech Gross Output as a percentage of Total Manufacturing Gross Outjrut
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Tabic 6.1: Quantitative CSC) Data
Region
Col 1

State
Cork
Dublin
Galway
Other

Units
No.
Col 2

215
48
28
18
121

BME
No.
Col 3

RC EMP
No.
Col 4

RC NET
No.
Col 5

BGO
€,000
Col 6

BGO%
%
Col 7

BGO p C
€
Col 8

30,946
7,358
3,294
5,100
15,194

2001
1.00
1.97
0.44
3.00
0.85

1.00
2.14
0.25
1.05
0.72

€25,664,668
€14,253,397
€1,641,038
€879,118
€8,891,116

26.0%
61.6%
6.5%
29.6%
18.7%

€6,552
€31,828
€1,462
€4,205
€4,160

1.00
1.94
0.58
0.82
0.89

€9,076,069
€3,274,664
€1,149,295
€284,618
€4,367,490

18.6%
36.5%
9.8%
16.8%
16.5%

€2,503
€7, (87
€1,086
€1,507
€2,230

1.00
0.17
0.40

€5,351,955
€124,301
€373,659

18.7%
2.2%
6.1%

€1,518
€303
€364

-

-

-

-

28.8%

€2,542

State
Cork
Dublin
Galway
Other

208
46
32
10
120

22,080
5,206
2,458
2,039
12,377

1996
1.00
1.99
0.45
1.98
0.96

State
Cork
Dublin
Galway
Other

198
10
14

19,184
1,003
1,792

1991
1.00
0.45
0.35

-

-

174

16,389

-

1.38

0.15

€4,853,993

Notes:
• Units = Number of Biotech Units per Region
• BME = Bioteeli Manufacturing Employment
• R.C EMP = Relative Concentration of Biotech Employment per Region
• RC NET = Relative Concentration of Biotech Net Output per Region
• BGO = Biotech Gross Output
• BGO% = Biotech Gross Output, as a % of Total Manufacturing Gross Output
• BGO p C == Biotech Gross Output per Capita Population of Region
•

No figures are reported for Gahvay in 1991 as there were no companies operating
under the selected NACE codes d.uring that year
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Table 6.2: Regional Population Data for 2001, 1996 & 1991

Region

1991

1996

2001

State
Cork
Dublin
Galway
Other

3,525,719
410,396
1,025,304
180,364
1,909,682

3,626,087
420,510
1,058,264
188,854
1,958,459

3,917,203
447,829
1,122,821
209,077
2,137,476

Source: Census of Population 2002 (Vol by Area)

6.2.8

Biotech Employment per Km^ as a Concentration Mea
sure

Through the use of a quotient® of biotech employment and square kilometers for each
region^®, density effects are captured and results are presented in Table 6.3. It is apparent
from Table 6.3 that in 2001, Dublin has the largest number of biotech employees per km^,
at 3.58, Cork has the second largest at 0.98, followed by Galway 0.83 and ‘Other’ at
0.27. Cork, Dublin and Galway are all above the national average of 0.44. These figures
show that there are more biotech employees per km^ in Dublin, which may enable easier
face-to-face contacts.
Data for total manufacturing employment per km^ reads in much the same manner as
biotech employment per km^ for 2001 (See table 6.4). Dublin has the largest number of
persons employed in manufacturing per km^, at 71.22. Cork reports a figure of 4.32, while
Galway’s result is 2.39. Similar to the biotech per km^ figures the ‘Other’ region (2.80)
is the only region that records a figure below the national average of 3.82.
Also included in Table 6.3 are percentages of total national biotechnology employment
made up by the biotech workforce in each study region. It is apparent from Table 6.3 that
®'rhe quotient of einploynient and square kilometers, was enqjloyed by Lublinski (2002) to measure
aeronautic employment jier square kilometer
I'o achieve tins biotech emj)loyment i)er region is divided by the kilometers'^ per Region
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Cork (2o.78%) has the largest share of national biotech/pharma employment, followed by
Galway (16.48%) and Dublin (10.64%). Table 6.4 provides the share of manufacturing
employoent in each study region.
The autior considers the quotient of biotech employment and square kilometers for each
region, rot to be a reliable concentration measure for clusters due to these reasons:

1. Tie biotech employment per km^ results are not representative if a large proportion
af the land area has no biotechnology employment. This occurs in county Cork
wlere biotech and pharmaceutical manufacturing is located in a small area at Little
Islmd and Ringaskiddy on Cork harbour, and near Kinsale.
2. The biotech employment per km^ results, whilst showing a large figure for Dublin
n particular, do not take into account factors such as travelling time within the
regions^^ . As a result, it is not necessarily true that face-to-face contact is more
easily achieved in Dublin when compared to counties Cork or Galway.

6.2.9

Average Manufacturing and Biotech Wages

Data for average manufacturing wages (in all NACE Rev. 1 codes in the Census of Indus
trial Frcduction) and average biotech/pharma wages are provided in table 6.5. Dublin
(€43,332) and Cork (€34,457) regions have biotech wages above the national average of
€29,9)2. It is apparent from table 6.5 that average biotech wages are larger than average
manulacmring wages for all years studied, with the exception of county Galway.
This eecdon concludes the first stage of the measurement of a cluster, with results in
dicating concentrations of manufacturing employment and output in counties Cork and
Galway The focus of this chapter now switches to the measurement of interlinkages
between cluster actors, within the counties included in the study.
^^Du)li]i has major traffic delays, so travelling within the region during working honrs, is generally
acceptel to take longer than travelling within county Cork or Galway.
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Table 6.3; Biotechnology Employment Per Kilometer^

Region
State
Cork
Dublin
Galway
(3ther

1991
BEpKrn"
%BE
0.27
100.00%
0.13
5.23%
9.34%
1.95
0.27
85.43%

1996
BEpKrn%BE
0.31
100.00%
0.69
23.58%
2.67
11.13%
0.33
9.23%
0.22
56.06%

2001
BEpKni%BE
0.44
100.00%
0.98
23.78%
10.64%
3.58
0.83
16.48%
0.27
49.10%

70,182
70,182
7,508
921
6,151
55,603

Kni'^
KnP
KnP
KrnKm^
Kni'^
Kiri^

Notes:
1. % of Biotechnology Einpl (%BE) = the % of Total National Biotechnology Employ
ment made up by the workforce in that Region.
2. No figures are reported for Galway in 1991 as there were no companies operating
under the selected NACE codes during that year.

Table G.4: Manufacturing Employment Per Kilometer^

Region
State
Cork
Dublin
Galway
Other

1991
MEpKin"
%ME
3.07
100.00%
3.35
11.69%!
61.90
26.49%
61.82%
2.15

1996
MEpKnr
%ME
3.49
100.00%
3.87
11.86%
24.83%
65.98
4.66%
1.85
2.58
58.65%

2001
MEpKirP
%ME
3.82
100.00%
4.32
12.08%
71.22
24.43%
5.49%
2.39
2.80
58.00%

70,182
70,182
7,508
921
6,151
55,603

KmKm'-^
KnP
KnP
KnP
KrnKm'^

Notes:
1. % of Manufacturing Empl (%ME ) = The % of Total National Manufacturing Em
ployment made up by the workforce in tliat Region.
2. No hgures are reported for Galway in 1991 as figures for total manufacturing in the
region were not provided for 1991.
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Table 6.5: Average Wages
Average Mariiifactiiring Wages
Region

1991

1996

2001

State
Cork
Dublin
Galway
Other

€17,400
€18,555
€18,970
€16,509

€20,694
€21,920
€23,280
€18,239
€19,546

€27,596
€28,924
€31,395
€22,908
€26,783

Average Biotech Wages

6.3
6.3.1

Region

1991

1996

2001

State
Cork
Dublin
Cal way
Other

€22,107
€20,800
€31,502
€21,160

€24,918
€29,632
€33,085
€16,625
€22,680

€29,902
€34,457
€43,332
€22,003
€27,436

Survey Findings on Cluster Linkages
Cork Academic Biotechnology Survey

Questionnaires were sent out online, to all 41 members of the database created to represent
Cork academia engaged in biotech research.

There were 16 respondents to the Cork

academic biotech survey, a response rate of 39%. 11 of these respondents are in University
College Cork, with 5 respondents based in Cork Institute of Technology.
In question 2 respondents were asked to provide an estimate of the number of researchers
in their department/centre. Many respondents gave figure for their particular research
group whilst others gave numbers for their department. The average number of researchers
per department in Cork is 71.
Figure 6.3 shows the fields within which respondents are conducting research. In many
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Figure 6.3: Sectors of Research Actively Being Pursued by Cork Academics
□ Agrifood Industry

I Healthcare Therapeutics

None of the Above

2%
Bio-Informatics

Agrifood Industry
19%

□ Healthcare Diagnostics

□ Pharmaceutical
Bio-Environmental
18%
I Pharmaceutical Services

□ Medical Devices
Healthcare Therapeutics
19%

Medical Devices

6%

I Bio-Environmental

Pharmaceutical Services

2%
□ Bio-Informatics
Pharmaceutical

10%

Healthcare Diagnostics
16%

I None of the Above

instances respondents had been researching in more than one of the sectors. Therefore,
total number of responses was aggregated and the percentages reported in Figure 6.3
result from dividing the number of responses for individual sectors by the total number of
responses for all sectors. The largest areas of interest to this sample of researchers from
Cork are healthcare therapeutics and the agrifood sector.
Questions 4 and 11 in the academic surveys are linked. They aim to assess the level of
contact between academia and biotechnology firms with regard to the skills they require
graduates to possess, and furthermore if such dialogue is creating employment gateways for
graduates into firms within that locality. Results indicate that there is dialogue between
academia and industry (Q4). 11 respondents indicate that dialogue occurred with regard
to future skills required, 4 respondents felt there was no interaction between their academic
department and industry, and 1 respondent was unaware of any dialogue. 14 of the 16
respondents to Qll indicated that graduates from their department are now working in
biotech/pharma industry in Cork.
In question 5 an attempt is made to discover in what areas of knowledge and skills
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Table 6.6: Coinmercialising a new discovery: favoured options of Cork acadeiriics

Description
Commercialise with an Industry Partner
Patent and License Out
Collaborate with your University/Institute
Patent and Sell the Patent
Patent and Commercialise Discovery Yourself

Result
4.06
4.06
3.81
2.88
2.31

transfer, does academia have linkages to firms in industry. 8 respondents indicated that
their department has links with local biotech/pharma companies in the area of consul
tancy/funded research. 6 respondents indicated linkages in both personal research and
training. 2 respondents reported linkage in analytical services. 3 respondents felt there
was no linkage between their academic departments and local industry, on any of the
variables mentioned.
Question 6 was included to assess what options researchers would take in the event of
their discovering a new technology, product or process. This question was included on the
request of Rosemary Durcan of IBIA. The question is answered in the form of a Likert
scale, as used previously in the work of Lublinski (2002). The Likert scale is a rating
scale ranging from 1 = not likely to 6 == extremely likely. Average results for the various
options can be seen in Table 6.6.
Questions 7 and 8 assess perceptions on availability and source of research funding. 10
of the 16 respondents found funding to be more accessible in the past two years, while
5 respondents felt funding was less accessible during that period. SFI received the most
frequent mention being indicated by 7 respondents. PRTLI were the main supporters of
research in 4 instances. Enterprise Ireland were put forward by 2 respondents, 1 respondent
felt industry partners were responsible for the majority of their funding, 2 respondents
named their major funding sources as the ERA (under the NDP) and the Irish Cancer
Society/Wellcome Trust.
Questions 9, 10 and 12 explored the extent of contact and face to face meetings be126
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Table 6.7; Cork academics meetings with employees of biotech companies
Timeline
In the Past Whek
In the Past Month
In the Past 3 Months
More than 3 Months ago
No Contact

Social Context
2
3
0
1
6

Business Context
1
3
5
2
5

Table 6.8: Cork academics meetings with graduates working in biotech hrins
Timeline
In the Past Month
In the Past 3 Months
More than 3 Months ago
No Contact

Social Context
1
1
4
4

Business Context
2
3
0
i

tween academia and firms engaged in biotechnology. Question 9 results indicate that 8
respondents have personal contacts in 1 to 3 biotech/pharma companies, 1 respondent
has personal contacts in 4 to 6 biotech/pharma companies, 3 respondents have contacts
in more than 6 biotech/pharma companies. 4 respondents reported that they have no
personal contacts in biotech/pharma companies.
Question 10 addresses frequency of social and business contact that respondents have
had with employees of biotechnology firms in Cork. Results for the 16 respondents are
presented in Table 6.7. More respondents report business meetings with employees of
firms involved in the industry, than the number of respondents who do not.
Question 12 addresses the amount of social and business contact that respondents have
had with graduates of their institutions, who are now employees of biotechnology firms.
Results for the 16 respondents are presented in Table 6.8. More respondents have social
contact with former graduates who are now employees of firms involved in the industry,
than the number of respondents who do not.
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Question 13 is an open question, asking how co-operation between academia and industry
within the Cork region might be enhanced. 6 out of the 12 respondents to this question
indicated that a possible area to increase co-operation would be to open clearer channels of
communication, e.g. semiformal or formal networks, e.g. “A clear ofhce or person whom
I could approach for advice to facilitate meetings with appropriate companies”. “Set up
a semi-formal network to facilitate exchange of information and ideas which may go on to
result in funded research projects” Two other respondents indicated that perhaps there
should be more communication between local researchers and multinational companies’
research bases (i.e. those based abroad).

6.3.2

Cork Company Biotechnology Survey

Questionnaires were sent out online, to all 66 persons on the database created to represent
Cork biotechnology companies. There were 16 respondents to the Cork company biotech
survey, a response rate of 24%. Results for Question 1 are in Table 6.9 .
Question 2 distinguishes between multinational and indigenous hrms; 10 multinational
firms and 6 indigenous hrms responded to the survey.
Question 3 asked respondents in what sector their company conducts its main business,
in which sectors they do R-kD, and hnally the sector in which they have products on the
market. Results can be seen in Figure 6.4.
Question 4 related to turnover and R&D as a % of turnover. 11 of the 16 hrms reported
their turnover, with 10 respondents reporting a turnover of €5 million or over, three of
these reported a turnover hgure of over €100 million. Ten respondents reported a hgure
for R&D as a % of turnover; two respondents reported 0%, seven respondents reported
hgures less than or equal to 5%, and one respondent reported a hgure greater than 10%.
Questions 5 and 6 relate to the destination of sales and the sources of raw materials or
inputs. Average percentages for the 15 respondents to these questions are in Table 6.10.
Question 7 asks what factors are important in leading biotech companies to locate in
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Table 6.9: profile of respondents to Cork Coinpany Survey (Ql)
Companies Principal Prodiict/Service

Position in Company

Medical Device - lOL
Contrast media for X-ray and MRI
Manufacture of food ingredients
Active Pharmaceutical Ingredients
Orthopedic Implants
Consultancy
High Purity Stainless Steel Equipment
Tablet Manufacturing
Precliriical products
Innovative and Branded Medicines
Citric Acid
Oxygen Monitoring
A u t omat ion/ Elec t, r ica l
Pharmaceutical Tablets
Bidk Pharmaceuticals
Process Engineering Solutions

Personal Ass. to Plant Mgr.
Managing Director
Managing Director
Director of Quality
Plant Manager
Director
Marketing Executive
Accountant
Research Director
QP/QA Manager
HR Manager
Chief Executive Officer
Group Manager
Site Leader
Process development Mgr.
Commercial Manager

Table 6.10; Destination of sales and origin of inputs for Cork respondents
Market

Cork
Rest of Ireland
Rest of Europe
Rest of the World

% of Sales
9.7%

% of Raw Materials

18.7%

13.7%

33.1%

51.7%
21,5%)

38.4%
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Figure 6.4: Business Sectors Pursued by Cork Company Respondents
O Main Business

I R&D Phase

□ Products on Sale in Market

Industrial Sectors

county Cork. All 16 respondents to the questionnaire answered this question, results can
be seen in Figure 6.5. The results can be interpreted in the following manner, e.g for the
factor ‘Similar Companies in the Area’, 2 respondents felt this was the most important
factor, one respondents gave a number 2 rating, two gave a number 3 rating, with three
respondents each indicating a number 4 and 5 response. It is apparent (Figure 6.5) that
‘Highly Skilled Workforce’ is the main reason respondents felt biotech companies choose
to locate in Cork, with ‘State Support’ viewed as the second most important factor.
Question 8 asked how many business customers, suppliers and competitors each respon
dent has in Cork. For the 14 respondents to this question the average answers for each
entity were: 8 Business Customers, 12 Suppliers and 2 Competitors within County Cork.
Question 9 sought information on total employment and also the numbers of R&D em
ployees within the respondent company in county Cork. The averages for the these two
variables for 15 respondents to this question were as follows, 131 employees per unit with
130
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Figure 6.5: Ranking of Importance Factors that lead Companies to choose a Cork Location

O Number 3's
Number of Respondents

2

□ Number 4's

^

Similar
Companies
in Area

State
Support

Close to
Major
Airport

Close to
Major
Harbour

Close to
Highly
3rd Level
Skilled
Institutions Workforce
Factors

Access to
European
Market

Wage
Rates

■ Number 5's

Supportive
State
Agencis

approx 5 R and D employees per unit.
Question 10 was answered by 14 respondents. It relates to the source of new recruits to
the company. On average 32% of employees were recruited from other Cork companies in
similar industries, and 21 % were recruited straight from third level institutions in Cork.
Question 11 asked about the frequency with which company employees may be recruited
by other companies. Respondents were asked to answer on a Likert scale from 1-6, where
1 represents very infrequent, and 6 represents quite frequent. Average results for 14
respondents are: recruited by Cork based companies (2.81), by Irish companies (2.75)
and hnally by companies abroad (1.87). These averages indicate that respondent company
employees are not recruited by other companies frequently.
Question 12 asked what skills respondents felt their companies would need to supplement
through recruitment if their Cork operation were to expand. 3 respondents felt business
development needed to be supplemented, 3 were of the opinion that engineering would
be supplemented, 9 respondents felt that manufacturing skills would be supplemented
131
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Tabic 6.11: Likelihood that company respondents could recruit skills in county Cork
Skill Type
Legal/lP
Marketing
Manufacturing
Other
Engineering
Business Development
Research/Scientihe
Clinical

Average Result
6.0
5.0
4.9
3.5
3.0
2.8
1.7
1.0

and 1 respondent felt the research/scientihe function would be supplemented through re
cruitment. All 16 respondents answered this question. None of the respondents indicated
that recruitment would be necessary of skills in the clinical, legal/IP, marketing or other
categories.
Question 13 is related to 12. Question 13 asked “Regarding skills you would need to
recruit (Q12), please indicate the likelihood that you would manage to source these skills
within county Cork, on a scale of 1 = most unlikely to 6

highly likely.” Answers for this

question were averaged with the divisor being the number of respondents who answered
that particular variable. Results (shown in Table 6.11) indicate that it would be more
difficult to locate research/scientihe, clinical and business development staff within Cork,
as opposed to other functions.
Section 2 of the survey “Academic Linkage, Collaboration, Innovation and Policy”, begins
with question 14, which asks in which activities do companies have linkages with academic
institutions in county Cork. Results are reported in Table 6.12
Questions 15 and 16 address the level of collaboration between companies in county
Cork, and also in which area companies feel there could be potential collaboration. Re
sults presented in Table 6.13 show that the majority of collaboration (Q15) takes place
in training initiatives (8) and also in sub contracting of manufacture (6), followed by
marketing/sales/distribution (4). As there is collaboration across all variables prompted
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Table 6.12: Cork Linkage between Industry and Aeademic Institutions

Institution
University College Cork
Cork Institute of Technology
National Microelectronic Centre
National Food & Biotech Centre
Other Cork Based

Training
1
3
0
0
0

R&D
4
0
2
1
0

Employment
4
5
0
1
1

Course Content
1
0
0
0
0

Table 6.13: Cork industry respondents levels of collaboration

Variable
Shared Technology
Licensing Arrangements
Researcli and Development
Training
M ar ket i ng/ S ales /Distribution
Sub Contracting of Manufacturing
Other .loint Ventures

Current
Collaboration
Question 15
No
Yes
12
2
12
1
2
12
5
8
4
9
7
6
0
11

Potential
Collaboration
Question 16
Potential
3
3
5
6
2
6
1

in Table 6.13, this is indicative of mild clustering. The ‘Potential’ column relates to the
numbers of respondents who feel there is room for collaboration under specified headings;
training (6), sub contracting of manufacture (6) and R and D (5) are the top areas for
potential collaboration.
Question 17 asks what respondents view as signihcant barriers to joint collaboration. This
question is also linked to questions 15 and 16. 12 respondents answered this question, 8
felt that the availability of suitable partners was the most significant barrier to collabora
tion, 5 respondents believed commercial confidentiality was a significant barrier, while 2
respondents indicated government support; availability of capital and the availability of
qualified personnel were each indicated by 1 respondent.
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Question 18 is an open question asking, if there is one thing that could be done to enhance
co-operation between companies in Cork, what would it be? 7 respondents answered
this question, 5 of these indicated that more active networking possibilities and linkage
opportunities need to be encouraged. Within these networks respondents indicated they
would like to see involvement of multinational firms, indigenous hrms and supplier hrms.
Other respondents indicated they would like to see an “Increase in the number of biotech
companies” and an “Improvement in the mechanical engineering skills base”.
In question 19, respondents were asked what significance do customers, suppliers, com
petitors and academic institutions within Cork have as a source of knowledge for their
product development. Answers were again on a Likert scale basis from 1-6, where 1 =
low significance and 6 = high significance. A “Not applicable column is also included
(N/A)^^. Answers for this question were averaged with the divisor being the number of
respondents who answered that particular variable. Business customers in Cork (1.83),
suppliers in Cork (1.77) and competitors in Cork (0.92) were rated as having low signif
icance, while academic institutions in Cork scored an average figure of 3.54, indicating
that academic institutions in Cork have moderate significance as a source of knowledge
for product development.
Question 20, using the Likert scale format, asks respondents how important are trust and
face-to-face contact to the foundation of an effective business relationship. Respondents
were asked to rate the factors on a scale of 1 = Not Important to 6 = Very Important. 13
respondents answered this question, with Trust recording an average result of 5.38, and
Face-to-face contact 4.54. Both factors are viewed as important factors in the foundation
of business relationships.
Question 21 is another Likert scale type question. It asks respondents to rate the level
of support that they receive from a number of different organisations, on a scale of 1 6, where 1 = Little support and 6 = Large support. A Not applicable (N/A) column
is includediT Average results can be seen in Table 6.14. The IDA (2.38), Enterprise
N/A is the selected answer for a particular variable, that varial)le receives a 0 as its resalt, therefore
all responses are taken into account
13 The N/A column is calculated as per question 19
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Table 6.14; Level of support received by Cork industry respondents

Organisation
IDA Ireland
Enterprise Ireland
Other Government Agencies
Gharnber of Commerce
Other Trade Associations
Local Government
National Government
Science Foundation Ireland
Irish Bioindustry Association

Average Result
2.38
2.36
2.29
1.93
1.71
1.57
1.50
0.77
0.71

Ireland (2.36) and Other Government Agencies are viewed as the organisations whom
give greatest support to Cork respondent companies.
Question 22 is an open question, in which respondents are asked how could policy be
enhanced to help their operations. Answers to this question were varied. Suggestions
include:

“Policy is adequate, we need to get industry more proactive in utilising what’s
already there!”
“Increased grants for biotech companies. SFI grants encouraging transfer of knowl
edge from universities to industry.”
“National government and national agencies should give more assistance to the
indigenous industry, when they have expansion plans, even though product devel
opment assistance is available.”
“Increase tax relief for R&D. Tax free salaries for the first three years of starting up
business, as is currently the case in France.”
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6.3.3

Academic Survey Comparison: Cork, Dublin

Galway

Numbers of respondents and response rates for the academic surveys in Cork, Dublin and
Galway can be viewed in Table 6.15
Results for the academic surveys are reported in two groups: questions relating to the
prohle of respondents and questions relating to the level of Interlinkages.
Questions relating to the profile of respondents

In the academic surveys questions 1, 2, 3, 6, 7 and 8, are mainly concerned with building
a profile of the respondents.
Question 1 sought general respondent details. Results for this question show the academic
affiliation of respondents for each study area as follows; Cork: 11 university and 5 institute
respondents, Dublin: 12 university and 1 institute respondent and Galway: 12 university
and 2 institute respondents.
Respondents were asked for the number of researchers that are working in their depart
ment in question 2. Table 6.15 shows that Dublin has the highest average number of
researchers per department (73), followed by Cork (71) and Galway (55).
Question 3 sought to assess what sectors of research are being pursued by respondents.
The results again shown in Table 6.15 indicate that healthcare therapeutics is the area of
greatest interest to respondents to the survey.
Question 6 is included on the request of the Irish Bioindustry Association. The question
seeks to assess which option is the most likely route for a researcher who discovers a new
technology. Patent and licence out along with commercialise with an industry partner
are the joint (4.06) preferred courses of action in Cork, whilst collaboration with the
university or institute is the most popular choice in Dublin (3.77) and Galway (3.57). See
Table 6.15 for a full list of responses for each category.
Question 7 asked respondents if they viewed funding as more accessible in the last 2 years.
100% of Dublin respondents felt funding was more accessible, while the hgures for Cork
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and Galway were 63% and 29%.
Question 8 seeks to determine which funding agencies have been to the forefront of fund
ing of research in respondents’ departments. Science Foundation Ireland is to the fore
in Dublin (92%) and Cork (44%) while Enterprise Ireland support was seen as most
signihcant in Galway (42%).
Questions relating to the level of Interlinkages
In the Academic surveys questions 4, 5, 9, 10, 11, 12 and 13 are concerned with various
linkages between the academic community (the respondents) and other biotech actors.
In question 4 academics were asked if their departments have contact with industry with
regard to the skills industry require third level graduates to possess. 69% of Cork respon
dents indicated that there was contact in this area. 71% of Galway respondents indicated
linkage in this category whilst the figure for Dublin was 39%.
Question 5 asked academic respondents if their departments had links with biotechnology
industry in regard to the following areas, consultancy/funded research, personal research,
analytical services, training and not applicable. Results presented in Table 6.15 indicate
that a higher percentage of Cork academics have linkage with industry in all areas ex
cluding analytical services, where Galway had a higher percentage of linkage.
Question 9 asked academic respondents if they have personal contact with employees of
biotech companies within the region. Respondents were asked to select from a list of
options: personal contact in 1-3 companies, 4-6 companies, 6-|- companies or no personal
contact. Responses across the variables for all regions were similar and can be viewed in
Table 6.15.
Question 10 asked about the frequency with which respondents met with employees of
biotech companies in a social situation and a business context. Results in Table 6.15
can be interpreted as follows; respondents in Gork survey show that in the past week 2
respondents have met with employees of the biotech industry in a social context and 1
respondent met employees of the industry in a business context.
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Table 6.15: Academic Survey Comparison
Cork

Dublin

Galway

16

13

14

39%

34%

29%

71

73

55

AgriFood Industry

19%

0%

11%

Healthcare Therapeutics

19%

20%

23%

Healthcare Diagnostics

16%

11%

16%

Pharmaceutical

10%

21%

11%

Pharmaceutical Services

2%

0%

3%

Medical Devices

6%

5%

5%

18%

11%

18%

Bio-Informatics

8%

11%

5%

None of the Above

2%

21%

8%

Description

Question

Respondents
Response Rate

2

3

Researchers Per Department

Bio-Environmental

4

Dialogue between academia and industry

69%

39%

71%

5

Consultancy/Funded research

50%

38%

43%

Personal research

38%

31%

29%

Analytical services

13%

8%

29%

Training

38%

23%

36%

Not Applicable

19%

23%

14%

Continued on next page
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Question

Description

Cork

Dublin

Galway

Patent and sell the patent

2.88

2.23

2.71

Patent and license out

4.06

3.62

3.00

Patent and commercialise yourself

2.31

2.31

0.93

Commercialise with industry partner

4.06

3.23

2.86

Collaborate with University/Institute

3.81

3.77

3.57

7

Funding more readily available

63%

100%

29%

8

Science Foundation Ireland

44%

92%

21%

PRTLI

25%

8%

21%

Enterprise Ireland

13%

0%

42%

Other

19%

0%

14%

Personal contact in 1 - 3 companies

50%

54%

64%

Personal contact in 4 - 6 companies

6%

8%

7%

Personal contact in 6+ companies

19%

8%

14%

No Personal contact

25%

31%

14%

6

9

10

11

In the past week:

social/business

2/1

2/2

1/0

In the past month:

social/business

3/3

4/4

1/2

In the past 3 months:

social/business

0/5

1/2

3/3

More than 3 months ago:

social/business

1/2

0/1

3/6

No contact:

social/business

6/5

5/4

0/2

88%

69%

86%

Graduates working in the region

Continued on next page
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Question

12

Description

Cork

Dublin

Galway

In the past month:

social/business

1/2

2/1

2/3

In the past 3 months:

social/business

1/3

4/3

1/4

More than 3 months ago:

social/business

4/0

2/4

1/1

No contact:

social/business

4/7

5/4

5/5

In question 11 respondents were asked if graduates from their department are at work
in the biotech industry in their county. 88% of Cork respondents indicated that their
graduates are working in biotechnology in the area. 86% of Galway respondents gave a
positive response whilst the figure for Dublin was 69%.
Question 12 asked respondents how long has it been since they met with employees of
biotech companies who were previously graduates of their departments, in both a social
context and a business situation. Results can be interpreted as per question 9 and are
reported in Table 6.15.
Question 13 asked respondents what could be done to enhance co-operation between
companies and academia. The general consensus across study regions is that regular
forums between academia and industry should be organised. In these meetings researchers
hope to receive information from companies with regard to which areas they (the biotech
companies) are currently interested in. This could perhaps lead to meetings between
individual companies and researchers to arrange collaboration on projects. Also these
meetings would create a bridge between academia and industry, in that academics would
have more potential contacts when or if they wanted to pursue collaborations.

6.3.4

Company Survey Comparison: Cork, Dublin & Galway

Numbers of respondents and response rates for the company surveys in Cork, Dublin and
Galway can be seen in Table 6.16
Results for the company surveys are be reported in two groups: questions relating to the
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profile of respondents and questions relating to the level of Interlinkages.
Questions relating to the profile of respondents

In the company survey questions 1 - 7, 9, 12, 17 and 22 are primarily concerned with
building a profile of respondents.
Question 1 provided general respondent and company information, principal product, year
established and respondent’s position in the company are provided in Table 6.9 and also
in Appendixes Tables F.4 and G.4.
Question 2 (results are reported in Table 6.16) indicates what percentage of respondents
companies are multinational and what percentage are indigenous. Responses were on
average 60:40 in favour of multinational companies.
In question 3 respondents were asked in which sectors of the biotechnology industry are
they operating, if they have products or processes in the R&D phase or on the market.
Results are presented in Table 6.16. For the pharmaceutical sector the result in Cork was
7/3/3; this can be interpreted as follows; 7 respondents from Cork indicated that their
main business (MB) was in the pharmaceutical sector, 3 respondents indicated they had
products or processes in the research and development phase (RD) and 3 respondents
have products actually on sale in the market (PM).
Question 4 related to turnover and what percentage of turnover is spent on research and
development. Approximately 28 of the 55 respondents to the company surveys answered
this question. Results can be viewed in Table 6.16. There is a large variation in results
in the study regions.
The aim of question 5 was to see what level of respondent company sales are accounted
for within the county, and to progressively wider markets. The results in Table 6.16, show
that Dublin respondents make the most sales within their county (26%). Cork respondents
make 10% whilst Calway respondents make 6% of their sales within the region. Dublin
results show that approx 46% of their sales are made within Ireland. The other regions
record figures of 29% (Cork) and 24% (Calway).
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Question 6 is concerned with the percentage of raw materials that are sourced locally
and progressively further afield. Dublin is again the leader as respondents indicate that
34% of their raw materials are sourced in the county, while 43% of their raw materials
are sourced from the rest of Ireland. Cork sources 13% locally and 27% from the rest of
Ireland, whilst Galway sources 8% locally and 26% elsewhere in Ireland. Full results for
the question can be seen in Table 6.16.
Respondents to question 7 were requested to rank the factors which they felt were most
important in leading a biotechnology company to locate within their specihc region. Re
spondents were asked to rank a range of variables from 1-5, 1 being the most important,
2 being 2nd etc. Results for most important factors (1) are shown in Table 6.16, these
results show that Cork respondents rate state support and highly skilled workforce as
more important factors. Dublin respondents rate highly skilled workforce more impor
tantly than the other regions. Galway companies indicate that state support is the factor
of most importance.
Question 9 addresses the issue of how many R&D employees companies have on average in
the various regions studied. This question asked respondents for total number of employees
and also how many dedicated research and development employees were working in their
firm. Results for the regions are reported in Table 6.16. The numbers of R&D employees
for all regions is small, especially in comparison to the large numbers of employees per
company reported in Galway and Cork. To make results more comprehensible average
percentage of R&D employees per unit show that Dublin, (the region with the lowest
average number of employees (52) per biotech company) has the largest average percentage
of R&D employees (5.8%); Galway reports a figure of 5.5% and Cork 3.8%.
In question 12 respondents were asked to indicate which skills would need to be sup
plemented through recruitment during an expansion of respondents current operation.
Results (in Table 6.16) show that manufacturing skills were indicated by 56% of Cork
respondents, business development and manufacturing were each indicated by 25% of
Dublin respondents. Galway respondents regarded research/scientific as the skill they
would need to supplement.
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Question 17’s results could prove helpful for the facilitation of more collaborations. Re
spondents were asked which of the following factors would they view as significant barriers
to joint collaboration^'^. The results can be seen in Table 6.16. Dublin respondents viewed
suitable partners (13) and availability of capital (9) as the most significant barriers to
collaboration, whilst Cork indicated suitable partners (8) and commercial confidential
ity (5). Galway respondents felt that commercial confidentiality (5) and availability of
capital were the largest barriers to collaboration. Other barriers mentioned by Dublin
respondents were ‘head office support’, ‘IP ownership issues’ and ‘knowledge of market .
The other issue mentioned as a significant barrier in Galway was ‘Attitudes .
Question 22 asked respondents how policy could be enhanced to help their operations.
Responses across the regions were similar, increased tax relief for R&D is mentioned by
respondents in all regions. This point is reinforced by a Dublin respondent who suggests
that there should be a “Continued focus on development of the biopharma sector and in
particular the encouragement of R&D in bioprocessing/biopharma within Ireland .

Tax

free salaries for first three years of starting up business as is the case in France was
offered by a Cork respondent.
Questions relating to the level of Interlinkages
In the company survey questions 8, 10, 11, 13, 14, 15, 16, 18, 19 and 21 were concerned
with various linkages between the biotech industry (companies represented by the respon
dents) and other biotech actors in the study area.
In question 8 respondents were asked to indicate numbers of their business customers,
suppliers and competitors within the region. Results are reported in Table 6.16 for Cork,
Dublin and Galway.
Question 10 is concerned with recruitment of employees. Respondents were asked what
percentage of their employees were recruited from firms in the same area and also straight
from 3^*^ level institutions in the same areas. Average responses are shown in Table 6.16.
Question 11 asked respondents to indicate the frequency with which their employees may
^'‘Respondents were invited to indicate more than one variable if appropriate
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be recruited by other companies, in the county, in the rest of Ireland and by companies
operating abroad. Responses may be interpreted as follows, respondents were required to
answer on a Likert scale from 1 very infrequent to 6 quite frequent. Average responses
for all regions indicate that head hunting of employees by other firms does not seem to
be an issue. Table 6.16 includes results for each of the regions participating in the study.
Question 13 is another Likert scale question, where respondents are aisked if their local
operation was due for expansion, could they indicate on a scale of 1 = most unlikely to 6
= very likely the likelihood that they would be able to source the required skills within
the region they are currently operating in. Regional average responses for the 8 variables
in question 13 can be viewed in Table 6.16.
In question 14 respondents^^ were asked which of the following institutions (in your
county) do you have linkages with, and in which areas are these linkages. For this ques
tion different regions contained the relevant nearby institutions^®. Linkages named in
question 14 were; Further training, R&D, Employment and Course content. Results (see
Table 6.16) can be interpreted as follows; under the training variable in column 2, the
Cork results were 1/3/0/0. These figures show that 1 Cork respondent had a training
linkage with a University, 3 had training linkages with an Institute, no respondents had
training linkages with research centres and none had training linkages with other Cork
based institutions.
Question 15 and 16’s results are reported together in Table 6.16. Question 15 asked re
spondents do their companies currently have collaborations with other firms in the region
in any of the listed areas. In question 16 respondents were asked which of these areas do
they see as having potential for collaboration. The results for these questions are inter
preted as follows: Cork reports a figure of 2/3 for the variable Shared Technology, this
^'’qn this question tlie keys to interpret the variables listed in Table 6.16 are: Uni = Universities; Ins
= Institutes of Technology; Cen — Research Centres and 0th = Other Institutions based in the county.
^®In the Cork Coinpau}^ Biotechnology Cluster questionnaire included in Appendix E, University Col
lege Cork, Cork Institute of Technology, National Food and Biotechnology Centre and the National
Microelectronic Research Centre are listed in question 13. The Dublin version of this (piestionnaire in
cludes all relevant Universities, Institutes and Research Centres e.g. 4'rinity College Dublin, University
College Dublin and Dulrlin Institute of Technology etc.
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indicates that two Cork based respondent companies have shared technology collabora
tions in Cork, also 3 Cork based respondents feel that shared technology is an opportunity
area for potential collaboration in Cork.
Table 6.1G: Company Survey; Comparison of findings from three counties
Cork

Dublin

Galway

16

28

11

Response Rate

24%

25%

48%

2

Multinational

63%

50%

64%

Indigenous

38%

50%

36%

AgriFood Industry MB/RD/PM

4/2/2

1/0/0

2/1/1

Healthcare Therapeutics MB/RD/PM

1/1/1

2/3/0

0/0/0

Healthcare Diagnostics MB/RD/PM

0/1/0

3/1/2

1/1/0

Pharmaceutical MB/RD/PM

7/3/3

7/9/5

1/1/0

Pharmaceutical Services MB/RD/PM

3/1/2

3/0/0

1/0/0

Medical Devices MB/RD/PM

2/1/3

4/2/3

7/4/4

Bio-Environmental MB/RD/PM

0/1/0

1/0/0

0/0/0

Bio-Informatics MB/RD/PM

0/0/0

2/0/1

0/0/0

None of the Above MB/RD/PM

1/0/0

5/1/1

0/0/0

64M

6M

365M

4%

32%

21%

Question

Description

Respondents

3

4

Average Turnover €000,000
R and D Spend / Turnover (%)

Continued on next page
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Question

Description

5

6

7

8

Cork

Dublin

Galway

% Sales Made in County

10%

26%

6%

% Sales Made in Rest of Ireland

19%

20%

18%

% Sales Made in Rest of Europe

33%

29%

34%

% Sales Made in Rest of World

38%

25%

42%

% Raw Materials Sourced County

13%

34%

8%

% Raw Materials Sourced Rest of Ireland

14%

9%

18%

% Raw Materials Sourced Rest of Europe

52%

37%

26%

% Raw Materials Sourced Rest of World

22%

20%

48%

Similar Companies in Area

2

1

1

State Support

4

3

3

Close to Major Airport

0

1

0

Close to Major Harbour

1

0

0

Close to 3rd Level Institutes

1

4

0

Highly Skilled Workforce

4

10

2

Access to European Market

2

4

1

Wage Rates

0

0

0

Supportive State Agencies

2

0

1

Business Customers

8

12

17

12

13

7

2

2

2

Suppliers
Competitors

Continued on next page
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Cork

Dublin

Galway

131

52

599

5

3

33

Recruited from companies in the county

32%

42%

36%

Recruited from 3^^ level in the county

21%

26%

14%

Employees recruited by firms/county

2.81

3.18

3.25

Employees recruited by hrms/Ireland

2.75

3.27

2.66

Employees recruited by hrms/abroad

1.87

2.18

3.00

Business Development

19%

25%

11%

0%

4%

11%

19%

8%

11%

Legal/IP

0%

13%

0%

Marketing

0%

4%

0%

56%

25%

11%

Research / Scientihc

6%

8%

45%

Other

0%

13%

11%

Question

Description

9

Average No. of Employees
Average No. of R and D Employees

10

11

12

Clinical
Engineering

Manufacturing

Continued on next page

147

CHAPTER 6. RESULTS

Cork

Dublin

Galway

Business Development

2.8

4.4

2.3

Clinical

1.0

3.5

1.8

Engineering

3.0

3.4

3.5

Legal/IP

6.0

3.4

3.8

Marketing

5.0

4.2

3.0

Manufacturing

4.9

3.2

3.2

Research / Scientific

1.7

3.9

3.3

Other

3.5

2.3

1.0

Training Uni/lns/Cen/Oth

1/3/0/0

l/l/O/O

2/1/0/2

R&D Uni/Ins/Cen/Oth

1/5/0/0

Employment Uni/Ins/Cen/Oth

4/0/3/0 16/2/1/1
4/5/1/P
13/2/0/1

O/O/O/l

Course Content Uni/Ins/Cen/Oth

l/O/O/O

3/0/0/0

2/1/0/0

Shared Technology Yes/Potential

2/3

0/9

3/3

Licensing Arrangements Yes/Potential

1/3

4/10

2/2

Research & Development Yes/Potential

2/5

5/12

4/8

Training Yes/Potential

8/6

2/1

4/4

Marketing/Sales/Distrib Yes/Potential

2/2

6/6

2/4

Subcontracting of Manuf Yes/Potential

6/6

3/4

5/4

Other Joint Ventures Yes/Potential

0/1

4/2

0/0

Question

Description

13

14

15/16

Continued on next page
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Question

Description

17

19

20

21

Cork

Dublin

Galway

Suitable Partners

8

13

3

Availability of Capital

1

9

4

Government Support

2

8

2

Commercial Confidentiality

5

5

5

Availability of Qualified Personnel

1

4

0

Other

0

3

1

Business Customers

2.75

2.75

2.43

Suppliers

2.30

2.43

3.14

Competitors

1.57

1.92

3.13

Academic Institutions

3.54

3.65

4.57

Trust

5.38

5.45

5.44

Face-to-Face

4.54

5.15

5.22

Irish Bioindustry Association

0.71

3.24

1.22

Other Trade Organisations

1.71

2.41

2.22

Chamber of Commerce

1.93

1.47

2.67

IDA Ireland

2.38

2.06

4.00

Enterprise Ireland

2.36

3.22

3.78

Science Foundation Ireland

0.77

2.31

1.78

Other Government Agencies

2.29

1.50

1.78

National Government

1.50

1.88

1.89

Local Government

1.57

1.06

1.33
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Question 18 is an open end question that seeks feedback from companies with regard
to how co-operation between companies in the same location can be encouraged. Ideas
coming back suggest the establishment of networks and forums to explore co-operation
possibilities, which would create a greater chance of relevant companies making contact
with each other. The point is made by a respondent in Galway “Establish some type
of biotech industry association specific for Galway. Other associations are dominated by
Dublin organisations”.
Question 19 asked respondents what significance do the following (customers, suppliers
etc) have as a source of knowledge for their companies’ product development. Respondents
were asked to answer in Likert scale format where 1 = low significance and 6 = high
significance. A N/A column was included in case respondents were of the opinion that
these groups had no significance for their product development. Results can be viewed in
Table 6.16.
Question 21 asked respondents to rate the level of support that they have received from
a list of organisations on a Likert scale from 1 = Little support to 6 = Large support.
Organisaitions listed include Irish Bioindustry Association, Chamber of Commerce, IDA
Ireland, Enterprise Ireland and Science Foundation Ireland to name a few^^.

6.4

Summary

This chapter reported results obtained from the measurement of geographic proximity,
and also measurement of interlinkages between biotech actors within this proximity.
Data pertaining to geographic proximity was obtained from CSO, while the data on
interlinkages was obtained from responses to online surveys. Results from Cork academics
and company respondents have been reported in this chapter, additionally, comparisons
have been made with the other regions studied.
^^All organisations are listed in question 21 in figure E.5 The Cork Company Biotechnology Cluster
Survey in Ai)pen(lix E
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Chapter 7 includes discussion of these findings, a conclusion and also the recommendations
to arise from this study.
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Chapter 7
Discussion, Conclusion &;
Recommendations

7.1

Discussion

Location quotients calculated from ‘Census of Industrial Production’ data provide con
vincing evidence of a large concentration of biotechnology output and employment in
Cork. This concentration is due in large part to the group of pharmaceutical and chem
ical plants around Cork city, owned by leading multinational companies. Galway has a
high relative concentration of biotech employment, yet in Galway biotech net output is
no more concentrated than the general pattern in the state.
Geographic proximity of production units, and concentrations of output and employment
are necessary components of an industry cluster. However, it is the interlinkage of proxi
mate hrms, and spillovers of knowledge, skills and ideas from nearby research institutions,
which animate a cluster and give rise to agglomeration advantages.
The surveys conducted of biotech companies and biotech academic researchers in Cork,
Dublin and Galway, sought to uncover cluster type interactions in each location and to
measure their strength where possible. This approach follows that of Lublinski’s study
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(2002) of an aeronautic cluster in Northern Germany. The present study did not seek
to measure the economic benehts of a cluster, such as growth rates in employment and
output, innovation rate and new company formation.
It should be noted that respondents to the Cork company survey (Table 6.9) include
manufacturers (of e.g. medical devices, pharmaceuticals, food ingredients) and service
providers such as oxygen monitoring, process engineering and consultancy. Views and
experiences of such organisations are relevant to the functioning and vigour of an industry
cluster.
Data from the academic and biotech company surveys is wide ranging, but respondent
numbers are too small for detailed statistical analysis. The findings provide insights
and impressions about the extent and vigour of cluster linkages in the study areas. A
commentary on these linkages follows, organised around themes of:
1. The match between Cork biotech company activities and the fields of biotech re
search in Cork third level institutions.
2. Vertical linkages between Cork biotech companies and co-located customers, sup
pliers and competitors.
3. Collaboration among biotech companies in the locality.
4. Availability of a pool of skills in the region.
5. Meetings and collaboration between local academics and biotech companies.
1) Fields of biotech academic and industry activity.

Focusing on the survey findings from Cork academics and Cork biotech companies, one
is struck by the fields of biotech research currently pursued in Cork research institutions.
Most frequently mentioned are (Figure 6.3):
Agrifood industry 19% (of mentions). Healthcare therapeutics 19%, Bio-Environmental
18% and Healthcare diagnostics 16%.
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Pharmaceutical research and pharmaceutical services research total just 12% of mentions.
While one should not read too much into this, given that the greater part of biotech
production activity in Cork is in pharmaceutical products, the findings imply that Cork
biotech researchers are pursuing their own research interests. Put another way the figures
suggest that the local major pharma manufacturers are not dictating the research agenda
in Cork research institutions.
Seven Cork companies of the sixteen surveyed, reported pharmaceutical as their main
business sector, a further three reported pharmaceutical services, (see Figure 6.4) as their
main business sector. Not many Cork companies reported having products in R and D,
yet two respondents reported the R and D phase as their stage of development. The two
companies are in the healthcare diagnostics and bioenvironmental sectors.
2) Vertical linkages among Cork biotech companies, customers and suppliers.

Questions 5 and 6 in the company questionnaire, sought information on the destination
of sales and source of raw materials and inputs. The survey found that just 10% of sales
are to Cork customers, while more than 70% are exported to Europe and the rest of the
world. This is consistent with the commonly held view that large IDA supported pharma
plants have primarily an export mission. It is not surprising that more than 70% of inputs
and raw materials of Cork respondent firms are imported from European countries and
the rest of the world. It has long been an aspiration of Irish industrial policy since Telesis
(1982) and earlier O’Earrell and O’Loughlin (1980), to build backward linkages between
foreign multinational hrms based here and suppliers in the Irish economy.
The sourcing of materials and inputs follows a fairly similar pattern in the Dublin and
Galway surveys, with Galway biotech companies reporting the greater reliance on imports.
Patterns of heavy reliance on export markets are reported in Dublin and Galway also,
with Dublin having the greatest reliance on the home market as an outlet for sales.
Question 19 in the company questionnaire, explored to what extent various groups in
the locality serve as a source of knowledge for product development. In Cork, business
customers, local suppliers and local competitors were all rated as having low significance
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as a source of knowledge for product development. The average figure for local academic
institutions in Cork was 3.54 (on a Likert scale of 1 = low significance to 6 = high
significance). The pattern for Dublin and Galway respondent companies is similar, with
Galway biotech companies awarding the most significance (of the three regions) to the
impact of local academic institutions in their product development.
These findings about spatial distribution of sales, geographical source of raw materials
and inputs, and contribution of local suppliers, customers, competitors and academics
towards product development, have profound impact on cluster theory and its application
to the biotech sector in Gork. These findings suggest a quite limited local purchasing
of raw materials and inputs, limited exposure to (demanding or otherwise) buyers in
the locality, and limited reference to competitors in the product development process.
Findings suggest that the scope for some key agglomeration advantages found in cluster
literature (see Ghapter 3), is at best attenuated in the three study areas.
3) Collaboration among biotech companies in the locality.

On the theme of collaboration with other companies in county Gork, the fields of train
ing and sub contracting of manufacturing are the most freciuently reported activities.
In Dublin marketing/sales/distribution is the area of most collaboration among biotech
companies, however, most potential is seen in collaborating in licensing arrangements.
Interfirm collaboration in Galway is closer to the pattern in Gork.
Finding suitable partners and concerns about commercial confidentiality were seen as
barriers to collaborating with local firms in each of the regions studied. Availability of
capital was seen as a barrier to interfirm collaboration by firms in Dublin and Galway.
Gompanies surveyed in all three areas (question 20). rated trust and face-to-face contact
quite importantly as a foundation for an effective business relationship.
4) Availability of a pool of skills in the region.

The findings suggest active dialogue between third level institutions and biotech com
panies in regard to the type of skills required by biotech employers (question 4 in the
academic survey) in Gork. This was generally true for Dublin and Galway, but the dia155
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logue about the skills biotech graduates will need, seems less widespread in Dublin. Input
of employers into the curriculum design for biotech university courses was a feature of the
Boston cluster (see Section 5.3).
Academic respondents reported a high incidence of their graduates hnding employment in
co-located biotech companies. This feature was most pronounced in the Cork and Dublin
areas (question 11 in academic surveys).
Cluster theory holds out the local availability of suitable educated graduates and expe
rienced skilled employees as an important agglomeration advantage. Findings from the
company survey (questions 10 and 11) suggest that sourcing qualihed graduates from co
located third level institutions, and recruiting employees from companies in the locality,
are not a predominant feature of the labour market in any of the study regions. The
somewhat moderate reliance on the local labour market is largely supported in company
responses on the likelihood of sourcing skills necessary for expansion (Company question
naire, question 13). However Cork respondents look to the local labour market for recruits
in legal/IP, marketing and manufacturing.
The issue about reliance on the labour pool in the cluster arises from another standpoint,
when companies were asked in question 7, about what factors lead them to choose Cork
as a location. Cork and Dublin biotech respondents gave greatest weight to the highly
skilled workforce (Figure 6.5 and F.3).
It is recognised that recruiting employees is not the only way in which companies can access
necessary skills. Design engineers, project engineering firms, research labs and consultants
all provide skills on an outsourcing basis, and form an integral part of industry clusters.
While there is evidence of such services available to biotechnology companies in Cork,
time constraints did not permit a systematic enumeration.
5) Extent and nature of meetings and collaboration between academics and
biotech companies in the region.
The academic surveys found substantial incidence of research and consultancy linkages
between academic departments and Cork biotech companies, and to as lesser extent in
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Galway and Dublin. Other notable academic industry linkages were related to training
in the three survey regions.
Most academics surveyed claimed to have personal contact with employees in biotech
companies in their respective regions, yet the numbers who had met biotech company
employees within the last month were more modest.
Academic researchers surveyed seem conscious of the value of industry collaboration for
the purpose of exploiting a new product or technology (Table 6.6), and they made positive
suggestions about how communication and networking between Cork academia and Cork
biotech companies could be enhanced (question 13).

7.2

Conclusion

The question set out in this thesis is whether there is a biotechnology cluster in Cork?
The evidence from this study is no, not yet. Many elements of a biotech cluster are
present in Cork; many large export oriented production plants owned by American “Big
Pharma”, a major concentration of biotech output and employment, specialised supply
and support companies and services that have grown and prospered over the past 30 years,
major strengths in biotech relevant research and education in third level institutions, and
all supported by the very pro biotechnology government policy and funding channelled
through IDA Ireland, Enterprise Ireland, SFI, PRTLI and HRB (Health Research Board).
However, to have a functioning biotechnology cluster, more interactions, networking, link
ages and collaboration are necessary. The surveys in this study found generally positive
attitudes to such linkages and collaborations, but they have not yet developed to a level
where one could say there is a biotech cluster in Cork. There are the examples of Eirx
and Luxcel, both spinoff companies from research in UCC. Many more are needed.
Spinoffs of start up companies, recognised growth trajectories of new biotech start ups,
and a culture of networking and collaboration between large biotech companies, research
institutions and top medical professionals are features of the Boston biotechnology cluster.
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Cork needs more of these kinds of interlinkage and this suggests a stronger network
building or relationship broking role for IBIA and the leading state agencies. The supply
and demand of skills in the biotechnology sector report (Forfas, 2003) suggested that a
cluster could develop either on a node of production or a node of research and product
development. Cork has proven strengths in pharma production, and growing strengths
in biotech RandD mostly based in UCC and CIT. Some means of drawing together these
two strands of biotech activity needs to be found.
The recent state policy of encouraging foreign companies to set up R and D facilities in
Ireland has an important role to play. Centocor and GlaxoSmithKline (€34 Million) have
both recently opened Bio-research centres joint funded by the IDA in Cork.
The fact that much of the pharmaceutical production in Cork is derived from imported raw
materials and is destined for overseas markets means that Porter’s competitive diamond
of local industry clustering (Figure 3.2) will not readily apply in Cork. However this may
present an opportunity for Cork based R&D, backed by generous state funding, to become
a powerhouse of IP and new products to develop a full blown biotech cluster in Cork.

7.3

Recommendations

It is apparent that a number of policy measures would enhance cluster activity and per
formance in Cork.

1. More interactions between industry and biotech/life sciences academics and re
searchers. This should help to speed up technology development and bring a com
mercial slant to ongoing research. There seems to be a role for development agencies
to facilitate meetings and networking, (similar to the ‘Networking Events’ imple
mented by Irish Bioindustry Association and Science Foundation Ireland).
2. Since biotechnology embraces many sectors of industry, and service sectors such as
university departments, clinical research organisations and teaching hospitals, there
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is a need at a national level to define and report employment, output and innovation
trends for the biotech industry. This would require involvement of CSO with de
velopment agencies and biotech actors. Given the large sums of state investment in
biotechnology, an accurate system for measuring progress and outputs is an urgent
necessity.
3. A more active role for IDA and Enterprise Ireland to identify spin off product op
portunities, and to provide advice, mentoring, IP support and grant aid to generate
a flow of new biotech start ups arising from third level research or from resident
multinational hrms.

159

Appendices

160

Appendix A
Cluster Case Studies
The methods outlined in chapter 4 are top-down approaches, used by academics to identify
clusters. However none of these methods can be used to identify a specihc cluster, as is
the goal of the present research. A review of two case studies taken from Lublinski (2002)
is now presented.
1. A qualitative study by Saxenian (1994) that compared the geographic concentrations
of electronics industries in Silicon Valley (California) and Route 128 in Boston.
2. A quantitative study by Sivitandiou (1999) on the spatial preferences of software
firms in Souther California.

A.l

Silicon Valley and Route 128 Case Study

“The qualitative case study of Saxenian.” Adapted from Lublinski (2002, p 57-60)
Saxenian (1994) compared two of the most spectacular phenomena of geographic concen
tration of industries. Northern California’s Silicon Valley and Boston’s Route 128. Both
have become known as highly innovative and world leading centres in electronics since
the 1970s. She observed that the performance of these two regional economies diverged in
the 1980s. While Route 128 reportedly lost ground to international competitors as well as
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to the Silicon Valley, the latter successfully adapted to increasingly intense international
competition. Saxenian set out to understand why this happened. The fact that hrms in
both regions are spatially proximate cannot explain why they have performed differently.
Various types of empirical material, both from interviews as well as from a variety of
public and private data bases, industry and trade press, and from corporate documents,
were collected. (Saxenian, 1994, p 209) Employment data, taken from the U.S. Bureau of
the Census, were used to compare growth between the two regions. Other data sources,
such as number of establishments by employment size, as well as performance indicators,
like profitability or output, had the drawback that the data were assigned to the location
of firms’ headquarters, rather than plants. Firm-level information has been published
only for a group of publicly traded firms. However, many hrms in these two regions
are non-publicly traded enterprises.

While these data sources may be informative to

studies of a single cluster, they could only be used with some limits for this comparative
analysis of regions. Hence, Saxenian’s arguments rest primarily on interviews with hrm
representatives. These numbered a respectable 160 or more, of which the majority were
conducted between 1988 and 1991.
While Saxenian’s research interest has primarily been to describe the two clusters in ways
which they differ, thereby detecting some of the causes of their differing performance, the
clusters have been identihed in an ad-hoc manner. The author used data for the following
high technology industries in order to determine their functional boundaries: Computer
and Office Equipment (SIC 357), Communications Equipment (SIC 366), Electronic Com
ponents and Accessories (SIC 367), Guided Missiles and Space Vehicles and Parts (SIC
376), Instruments (SIC 38), and Computer Programming and Data Processing (SIC 737)
(Saxenian, 1994, p 209).
The geographical boundaries of the clusters were defined by either four state counties
or three-digit telephone code areas depending on the data bases used. (Saxenian, 1994,
p 211) Silicon Valley’s boundaries were determined by Californian counties Santa Clara,
San Mateo, Alameda, and Santa Cruz or telephone code areas 408, 415, or 510. Route
128 refers to Massachusetts counties Middlesex, Suffolk, Norfolk, and Essex, or firms
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headquartered in the telephone areas 617 or 508.
She argued that it is helpful to compare the two regions’ industrial systems along three
dimensions: local institutions and culture, industrial structure, and corporate organiza
tion. These dimensions are interdependent. They “tend, in practice, to become mutually
reinforcing components in coherent regional economies” (Saxenian, 1994, p 8).
The two local educational and research institutions, Stanford University and the Mas
sachusetts Institute of Technology (MIT), that, in principle, take on similar functions as
sources of knowledge, have had a different economic impact in their regional economies.
In contrast to MIT, Stanford University has arguably been far more active in promoting
the diffusion of knowledge in the regional economy by, for instance, supporting spin-offs
and technology start-ups (Saxenian, 1994, p 8).
Moreover, the provision of risk capital by business-angels in Silicon Valley has arguably
been an advantage over Route 128 where financial institutions have tended to be rather
cautious, formal and slow (Saxenian, 1994, p 64).
Silicon Valley firms had a culture that promoted open exchange and informal cooperation.
In contrast, Boston’s Route 128 has cultivated “practices of secrecy and corporate loyalty
[that] govern relations between firms and their customers, suppliers, and competitors,
reinforcing a regional culture that encourages stability and self-reliance” (Saxenian, 1994,
P 3).
Silicon Valley was characterized as a fragmented network-based industrial structure of
firms that specialize and that engage in relations with other specialists. Geographic prox
imity enhances frequent interaction, which sustains the network through the development
of trust between firms. In contrast. Route 128 was described as an independent firmbased system of large vertically integrated corporations that tend to internalize resources
(Saxenian, 1994, p 161).
Internal corporate organization in Silicon Valley has reportedly been highly decentralized.
Firm’s activities have been horizontally coordinated, with a high degree of professional au
tonomy and a strong emphasis on teamwork, which has blurred the traditional boundaries
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of corporate functions within the firms. (Saxenian, 1994, p 50) Corporations in Boston’s
Route 128, in contrast, have a reportedly high degree of centralization and hierarchical
coordination, with formal flows of information. This organizational structure is said to
be “separate and self-sufficient” (Saxenian, 1994, p 161).
In the conclusion, Silicon Valley’s network-based structure of firms that have each been
organised in a decentralized manner, paired with the region’s institutions and culture
that enhance knowledge diffusion, has arguably fostered their superior capacity to adapt
to fast changing competitive patterns and have thus been key determinants of its economic
growth. In contrast to many other studies in the urban and regional science literature,
(Saxenian, 1994, p 3) she has not only investigated the manner in which co-located firms
interact, she has also looked inside the firm. Specifically, she has shown that the capacity
to generate as well as to exploit agglomeration advantages does not only depend on what
other firms as well as institutions are located nearby. A critical success factor can also
be the corporate organisation, in which incentives for individual employees and project
teams to interact with other firms are embedded.

A.2

Southern California Computer Software Case Study

“The quantitative case study of Sivitandiou.” Adapted from Lublinski (2002, p 60-62)
The study of Sivitandiou (1999) had two research tasks, which focused on the spatial
preferences of computer software firms located in Southern California. First, it analysed
what the perceived relative importance of location attributes is. Second, Sivitandiou
related the preferences for such attributes with the general firm profile (e.g. organisational
structure, size of operations, age) as well as with their functional traits (e.g. core functions,
outsourced activities, markets served). The study area was confined to Southern California
ranging from San Diego in the Southeast to Santa Barbara in the Northwest and San
Bernadino in the Northeast.
Given the absence of published secondary data, this study used direct survey data. From a
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mailing list of over 3,000 software companies, a sample of 120 firms returned questionnaires
with valid responses.
Anecdotal accounts and existing empirical literature, suggested that the sample was fairly
representative. (Sivitandiou, 1999, p 116-118) Moreover, a mapping exercise revealed that
the spatial distribution of hrm locations parallels that of software hrms registered at the
California Manufacturers Association (1996).
The majority (91%) of the sample firms did not represent parts of corporate entities. They
were on average as young as 10 years and almost 80% had less than 25 workers. Almost
90% of the sample enterprises focused on the development of software innovations, of
which most ideas stemmed from company workers and clients rather than from other hrms’
workers or academia. Most of them serve primarily domestic markets characterized as
‘Government’, ‘Professional Services’ and ‘Manufacturing’. Each of these market segments
provided a customer base for about 40-45% of the sample hrms. These hrms employ highly
skilled workers. Almost 80% of sample hrms’ employees had on average a four-year college
degree, master’s degree or doctoral degree (Sivitandiou, 1999, p 116).
Concerning the methodology, company executives had been asked to assign preference
ratings, ranging from 1 (lowest) to 5 (highest), to a selection of location attributes. Next,
these preferences were related to company traits by econometric analysis.
The most highly rated location attribute was the access to skilled labor. 64% of the
sample hrms considered it either very important (rating = 5) or important (rating = 4)
for the hrm’s success. Other factors that had on average been regarded as important
were the following, stated in the order of relevance: access to a good environmental
quality, low crime districts, regional/international airports, freeways and domestic clients,
other high tech hrms, universities, urban/residential amenities and high-quality districts
(Sivitandiou, 1999, p 120).
The hndings of the econometric analysis suggest that company prohles as well as func
tional traits matter. (Sivitandiou, 1999, p 145) Single-unit independent or single-unit
companies tend to have higher preferences for spatial access to markets of qualihed labor.
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Younger firms have higher preferences for access to other high technology firms and clients.
Companies that place more importance on software development show higher preferences
for access to labor, other high technology firms and universities. Firms outsourcing clientrelated functions express higher preferences for access to other high technology firms. And
lastly, firms that tend to use various forms of telecommunications (telephone, Internet and
video-conferencing) as an alternative to face-to-face contacts show lower preferences for
access to other firms, airports and freeways.
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Appendix B
Variables from CIP Tables Defined
Census of Industrial Local Units - Definitions of Variables included in the Tables of The
Census of Industrial Production (CSC, 2004a, p 165).

1. Number of Local Units (code 1): The local unit is defined as an enterprise or
part thereof situated in a geographically identified place. (The different geographical
locations in which an enterprise conducts industrial activities are treated as separate
local units. A separate return is sought for each industrial local unit. The extent
to which separate returns are obtained in practice, however, depends on the avail
ability of separate records in the business for the different local units.) The number
counted includes all the separate industrial local units of multi-national enterprises
even if separate details are not provided by the respondent. In regional and size
classifications, groups of local units for which separate data cannot be determined
are, in general, classified as non attributable.
2. Employees (codes 2 to 14): are persons who are paid a fixed wage or a salary.
Persons at work or temporarily absent because of illness, holidays, strikes etc. are
included, as are part-time workers. Outside piece-workers, i.e. home-workers (code
19), are excluded. The numbers given for each year refer to a week in September.
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3. Gross Output (code 20): represents the net selling value of all goods manu
factured in the year, whether sold or not, including work done and capital assets,
manufactured for own use. Operating subsidies related to the production or sales
of the output are included in the value of gross output; excise duty and Vat are
excluded.
4. Net Output (code 25): is the difference between gross output and industrial
input. Gross output is not a very satisfactory measure of the relative economic im
portance or comparative expansion of an industrial sector since only a proportion of
its value is actually created within the sector and the costs of materials incorporated
forms a widely variable proportion of the gross output in different sectors. There is
also a large degree of duplication due to the use by one industry of the products of
another e.g. flour, which is an output of the manufacture of grain milling products
(Nace 1561), is an input to the manufacture of bread; manufacture fresh pastry
goods and cakes (Nace 1581). Net output, which represents the value added to
industrial input, is therefore a more appropriate measure of the relative economic
importance of the different sectors.
5. Wages and Salaries (code 26 to 29): are defined as the gross amount paid
to employees before deduction of income tax, employees’ contributions to social
security, etc. Overtime pay, bonuses, commissions, holiday pay and sick pay are
included.
6. Remainder of Net Output (code 30): is defined as net output less wages and
salaries. It is the fund from which dividends, depreciation, labour costs (other than
wages and salaries), interest and other financing charges, hire and leasing charges,
taxes and all other expenses and overheads are paid.
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Appendix C
NACE Selection Questionnaire
Biotechnology Clusters
Survey to A55655 codes for Biotechnology
Assessment of Biotechnology

My Name is John Hobbs, I’m currently pursuing my Masters in the Cork Institute of
Technology, on the topic Biotechnology Clusters. To make an assessment of concentration
of Biotechnology within Ireland, I have tried to put together a list of NACE codes to
represent biotechnology. Below the NACE codes are listed along with their corresponding
Industrial sectors, please could you tick the codes which you feel are biotech in the boxes
provided.
As a guide the following definition is being used to define biotechnology for the study:
“Biotechnology is the application of biological knowledge to living organisms or parts of or
ganisms, and techniques pertaining to molecular, cellular, and genetic processes to develop
products, processes or services of value to individuals, organisations and society. ”
Table C.l: NACE codes for Biotechnology
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u
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□

NACE Code

Corresponding Industrial Sector

15

Manufacture of food products and beverages

151

Production, processing and preserving of meat
and meat products

1511

Production and preserving of meat

1512

Production and preserving of poultrymeat

1513

Production of meat and poultrymeat products

152

Processing and preserving of fish and fish products

1520

Processing and preserving of hsh and fish products

153

Processing and preserving of fruit and vegetables

1531

Processing and preserving of potatoes

1532

Manufacture of fruit and vegetable juice

1533

Processing and preserving of fruit
and vegetables n.e.c.

154

Manufacture of vegetable and animal oils and fats

1541

Manufacture of crude oils and fats

1542

Manufacture of rehned oils and fats

1543

Manufacture of margarine and similar edible fats

155

Manufacture of dairy products

1551

Operation of dairies and cheese making

1552

Manufacture of ice cream

156

Manufacture of grain mill products, starches
and starch products

1561

Manufacture of grain mill products

1562

Manufacture of starches and starch products

157

Manufacture of prepared animal feeds

1571

Manufacture of prepared feeds for farm animals
Continued on next page
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u
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□

NACE Code

Corresponding Industrial Sector

1572

Manufacture of prepared pet foods

158

Manufacture of other food products

1581

Manufacture of bread; manufacture of fresh
pastry goods and cakes

1582

Manufacture of rusks and biscuits; manufacture
of preserved pastry goods and cakes

1583

Manufacture of sugar

1584

Manufacture of cocoa; chocolate and sugar
confectionery

1585

Manufacture of macaroni, noodles, couscous and
similar farinaceous products

1586

Processing of tea and coffee

1587

Manufacture of condiments and seasonings

1588

Manufacture of homogenized food preparations
and dietetic food

1589

Manufacture of other food products n.e.c.

159

Manufacture of beverages

1591

Manufacture of distilled potable alcoholic beverages

1592

Production of ethyl alcohol from
fermented materials

1593

Manufacture of wines

1594

Manufacture of cider and other fruit wines

1595

Manufacture of other non-distilled
fermented beverages

1596

Manufacture of beer

1597

Manufacture of malt
Continued on next page
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u
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□
□

NACE Code

Corresponding Industrial Sector

1598

Production of mineral waters and
soft drinks

24

Manufacture of chemicals and chemical products

241

Manufacture of basic chemicals

2411

Manufacture of industrial gases

2412

Manufacture of dyes and pigments

2413

Manufacture of other inorganic basic chemicals

2414

Manufacture of other organic basic chemicals

2415

Manufacture of fertilizers and
nitrogen compounds

2416

Manufacture of plastics in primary forms

2417

Manufacture of synthetic rubber in
primary forms

242

Manufacture of pesticides and other
agro-chemical products

2420

Manufacture of pesticides and other
agro-chemical products

243

Manufacture of paints, varnishes and
similar coatings, printing ink and mastics

2430

Manufacture of paints, varnishes and
similar coatings, printing ink and mastics

244

Manufacture of pharmaceuticals,
medicinal chemicals and botanical products

2441

Manufacture of basic pharmaceutical products

2442

Manufacture of pharmaceutical preparations

245

Manufacture of soap and detergents.
Continued on next page
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NACE Code

Corresponding Industrial Sector
cleaning and polishing preparations,

□
□
□
□
□
□
□
□
□
□
□

o
□

perfumes and toilet preparations
2451

Manufacture of soap and detergents,
cleaning and polishing preparations

2452

Manufacture of perfumes and toilet preparations

246

Manufacture of other chemical products

2461

Manufacture of explosives

2462

Manufacture of glues and gelatines

2463

Manufacture of essential oils

2464

Manufacture of photographic chemical material

2465

Manufacture of prepared unrecorded media

2466

Manufacture of other chemical products n.e.c.

247

Manufacture of man-made hbres

2470

Manufacture of man-made hbres

29

Manufacture of machinery and
equipment n.e.c.

291

Manufacture of machinery for the production
and use of mechanical power,

□
□
□
□
□

except aircraft, vehicle and cycle engines
2911

Manufacture of engines and turbines,
except aircraft, vehicle and cycle engines

2912

Manufacture of pumps and compressors

2913

Manufacture of taps and valves

2914

Manufacture of bearings, gears, gearing
and driving elements

2921

Manufacture of furnaces and furnace burners

Continued on next page
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□

NACE Code

Corresponding Industrial Sector

2923

Manufacture of non-domestic cooling and
ventilation equipment

2953

Manufacture of machinery for food, beverage
and tobacco processing

33

□
□
□

Manufacture of medical, precision and optical
instruments, watches and clocks

331

Manufacture of medical and surgical equipment
and orthopaedic appliances

3310

Manufacture of medical and surgical equipment
and orthopaedic appliances

332

Manufacture of instruments and appliances for
measuring, checking, testing,
navigating and other purposes, except

□

industrial process control equipment
3320

Manufacture of instruments and appliances
for measuring, checking, testing,
navigating and other purposes, except

□
□
□
□

industrial process control equipment
333

Manufacture of industrial process control equipment

3330

Manufacture of industrial process control equipment

334

Manufacture of optical instruments and
photographic equipment

3340

Manufacture of optical instruments and
photographic equipment
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Appendix D
Academic Biotechnology
Questionnaire
This section Includes a replica of the Cork academic biotechnology cluster questionnaire.
Again the questionnaires for each region are similar and regionalised for each target loca
tion.
The academic questionnaire contained 13 questions. Early questions were predominantly
concerned with assessing which section of biotech research the respondents were involved
in. The survey progressed to ask respondents what areas are they currently collaborating
in and how much face to face contact they would have with companies.
The academic survey is shown in figures D.l to D.3 below:
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Figure D.l: Cork Academic Biotechnology Cluster, Questions 1,2,3,4,5 & 6
Cork Academic Biotechnology Cluster
1. Survey of Academics with potential link to Biotech Industry

1. Contact Details

Name of Respondent
Institution
Department/Centre
Telephone
2. Employment

Total number of Researchers in your Department/Centre
3. Nature / Sector of Biotechnology Research

AgriFood Industry

Research
^

Healthcare - Therapeutics
Healthcare - Diagnostics
Pharmaceutical

^

Pharmaceutical services
Medical Devices
Bio-Environmental

^

Bio-Informatics
None of the Above

^

4. Is there contact between your academic department/centre and companies in Cork, in regard
to the skills they require their graduate recruits to have?

Yes

No

Don't know

5. Does your department/centre have links with Cork based Biotech companies in any of the
following areas? (Please tick as appropriate)

Consultancy/Funded
Research

Personal
Research

Analytical
Services

Training

N/A

6. If your research discovers a new technology, product or process, on a scale of 1 to 6 how likely
are you to take the following options? 1 = not likely and 6 = extremely likely

Patent and sell the patent
Patent and Licence out
Patent and commercialise the
discovery yourself
Commercialise with an
Industry partner
Collaborate with your
University/Institute

y

U6
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Figure D.2: Cork Academic Biotechnology Cluster, Questions 7,8,9,10 & 11
7. Have you found funding for research to be more accessible in the last 2 years?
More

Less
>

J

8. Which of the following sources has been to the forefront for funding of research in your
department/centre?
Industry Partners
j Science Foundation Ireland

Enterprise Ireland
^ Program for Research in Third Level Institutions

^ EU framework programme
, Other (please specify)

9. Have you personal contact with employees in Biotech/Pharma companies within Cork. Please
choose from the following list
^ 1-3 companies
^ 4-6 companies
^ More than 6 companies
^ No personal contacts

10. Have you met employees of Biotech/Pharma companies within Cork recently? (Tick as
appropriate)
Social Context
In the past week
In the past Month

Business Context

r

r

r

r“

In the past 3 Months
More than 3 months ago
No contact

11. Are graduates from your department working in any Biotechnology companies within Cork?
^

Yes

y

No
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Figure D.3: Cork Academic Biotechnology Cluster, Questions 12 & 13
12. Have you met graduates from your department who work within Biotech companies in
Cork? (Tick as appropriate)
Social Context
In the past Month

Business Context

r

r

In the past 3 Months

r

More than 3 months ago

r

No contact

13. If there is one thing that could be done to enhance co-operation between Cork companies
and academia, what would it be?

d
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Appendix E
Company Biotechnology Cluster
Questionnaire
Included in this section is a replica of the Cork company biotechnology cluster question
naire. The questionnaires for each of the other regions in the study are similar. Each
questionnaire was regionalised for the target region it was sent out to. e.g. The Dublin
survey had Dublin in place wherever Cork appears within the following questionnaire.
Also all institutions named within each questionnaire are specific to that particular re
gion.
The Company questionnaire contained 22 questions in total. These questions were in two
sections. There are 13 questions in section one: ‘Company & Respondent Details’ and
9 questions in section two, the ‘Academic Linkage, Collaboration, Innovation h Policy’
section. The first section is concerned with data about the company such as sector of
industry the company is active in, R&D employment, where do the companies source
their inputs etc.
The company survey is shown in hgures E.l to E.5 below:
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Figure E.l; Cork Biotechnology Cluster, Questions 1,2,3,4 & 5
Cork Biotechnology Cluster
Section 1. Company & Respondent Details

1. Contact Details
Company name:
Principal product or service:
Year established in Ireland:
Name of respondent:
Position in company:
Telephone:

2. Type of company
Multinational

Indigenous

3. Nature / sector of biotechnology business.
Please tick the sector which describes your main business, please also indicate if you have
products and processes in R&D phase or on the market
Main Business
AgriFood
Industry
Healthcare Therapeutics
Healthcare Diagnostics
Pharmaceutical

R&D Phase

Products on sale in Market place

’

'

Pharmaceutical
services
Medical
Devices
BioEnvironmental
BioInformatics

4. Turnover - C(Euros)
Total
R&.D spend as % of Turnover

5.

What percentage of your sales are accounted for in the following markets?
Cork
Rest of Ireland
Rest of Europe
Rest of the World
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Figure E.2: Cork Biotechnology Cluster, Questions 6,7,8,9,10 &: 11
6. What % of raw materials and inputs does your company purchase from suppliers in?
Cork
Rest of Ireland
Rest of Europe
Rest of the World

7. In your opinion, please rank for importance the factors that lead Biotechnology companies
to choose a Cork location. Please rank the 5 most important factors 1 = Most important, 2 =
second etc.
Similar companies in the area
State support
Close to major airport
Close to major harbour
Close to 3rd level academic institutions
Highly skilled workforce
Access to European market
Wage Rates
Supportive state agencies/local government

8. Please indicate numbers for the following
Number of your Business Customers in County Cork
Number of your Suppliers in County Cork
Number of your Competitors in County Cork

9. Employment In your Cork unit
Total Employees in Cork
Number of R&D employees

10. What percentage of your employees in Cork were recruited from:
Cork based companies in similar industries
Straight from 3rd level educational institutes in Cork

11. Can you indicate the frequency with which your employees may be recruited by other
companies? (On a scale of 1 = very infrequent to 6 = quite frequent)
3

4

>

J

J

J

18U

J

1
by Cork
companies
by Irish
companies
by companies
abroad

2

5

6

J
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Figure E.3: Cork Biotechnology Cluster, Questions 12,13 & 14
12. If your Cork operation were to expand, please indicate which skills would need to be
supplemented through recruitment

Business Development

13. Regarding skills you would need to recruit (Q12), please indicate the likelihood that you
would manage to source these skills within Co. Cork, on a scale of 1 = most unlikely to 6 =
very likely
1
2
3
4
5
6

Business
Development

^

^

^

^

Clinical
Engineering

^

^

Legal / IP

^

^

Marketing

^
,

^
^

Manufacturing
Research /
Scientific
Other

^

^

^

^

^
^

^
^

^
^

^

^

j
^
^

Section 2. Academic linkage. Collaboration, Innovation & Policy

14. Which of the following Cork based Institutions do you have links with, and in which areas are
these linkages? (Please Tick as many as are relevant)

Further Training
University College Cork
Cork Institute of Technology
National Microelectronic Research
Centre
National Food and Biotechnology
Centre (UCC)
Other Cork based
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R&D

Employment

Course Content
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Figure E.4: Cork Biotechnology Cluster, Questions 15,16,17 & 18
15. Do you collaborate with other companies in Cork in the following areas?
Yes

No

Shared Technology

>

>

Licensing arrangements

>

>

R&D

V

>

V

>

>

>

Training
Marketing / Sales / Distribution
Sub contracting of manufacturing
Other Joint Venture

V

>

V

16. Please specify any areas where you see an opportunity for collaboration within Cork?
(Please Tick as appropriate)
Yes
Shared Technology

V

Licensing arrangements

V

R&D

V

Training

>

Marketing / Sales / Distribution

>

Sub contracting of manufacturing
Other Joint Venture

>

17. Which of the following would you see as significant barriers to joint collaboration? (Please
Tick as appropriate)
Availability of suitable partners
Availability of capital
Government support
Commercial confidentiality
Availability of qualified personnel
Other (please specify)

18. If there is one thing that could be done to enhance co-operation between companies in
Cork, what would it be?
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Figure E.5: Cork Biotechnology Cluster, Questions 19,20,21 & 22
19. What significance do the following (customers, suppliers etc.) have as a source of
knowledge for your product development, on a scale of 1 = low significance to 6 = high
significance
Business
customers in
Cork
Suppliers in
Cork
Competitors in
Cork
Academic
institutions in
Cork

1

2

3

4

>

V

>

V

>

V

V

>

6

5

>
.y

V

>

✓

>

w

V

N/A

>

V

>

>

>

20. How important are the following factors as a foundation of an effective business
relationship. Please rate on a scale of 1 (Not Important) to 6 (Very Important)
3

2

1
Trust
Face-to-Face
contact

4

5

6

J
V

21. Please rate the level of support you receive from the following organisations from 1 = Little
support to 6 = Large support.
1

2

3

4

Irish Bioindustry
Association
Other Trade
Associations
Chamber of
Commerce
IDA
Enterprise
Ireland
SFI
Other
Government
Agencies
National
Government
Local
Government

22. How can policy be enhanced to help your operations?

5

6

N/A

Appendix F
Dublin Survey Findings

F.l

Dublin Academic Biotechnology Survey

Questionnaires were sent out online, to all 38 members of the database created to represent
Dublin academia engaged in biotech research. There were 13 respondents to the Dublin
academic biotech survey, a response rate of 34%. 7 of the respondents are in Trinity
College Dublin, 4 in University College Dublin and the hnal 2 respondents are based in
Dublin Institute of Technology and Dublin City University.
In question 2 respondents were asked to provide an estimate of the number of researchers
in their department/centre. The average number of researchers per department in Dublin
is 73.
Figure F.l shows the helds within which respondents are conducting research. In many
instances respondents had been researching in more than one of the sectors. Therefore,
total number of responses was aggregated and the percentages reported in Figure F.l
result from dividing the number of responses for individual sectors by the total number of
responses for all sectors. The largest areas of interest to this sample of researchers from
Dublin are the pharmaceutical and the healthcare therapeutics sector’s.
Questions 4 and 11 in the acadc

c surveys are linked. They aim to assess the level of
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Figure F.l; Sectors of Research Actively Being Pursued by Dublin Academics
□ Agrifood Industry

Agrifood Industry, 0%
None of the Above, 21%

Healthcare Therapeutics, 20%

I Healthcare Therapeutics

□ Healthcare Diagnostics

□ Pharmaceutical

I Pharmaceutical Services
Healthcare Diagnostics, 11%

Bio-Informatics, 11%

□ Medical Devices

I Bio-Environmental
Bio-Environmental, 11

Medical Devices, 5%

□ Bio-Informatics
Pharmaceutical, 21%
I None of the Above

Pharmaceutical Services, 0%

contact between academia and biotechnology hrms with regard to the skills they require
graduates to possess, furthermore if such dialogue is creating employment gateways for
graduates into firms within that locality. Results indicate that there is dialogue between
academia and industry (Q4). 5 respondents indicate that dialogue occurred with regard to
future skills required, 8 respondents felt there was no interaction between their academic
department and industry. 9 of the 13 respondents to Qll indicated that graduates from
their department are now working in biotech/pharma industry in Dublin.
In question 5 an attempt is made to discover in what areas of knowledge and skills
transfer, does academia have linkages to hrms in Industry. 5 respondents indicated that
their department has links with local biotech/pharma companies in the area of consul
tancy/funded research. 4 respondents indicated linkages in personal research, 3 indicated
a training linkage and 1 respondent reported linkage in analytical services. 5 respondents
felt there was no linkage between their academic departments and local industry, on any
of the variables mentioned.
Question 6 was included to assess what options researchers would take in the event of
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Table F.l: Coirirnercdalising a new discovery - favoured options of Dublin acadeniics

Description
Collaborate with yonr University/Institute
Patent and License Out
Commercialise with an Industry Partner
Patent and Commercialise Discovery Yourself
Patent and Sell the Patent

Result
3.77
3.62
3.23
2.31
2.23

their discovering a new technology, product or process. This question was included on the
request of Rosemary Durcan, of IBIA. The question is answered in the form of a Likert
scale, as used previously in the work of Lublinski (2002). The Likert scale is a rating
scale ranging from 1 = not likely to 6 == extremely likely. Average results for the various
options can be seen in Table F.l.
Questions 7 and 8 assess academics perceptions on availability and source of research
funding. All 13 respondents found funding more accessible in the past two year period.
SFI received the most frequent mention being indicated by 12 out of the 13 respondents.
One respondent felt that PRTLI were the main supporters of research.
Questions 9, 10 and 12 explored the extent of contact and face to face meetings between
academia and engaged in biotechnology. Question 9 results indicate that 7 respondents
have personal contacts in 1 to 3 biotech/pharma companies, 1 respondent has personal
contacts in 4 to 6 biotech/pharma companies, 1 respondent has contacts in more than 6
biotech/pharma companies. 4 respondents reported that they have no personal contacts
in biotech/pharma companies.
Question 10 addresses frequency of social and business contact that respondents have
had with employees of biotechnology firms in Dublin. Results for the 13 respondents are
presented in Table F.2. More respondents report business meetings with employees of
firms involved in the industry, than the number of respondents who do not.
Question 12 addresses the amount of social and business contact that respondents have
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Tabic F.2: Dublin academics meetings with employees of biotech companies
Timeline
In the Past Week
In the Past Month
In the Past 3 Months
More than 3 Months ago
No Contact

Social Context
2
4
1
0
5

Business Context
2
4
2
1
4

Table F.3: Dublin academics meetings with graduates working in biotech firms
Timeline
In the Past Month
In the Past 3 Months
More than 3 Months ago
No Contact

Social Context
2
4
2
5

Business Context
1
3
4
4

had with graduates of their institutions, who are now employees of biotechnology hrms.
Results for the 13 respondents are presented in Table F.3. More respondents have social
contact with former graduates who are now employees of firms involved in the industry,
than the number of respondents who do not.
Question 13 is an open question, asking how co-operation between academia and industry
within the Dublin region might be enhanced. Responses to this question were varied out of
the 7 responses to this question, 4 respondents felt that regular adequately funded show
cases of academic research to industry would be a way of enhancing co-operation between
companies and academia. 1 respondent felt that companies should be more aware of the
potential within the universities, whilst another felt that multinational companies should
be encouraged “to do research in Ireland and to do at least some of this in collaboration
with academics in Ireland”. Finally one respondent feels that a “direct approach by an
individual in a company to individual academic” would be the best way of enhancing
co-operation between academia and industry.
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Table F.4: Profile of Respondents to Dublin Conipany Survey (Ql)

Companies Principal Product/Service
Drug Delivery Technology
Drug Development
Robotic Instrumentation
Product Development
IFitent Advice Services
Pharmaceutical Aledicines
Pharmaceutical Manufacturing
Pharmaceutical Manufacturer
Patent/Trade Mark Services
Idiarrna Moldings and Assemblies
Research Drug Delivery
Venture Capital
Chemical Technological Services
Medical Devices
Pharmaceutical
Medical Equipment
Bio-Processing Services
Fluid and Motion Control
Business Development Consultancy
Scientific Data Management
Diagnostics
Laboratory Equipment
Investment Bio-Sciences
Bulk Pharma Intermediates

F.2

Position in Company
Managing Director
Chief Executive Ofheer
Strategic Manager
Eounder
Partner
Managing Director
QTS Manager
Snr. ManagmentDirector
Marketing Manager
Director
Associate
Managing Director
Director
Managing Director
Operat ions Manager
General Manager
Sales Manager
Principal
Chief Executive Officer
Commercial Director
Director
Executive Chairman
Plant Manager

Dublin Company Biotechnology Survey

Questionnaires were sent out online, to all 114 persons on the database created to represent
Dublin biotechnology companies. There were 28 respondents to the Dublin company
biotech survey, a response rate of 25%. Results for Question 1 are in Table F.4.
Question 2 distinguishes between multinational and indigenous firms; 14 multinational
firms and 14 indigenous hrms responded to the survey.
Question 3 asked respondents in what sector their company conducts its main business.
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Figure F.2: Business Sectors Pursued by Dublin Company Respondents
□ Main Business

I R&d Phase

□ Products on Sale in Market

No of Respondents

Agnfood Industry

Healthcare
Therapeutics

Healthcare
Diagnostics

Pharmaceutical

Pharmaceutical
Services

Medical Devices

BioEnvironmental

Bio-Informatics

None of the
Above

Industrial Sectors

in which sectors they do R+D, and hnally the sector in which they have products on the
market. Results can be seen in Figure F.2.
Question 4 related to turnover and R&D as a % of turnover. 13 of the 28 hrms reported
their turnover, with hve respondents reporting a turnover of €5 million or over, five
respondents reported a turnover hgure of between €1 million and €5 million. Three
respondents reported turnover figures less than €1 million. Fourteen respondents reported
a hgure for R&D as a % of turnover; two respondents reported 0%, six respondents
reported hgures less than or equal to 5%, one respondent indicated a hgure between 5%
and 10% and hve respondents reported hgures greater than 10%.
Questions 5 and 6 relate to the destination of sales and the sources of raw materials or
inputs. Average percentages for the 15 respondents to these questions are in Table F.5.
Question 7 asks what factors are important in leading biotech companies to locate in
county Dublin. All 28 respondents to the questionnaire answered this question, results
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Table F.5: Destination of sales and origin of inputs for Dublin respondents
% of Sales

Market

Dublin
Rest of Ireland
Rest of Europe
Rest of the World

23.8%
17.8%

% of Raw Materials
32.4%
8.2%

35.7%

25.9%
23.0%

19.0%

Figure F.3; Ranking of Importance Factors that lead Companies to choose a Dublin
Location

Airport

Harbour

Institutions Workforce
Factors

Market

Agencis

can be seen in Figure F.3. The results can be interpreted in the following manner, e.g
for the factor ‘Similar Companies in the Area’, one respondent felt this was the most
important factor, five respondents gave a number 2 rating, six gave a number 3 rating,
with three respondents each indicating a number 4 and two respondents giving a number
5 response. It is apparent (Figure F.3) ‘Highly Skilled Workforce’ is the main reason
respondents felt biotech companies choose to locate in Dublin, with ‘Close to 3rd Level
Institutions’ viewed as the second most important factor.
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Question 8 asked how many business customers, suppliers and competitors each respon
dent has in Dublin. For the 14 respondents to this question the average answers for
each entity were: 12 Business Customers, 13 Suppliers and 2 Competitors within County
Dublin.
Question 9 sought information on total employment and also the numbers of R&D em
ployees within the respondent company in county Dublin. The averages for the these two
variables for 24 respondents to this question were as follows, 52 employees per unit with
3 R and D employees per unit.
Question 10 was answered by 14 respondents. It relates to the source of new recruits to the
company. On average 42 % of employees were recruited from other Dublin companies in
similar industries and 26 % were recruited straight from third level institutions in Dublin.
Question 11 asked about the frequency with which company employees may be recruited
by other companies. Respondents were asked to answer on a Likert scale from 1-6, where
1 represents very infrequent, and 6 represents quite frequent. Average results for 22
respondents across the variables, by Dublin based companies (3.18), by Irish companies
(3.27) and hnally by companies abroad (2.18), These averages indicate that respondent
company employees are mostly recruited by other Irish companies.
Question 12 asked what skills respondents felt their companies would need to supplement
through recruitment if their Dublin operation were to expand. 6 respondents felt business
development needed to be supplemented, 1 respondent felt clinical function would need
to be expanded, 2 were of the opinion that engineering would be supplemented, 3 respon
dents were of the opinion that the legal / IP function should be enlarged, 1 respondent
felt the marketing function should be expanded, 6 respondents felt that manufacturing
skills would be supplemented, 2 respondents felt the research / scientific function would
be supplemented through recruitment and 3 respondents felt Other functions should be
expanded, namely ‘Quality’, ‘Finance’ and ‘R&D’. 24 respondents answered this question,
respondents indicated that recruitment would be necessary in all categories included.
Question 13 is related to 12. Question 13 asked “Regarding skills you would need to
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Tabic F.6: Likelihood that company respondents could recruit skills in comity Dublin

Skill Type
Business Development
Marketing
Research / Scientihe
Clinical
Engineering
Legal/IP
Manul'acturing
Other

Average Result
4.4
4.2
3.9
3.5
3.4
3.4
3.2
2.3

Table F.7: Dublin Linkage between Industry and Academic Institutions

Institution
University College Dublin
Dublin City University
Trinity College Dublin
Dublin Institute of Technology
NUl Maynooth
Royal College of Surgeons
National Food Centre
Other Dublin Based

Training
0
0
0
1
1
0
0
0

R&D
5
2
4
2
2
3
1
1

Employment
5
7
3
2
1
2
0
1

Course Content
1
0
0
0
1
1
0
0

recruit (Q12), please indicate the likelihood that you would manage to source these skills
within county Dublin, on a scale of 1 = most unlikely to 6 = highly likely.” Answers
for this question were averaged with the divisor being the number of respondents who
answered that particular variable. Results (shown in Table F.6) indicate that it would
be easier to identify research/scientihe, marketing and business development staff within
Dublin.
Section 2 of the survey “Academic Linkage, Collaboration, Innovation and Policy”, begins
with question 14, which asks in which activities do companies have linkages with academic
institutions in county Dublin. Results are reported in table F.7
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Table F.8: Dublin industry respondents levels of collaboration

Variable
Shared Technology
Licensing Arrangements
Research and Development
Training
Marketing/Sales/Distribution
Sub Contracting of Manufacturing
Other Joint Ventures

Current
Collaboration
Question 15
Yes
No
0
16
4
14
5
10
2
13
6
9
11
3
4
10

Potential
Collaboration
Question 16
Potential
9
10
12
1
6
4
2

Questions 15 and 16 address the level of collaboration between companies in county
Dublin, and also in which area companies feel there could be potential collaboration.
Results presented in Table F.8 show that the majority of collaboration (Q15) takes place
in marketing/sales/distribution (6) and also in research and development (5), followed
by licensing arrangements (4). There is collaboration across all variables except shared
technology prompted in Table F.8. The ‘Potential’ column relates to the numbers of
respondents who feel there is room for collaboration under specified headings; R and D
(12), licensing arrangements (10) and shared technology (9) are the top areas for potential
collaboration.
Question 17 asks what respondents view as significant barriers to joint collaboration. This
question is also linked to questions 15 and 16. 13 respondents felt that the availability of
suitable partners was a significant barrier to collaboration, 9 respondents indicated avail
ability of capital, 8 respondents indicated government support, 5 respondents believed
commercial confidentiality was a significant barrier, while 4 respondents indicated avail
ability of qualified personnel. 3 respondents felt that ‘Head office support’, ‘Ip ownership
issues’ and ‘Knowledge of market’ were also significant barriers to collaboration.
Question 18 is an open question asking, if there is one thing that could be done to enhance
co-operation between companies in Dublin, what would it be? 13 respondents answered
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this question, there answers are:

• Better forum for shared information and better support from local government agen
cies. Some trade associations run by IBEC are quite informative.
• Lack of incubator or start-up facilities
• Replace Medialab closure with a similar body for life sciences!
• Government incentives
• As a VC fund we invest in early stage companies which are spin-ins or spin-outs
of Irish third level education institutions. As such, we actively seek suitable man
agement to join the company to provide it with the commercial expertise to get its
business off the ground (a large percentage of company founders are from academia).
Hence, from a VC perspective, increased communication between universities and
the ‘commercial world’ is key to these early stage companies achieving their poten
tial.
• Co-ordination of effort in marketing, branding etc.
• More companies!
• Availability of skillful workforce
• Government Support
• Development of knowledge of EU markets
• More opportunities to work together e.g. new investments
• Chamber of Commerce facilitate regular technology focused networking events
• Establishment of Technology Centre of Excellence Clarification of IP Issues Gov
ernment Incentives for Companies to collaborate (together or with 3rd level)
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In question 19, respondents were asked what significance do customers, suppliers, com
petitors and academic institutions within Dublin have as a source of knowledge for their
product development. Answers were again on a Likert scale basis from 1-6, where 1 =
low significance and 6 == high significance. A “Not applicable” column is also included
(N/A)L Answers for this question were averaged with the divisor being the number of
respondents who answered that particular variable. Business customers in Dublin (2.44),
suppliers in Dublin (2.00) and competitors in Dublin (1.44) were rated as having low sig
nificance, while academic institutions in Dublin scored an average figure of 3.89, indicating
that academic institutions in Dublin have some significance as a source of knowledge for
product development.
Question 20, using the Likert scale format, asks respondents how important are trust and
face-to-face contact to the foundation of an effective business relationship. Respondents
were asked to rate the factors on a scale of 1 = Not Important to 6 = Very Important.
20 respondents answered this question, with Trust recording an average result of 5.45,
and Face-to-face contact 5.15. Both factors are viewed as important in the foundation of
business relationships.
Question 21 is another Likert scale type question. It asks respondents to rate the level
of support that they receive from a number of different organisations, on a scale of 1 6, where 1 = Little support and 6 = Large support. A Not applicable (N/A) column is
included^. Average results can be seen in table F.9. The Irish Bioindustry Association
(3.24), Enterprise Ireland (3.22) and Science Foundation Ireland (2.31) are viewed as the
organisations whom give greatest support to Dublin respondent companies.
Question 22 is an open question, in which respondents are asked how could policy be
enhanced to help their operations. Answers to this question were varied. Suggestions
include:

‘Get people ‘from’ the cold face of business into the committees and decision bodies
Tf N/A is the selected answer for a i)articular variable, that variable receives a 0 as its result, therefore
all responses are taken into account
The N/A column is calculated as per question 19
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Table F.9: Level of support received by Dublin industry respondents
Organisation
Irish Bioindustry Association
Enterprise Ireland
Other Trade Associations
Science Foundation Ireland
Irish Development Authority
National Government
Other Governments Agencies
Chamber of Commerce
Local Government

Average Result
3.24
3.22
2.41
2.31
2.06
1.88
1.50
1.47
1.06

of state agencies.”
• “Make R&D incentives substantial.”
• “Enterprise Ireland is being increasing recognised at first port of call for many
entrepreneurs seeking to commercialise their technology/product. Improved and
continued support from El is key to the Irish ventures capital community.”
• “Joint marketing of Irish life sciences service companies”
• “Less unnecessary regulations from the government”
• “Overall support for small industries is good. Facilities for supporting companies
who are are burdened with product liability insurance premiums for EU markets is
required”
• “Continued focus on development of the biopharma sector and in particular the
encouragement of R&D in bioprocessing/biopharma within Ireland.”
• “Provide financial incentives to attract investors to high risk technology”
• “1. Enhance R&D tax credits to a volume based incentive. 2. Easier access to
R&D grant aid - more pro-active support from the state agencies (IDA, El) 3.
Government supports to promote industry sponsored R&D activities through the
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academic institutions, via PhD &/or Post-Doc studies 4. Establishment of code of
practice on IP issues for collaborative research (in progress) 5. Improved interface
between industry, the state agencies (SFI, ICSTI, PRTLI, etc.) and the academic
institutions regarding the nature of R&D activities being targeted / required by
each area and to provide an enhanced platform for knowledge sharing.”
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G.l

Galway Academic Biotechnology Survey

Questionnaires were sent out online, to all 48 members of the database created to represent
Galway academia engaged in biotech research. There were 14 respondents to the Galway
academic biotech survey, a response rate of 29%. 12 of the respondents are in National
University of Ireland Galway (NUIG), the final 2 respondents are based in Galway/Mayo
Institute of Technology (GMIT).
In question 2 respondents were asked to provide an estimate of the number of researchers
in their department/centre. The average number of researchers per department in Galway
is 55.
Figure G.l shows the helds within which respondents are conducting research. In many
instances respondents had been researching in more than one of the sectors. Therefore,
total number of responses was aggregated and the percentages reported in Figure G.l
result from dividing the number of responses for individual sectors by the total number
of responses for all sectors. The largest areas of interest to this population of respondents
from Galway are the healthcare therapeutics and the bio-environmental sectors.
Questions 4 and 11 in the academic surveys are linked. They aim to assess the level of
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Figure G.l: Sectors of Research Actively Being Pursued by Galway Academics
□ Agrifood Industry

I Healthcare Therapeutics
None of the Above, 8%

Agrifood Industry, 11%

Bio-Informatics, 5%
□ Healthcare Diagnostics

□ Pharmaceutical
Healthcare Therapeutics, 23%

Bio-Environmental. 18%

I Pharmaceutical Services

□ Medical Devices

Medical Devices, 5%
I Bio-Environmental
Pharmaceutical Services, 3%
Pharmaceutical, 11%

Healthcare Diagnostics, 16%
□ Bio-Informatics

I None of the Above

contact between academia and biotechnology firms with regard to the skills they require
graduates to possess, furthermore if such dialogue is creating employment gateways for
graduates into hrms within that locality. Results indicate that there is dialogue between
academia and industry (Q4). 10 respondents indicate that dialogue occurred with regard
to future skills required, 3 respondents felt there was no interaction between their academic
department and industry, and 1 respondent was unaware of any dialogue. 12 of the 14
respondents to Qll indicated that graduates from their department are now working in
biotech/pharma industry in Galway.
In question 5 an attempt is made to discover in what areas of knowledge and skills
transfer, does academia have linkages to hrms in industry. 6 respondents indicated that
their department has links with local biotech/pharma companies in the area of consul
tancy/funded research. 4 respondents indicated linkages in both personal research, and
analytical services. 5 indicated a training linkage and 2 respondents felt there was no
linkage between their academic departments and local industry, on any of the variables
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Table G.l: Comiricrcialising a new discovery - favoured options of Galway academics

Description
Collaborate with your University/Institute
Patent and License Out
Coininerciahse with an Industry Partner
Patent and Sell the Patent
Patent and Commercialise Discovery Yourself

Result
3.85
3.28
3.08
2.92
1.00

mentioned.
Question 6 was included to assess what options researchers would take in the event of
their discovering a new technology, product or process. This question was included on the
request of Rosemary Durcan, of IBIA. The question is answered in the form of a Likert
scale, as used previously in the work of Lublinski (2002). The Likert scale is a rating
scale ranging from 1 = not likely to 6 = extremely likely. Average results for the various
options can be seen in Table G.l.
Questions 7 and 8 academics perceptions on availability and source of research funding.
4 of the 13 respondents found funding to be more accessible in the past two years, while
9 respondents felt funding was less accessible during that period.

Enterprise Ireland

received the most frequent mention being indicated by 6 respondents. PRTLI and SFI
were the main supporters of research in 3 instances, 2 respondents named their major
funding sources as both the PRTLI and SFI.
Questions 9, 10 and 12 explored the extent of contact and face to face meetings be
tween academia and firms engaged in biotechnology. Question 9 results indicate that 9
respondents have personal contacts in 1 to 3 biotech/pharma companies, 1 respondent
has personal contacts in 4 to 6 biotech/pharma companies, 2 respondents have contacts
in more than 6 biotech/pharma companies. 2 respondents reported that they have no
personal contacts in biotech/pharma companies.
Question 10 addresses frequency of social and business contact that respondents have
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Table G.2: Galway acadeiriics meetings with employees of biotecli companies

Timeline
In the Past Week
In the Past Month
In tlie Past 3 Months
More than 3 Months ago
No Contact

Social Context
1
1
3
3
0

Business Context
0
2
3
6
2

TaTle G.3: Galway academics meetings with graduates working in biotech firms

Timeline
In the Past. Month
In the Past 3 Months
More than 3 Months ago
No Contact

Social Context
2
1
1
5

Business Context
3
4
1
5

had with employees of biotechnology firms in Galway. Results for the 14 respondents
are presented in Table G.2. More respondents report social and business meetings with
employees of firms involved in the industry, than the number of respondents who do not.
Question 12 addresses the amount of social and business contact that respondents have
had with graduates of their institutions, who are now employees of biotechnology firms.
Results for the 14 respondents are presented in Table G.3. More respondents have business
contact with former graduates who are now employees of firms involved in the industry,
than the number of respondents who do not.
Question 13 is an open question, asking how co-operation between academia and in
dustry within the Galway region might be enhanced. Responses to this question were
varied, out of the 8 responses to this question, 4 respondents felt that regular contact
and forums between academic researchers and industry would be a way of enhancing co
operation between companies and academia. Other ideas to be proposed in responses were
as follows “The development of a larger technology transfer/industrial liaison office that
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Table G.4; Profile of respondents to Galway company survey (Ql)

Companies Principal Product/Service
Medical Devices
Medical Devices
Medical Devices
Interventional Guide Wires
Diagnostics
Agri Products
Medical Devices
Plastic Photochrornic Lens
Medical Tubing Gomponents
Food Ingredients
Medical Devices

Respondents Position in Company
Senior Manager
Vice President
Business Dev. Mgr.
General Manager
Ghairman
Sales Manager
Financial Director
Plant Director
General Manager
Managing Director
General Manager

could offer greater support in the area of IP development and management”, “Develop
ment of a good student placement system” and “Focused events at which research in our
group/department could be ‘show-cased’, events at which companies could present their
needs in terms of research/technical support and graduate skills base they require. Gollaboration with the university in the organisation of training programs/courses for company
staff. Greater participation in organised events, such as postgraduate recruitment fairs
and sponsorship of key events to increase a company’s prohle. More professional expe
rience placements for undergraduate students in companies, and greater collaboration in
R&D partnerships”.

G.2

Galway Company Biotechnology Survey

Questionnaires were sent out online, to all 23 persons on members of the database created
to represent Galway biotechnology companies. There were 11 respondents to the Galway
company biotech survey, a response rate of 48%. Results for Question 1 are in Table G.4.
Question 2 distinguishes between multinational and indigenous firms; 7 multinational
firms and 4 indigenous firms responded to the survey.
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Figure G.2: Business Sectors Pursued by Galway Gompany Respondents
Q Main Business ■ R&D Phase d Products on Sale in the Market

No of Responses

Agrifood Industry

Healthcare
Therapeutics

Healthcare
Diagnostics

Pharmaceutical

Pharmaceutical
Services

Medical Devices

BioEnvironmental

Bio-Informatics

None of the
Above

Industrial Sectors

Question 3 asked respondents in what sector their company conducts its main business,
in which sectors they do R+D, and finally the sector in which they have products on the
market. Results can be seen in Figure G.2.
Question 4 related to turnover and R&D as a % of turnover. 5 of the 11 hrms reported
their turnover, 3 respondents reporting a turnover of €5 million or over (two of these
three respondents reported a turnover hgure of over €100 million). Seven respondents
reported a figure for R&D as a % of turnover; hve respondents reported hgures less than
or equal to 5% and two respondents reported a figure greater than 10%.
Questions 5 and 6 relate to the destination of sales and the sources of raw materials or
inputs. Average percentages for the 15 respondents to these questions are in Table G.5.
Question 7 asks what factors are important in leading biotech companies to locate in
county Galway. All 11 respondents to the questionnaire answered this question, results can
be seen in Figure G.3. The results can be interpreted in the following manner, e.g for the
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Table G.5: Destination of sales and origin of inputs for Galway respondents
Market

Galway
Rest of Ireland
Rest of Europe
Rest of the World

% of Sales
8.0%
20.8%
40.0%
59.0%

% of Raw Materials
12.2%

28.8%
35.5%
54.6%

Figure G.3: Ranking of Importance Factors that lead Companies to choose a Galway
Location

i

■ Number 1's

I Number 2's

Number of Respondents

□ Number 3's

2

□ Number 4’s
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Access to
European
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Supportive
State
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factor ‘Similar Companies in the Area’, one respondent felt this was the most important
factor, no respondents gave a number 2 rating, three gave a number 3 rating, with two
respondents each indicating a number 4 rating and no respondents indicating a number 5
response. It is apparent (Figure G.3) ‘State Support’ is the main reason respondents felt
biotech companies choose to locate in Galway, with ‘Highly Skilled Workforce’ viewed as
the second most important factor.
Question 8 asked how many business customers, suppliers and competitors each respon-
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dent has in Galway.

For the 8 respondents to this question the average answers for

each entity were: 17 Business Customers, 7 Suppliers and 2 Competitors within County
Galway.
Question 9 sought information on total employment and also the numbers of R&D em
ployees within the respondent company in county Galway. The averages for the these two
variables for 9 respondents to this question were as follows, 599 employees per unit with
approx 33 R and D employees per unit.
Question 10 was answered by 9 respondents. It relates to the source of new recruits to the
company. On average 36 % of employees were recruited from other Galway companies in
similar industries and 14 % were recruited straight from third level institutions in Galway.
Question 11 asked about the frequency with which company employees may be recruited
by other companies. Respondents were asked to answer on a Likert scale from 1-6, where
I represents very infrequent, and 6 represents quite frequent. Average results for 8 respon
dents are: recruited by Galway based companies (3.25), by Irish companies (2.66) and
finally by companies abroad (3.00). These averages indicate that respondent company
employees are recruited by Galway companies more frequently than companies located
elsewhere in Ireland or abroad.
Question 12 asked what skills respondents felt their companies would need to supplement
through recruitment if their Galway operation were to expand. 1 respondents felt business
development needed to be supplemented, 1 respondent felt the clinical function should be
expanded, 1 was of the opinion that engineering would be supplemented, 1 respondent
felt that manufacturing skills would be supplemented and 4 respondents felt the research
/ scientific function would be supplemented through recruitment and 1 respondent felt
that engineering, manufacturing and quality functions should be expanded. 9 out of the
II respondents answered this question. No respondent indicated that recruitment would
be necessary of skills in the legal/IP or marketing categories.
Question 13 is related to 12. Question 13 asked ’’Regarding skills you would need to
recruit (Q12), please indicate the likelihood that you would manage to source these skills
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Tabic G.6: Likelihood that coinpany respondents could recruit skills in county Galway

Skill Type
Legal/IP
Engineering
Research / Scientific
Manufacturing
Marketing
Business Development
Clinical
Other

Average Result
3.8
3.5
3.3
3.2
3.0
2.3
1.8
1.0

Table G.7: Galway Linkage between Industry and Academic Institutions

Institution
Galway/Mayo Institute
National University Galway
Other Galway Based

Training
2
1
2

R&D
1
5
0

Employment
0
0
1

Course Content
2
1
0

within county Galway, on a scale of 1 = most unlikely to 6 = highly likely.” Answers
for this question were averaged with the divisor being the number of respondents who
answered that particular variable. Results (shown in Table G.6) indicate that it would be
more difficult to locate clinical, business development and marketing staff within Galway,
as opposed to other functions.
Section 2 of the survey “Academic Linkage, Gollaboration, Innovation and Policy”, begins
with question 14, which asks in which activities do companies have linkages with academic
institutions in county Galway. Results are reported in table G.7
Question 15 and 16 address the level of collaboration between companies in county Galway,
and also in which area companies feel there could be potential collaboration. Results
presented in Table G.8 show that the majority of collaboration (Q15) takes place in sub
contracting of manufacture (5), training initiatives (4) and research and development (4),
followed by shared technology (3). The ‘Potential’ column relates to the numbers of
207

APPENDIX G. GALWAY SUHVEY FINDINGS

Table G.8: Galway industry respondents levels of collaboration

Variable
Shared Technology
Licensing Arrangements
Research and Development
Training
Marketing/Sales/Distribution
Sub Contract ing of Manufacturing
Other Joint Ventures

Current
Collaboration
Question 15
Yes
No
4
3
2
4
4
3
4
3
2
3
3
5
0
6

Potential
Collaboration
Question 16
Potential
3
2
8
4
4
4
0

respondents who feel there is room for collaboration under specified headings; R and D
(8), marketing/sales/distribution (4) and sub contracting of manufacture (4) are the top
areas for potential collaboration in Galway.
Question 17 asks what respondents view as significant barriers to joint collaboration. This
question is also linked to questions 15 and 16. 9 respondents answered this question, 3
felt that the availability of suitable partners was the most significant barrier to collabo
ration, 4 respondents indicated that the availability of capital was a significant barrier, 2
respondents indicated government support, 5 respondents believed commercial confiden
tiality was a significant barrier, while 1 respondents indicated that Irish attitudes are a
signihcant barrier to collaboration.
Question 18 is an open question asking, if there is one thing that could be done to enhance
co-operation between companies in Galway, what would it be? 7 respondents answered
this question, 2 of these indicated that more active networking possibilities and linkage
opportunities need to be encouraged. Other respondents indicated they would like to see
“other companies of a similar nature to their company based in Galway” and “uniformity
of salaries”. One respondent felt that there is “still a sense of caution to a certain amount
of begrudgery between some Irish companies”.
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In question 19, respondents were asked what significance do customers, suppliers, com
petitors and academic institutions within Galway have as a source of knowledge for their
product development. Answers were again on a Likert scale basis from 1-6, where 1 = low
significance and 6 = high significance. A “Not applicable” column is also included (N/A)L
Answers for this question were averaged with the divisor being the number of respondents
who answered that particular variable. Business customers in Galway (1.89), suppliers in
Galway (2.44) and competitors in Galway (2.79) were rated as having low significance,
while academic institutions in Galway scored an average figure of 3.56, indicating that aca
demic institutions in Galway have more significance as a source of knowledge for product
development.
Question 20, using the Likert scale format, asks respondents how important are trust and
face-to-face contact to the foundation of an effective business relationship. Respondents
were asked to rate the factors on a scale of 1 = Not Important to 6 = Very Important.
13 respondents answered this question, with Trust recording an average result of 5.44,
and Face-to-face contact 5.22. Both factors are viewed as important in the foundation of
business relationships.
Question 21 is another Likert scale type question. It asks respondents to rate the level
of support that they receive from a number of different organisations, on a scale of 1 6, where 1 = Little support and 6 = Large support. A Not applicable (N/A) column
is included^.

Average results can be seen in table G.9.

The IDA (4.00), Enterprise

Ireland (3.78) and Chamber of Commerce (2.67) are viewed as the organisations whom
give greatest support to Galway respondent companies.
Question 22 is an open question, in which respondents are asked how could policy be
enhanced to help their operations. Answers to this question were varied. Suggestions
include:

• “Increased Tax incentives for R&D”
Rf N/A is the selected answer for a particular variable, that variable receives a 0 as its result, therefore
all responses are taken into account
“The N/A column is calculated as per question 19
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Table G.9: Galway respondents levels of Support Reeeived from Various Organisations

Organisation
Irish Development Authority
Enterprise Ireland
Chamber of Commerce
Other Trade Associations
National Government
Other Government Agencies
Science Foundation Ireland
Local Goverriment
Irish Bioindustry Association

Average Result
4.00
3.78
2.67
2.22
1.89
1.78
1.78
1.33
1.22

• “Allow more work permits for non EU nationals to work in Ireland. We need work
permits for Indian people who have pharmaceutical experience.”
• “To somehow develop policy that truly understands the needs and limitations of
start-up biotech companies and actively encourage a dialogue between aedemia/government/start
up biotech’s.”
• “Make it cheaper to employ people, better tax relief for child care”
• “The new ERG (Enterprise Research) that is being talked about could help stimulate
collaboration between like minded companies when there is a visible support from
academic institutions.”
• “Grant aid available in the form of headcount beised grants for an operation like
ours, does not provide much support hnancially when compared to the investment
an organisation must make. Main emphasis is on R&D grants and while these are
good, many start-ups cannot avail of them off the blocks”
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Appendix H
E-mail Request
Dear [FirstName] [LastName],
My name is John Hobbs. I’m currently undertaking a Research Masters in Business Stud
ies in Cork Institute of Technology. My research looks at the Biotechnology/Pharmaceutical
Industry from a business cluster perspective. The aim of the study is to discover;

1. If there are business benefits for companies which locate in close proximity to
companies in the same sector.

2.

The nature of linkages between Biotechnol

ogy/Pharmaceutical companies, and between such companies and Academic/Research
Institutions.
2. In order to analyse the Irish Biotechnology/Pharmaceutical Industry, 3 counties
have been selected: Dublin Cork and Galway. Within these areas, concentrations of
activity and characteristics connected with the cluster concept are being assessed.
Your co-operation in answering questions in the survey will greatly contribute to
the research.

I would appreciate it if you could take the time to fill out the questionnaire. You can
open the survey by clicking the following link: [SurveyLink]
You may enter your responses to the questionnaire by clicking the cursor (and in a few
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questions, typing your answer in the space provided). When you are finished just click
“Done” and your results will be sent to the secure survey database.
If you feel that another person in your company is more suited to answer the survey,
would you please forward this e-mail to him/her.
The results will be reported in my thesis solely on an aggregated basis. I can give you
absolute assurance that individual answers you provide will not be disclosed or reported.
If you have any apprehension or questions before responding to this survey please feel free
to contact me on:
E-mail: jhobbs@cit.ie
Results of the study can be obtained through individual requests to the above e-mail
address. As a way of saying thank you, the names of those who complete the questionnaire
will be entered into a draw for 2 nights B&B for 2 persons in the Great Southern Hotel,
Killarney, during April/May.
Many thanks for your time and co-operation.
John Hobbs; Department of Management and Marketing. Cork Institute of Technology.
Endorsed by: Michael Delaney Head of Development. Cork Institute of Technology
E-mail: mdelaney@cit.ie
Please note: If you do not wish to receive further emails from us, please click the link
below, and you will be automatically removed from our mailing list. [RemoveLink]
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